{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 22088, "items": [{"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T07:03:41Z", "timestamp": 1574838221131}, "reference-count": 110, "publisher": "Springer Science and Business Media LLC", "issue": "1", "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["cerebellum ataxias"], "published-print": {"date-parts": [[2017, 12]]}, "DOI": "10.1186/s40673-017-0073-7", "type": "journal-article", "created": {"date-parts": [[2017, 9, 21]], "date-time": "2017-09-21T12:09:45Z", "timestamp": 1505995785000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Immune-mediated cerebellar ataxias: from bench to bedside"], "prefix": "10.1186", "volume": "4", "author": [{"given": "Hiroshi", "family": "Mitoma", "sequence": "first", "affiliation": []}, {"given": "Mario", "family": "Manto", "sequence": "additional", "affiliation": []}, {"given": "Christiane S.", "family": "Hampe", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2017, 9, 21]]}, "reference": [{"key": "73_CR1", "doi-asserted-by": "crossref", "first-page": "94", "DOI": "10.1111/nyas.12553", "volume": "1338", "author": "F Leypoldt", "year": "2015", "unstructured": "Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies. Ann N Y Acad Sci. 2015;1338:94\u2013114.", "journal-title": "Ann N Y Acad Sci"}, {"key": "73_CR2", "doi-asserted-by": "crossref", "first-page": "2313", "DOI": "10.1007/s12311-015-0664-x", "volume": "15", "author": "H Mitoma", "year": "2016", "unstructured": "Mitoma H, Adhikari K, Aeschlimann D, Chattopadhyay P, Hadjivassiliou M, Hampe CS, et al. Consensus Paper: Neuroimmune mechanisms of cerebellar ataxias. Cerebellum. 2016;15:2313\u201332.", "journal-title": "Cerebellum"}, {"key": "73_CR3", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1016/B978-0-444-51892-7.00011-5", "volume": "103", "author": "M Hadjivassiliou", "year": "2012", "unstructured": "Hadjivassiliou M. Immune-mediated acquired ataxias. Handb Clin Neurol. 2012;103:189\u201399.", "journal-title": "Handb Clin Neurol"}, {"key": "73_CR4", "doi-asserted-by": "crossref", "first-page": "1135", "DOI": "10.1136/jnnp.2003.034447", "volume": "75", "author": "F Graus", "year": "2004", "unstructured": "Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135\u201340.", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "73_CR5", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1016/S1474-4422(08)70060-7", "volume": "7", "author": "J Dalmau", "year": "2008", "unstructured": "Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol. 2008;7:327\u201340.", "journal-title": "Lancet Neurol"}, {"key": "73_CR6", "doi-asserted-by": "crossref", "first-page": "731", "DOI": "10.1111/ene.12368", "volume": "21", "author": "F Ducray", "year": "2014", "unstructured": "Ducray F, Demarquay G, Graus F, Decullier E, Antoine J-C, Giometto B, et al. Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experience. Eur J Neurol. 2014;21:731\u20135.", "journal-title": "Eur J Neurol"}, {"key": "73_CR7", "unstructured": "Jarius S, Wildemann B. \u2018Medusa-head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII. J Neuroinflammation 2015: doi: 10.1186/s12974-015-0356-y .", "DOI": "10.1186/s12974-015-0356-y", "doi-asserted-by": "publisher"}, {"key": "73_CR8", "unstructured": "Jarius S, Wildemann B. \u2018Medusa-head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC. J Neuroinflammation. 2015; doi: 10.1186/s12974-015-0357-x .", "DOI": "10.1186/s12974-015-0357-x", "doi-asserted-by": "publisher"}, {"key": "73_CR9", "unstructured": "Jarius S, Wildemann B. \u2018Medusa-head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook. J Neuroinflammation. 2015; doi: 10.1186/s12974-015-0358-9 .", "DOI": "10.1186/s12974-015-0358-9", "doi-asserted-by": "publisher"}, {"key": "73_CR10", "doi-asserted-by": "crossref", "first-page": "1582", "DOI": "10.1016/S0140-6736(98)05342-2", "volume": "352", "author": "M Hadjivassiliou", "year": "1998", "unstructured": "Hadjivassiliou M, Gr\u00fcnewald RA, Chattopadhyay AK, Davies-Jones GA, Gibson A, Jarratt JA, et al. Clinical, radiological, neurophysiological and neuropathological characteristics of gluten ataxia. Lancet. 1998;352:1582\u20135.", "journal-title": "Lancet"}, {"key": "73_CR11", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1001/archneur.58.2.225", "volume": "58", "author": "J Honnorat", "year": "2001", "unstructured": "Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, Andres C, et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies. Study of 14 patients. Arch Neurol. 2001;58:225\u201330.", "journal-title": "Arch Neurol"}, {"key": "73_CR12", "doi-asserted-by": "crossref", "first-page": "1009", "DOI": "10.1001/jamaneurol.2014.1011", "volume": "71", "author": "H Ari\u0144o", "year": "2014", "unstructured": "Ari\u0144o H, Gresa-Arribas N, Blanco Y, Mart\u00ednez-Hern\u00e1ndez E, Sabater L, Petit-Pedrol M, et al. Cerebellar ataxia and glutamic acid decarboxylase antibodies. Immunologic profile and long-term effect of immunotherapy. JAMA Neurol. 2014;71:1009\u201316.", "journal-title": "JAMA Neurol"}, {"key": "73_CR13", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1136/jnnp-2016-314863", "volume": "88", "author": "M Hadjivassiliou", "year": "2017", "unstructured": "Hadjivassiliou M, Martindale J, Shanmugarajah P, Gr\u00fcnewald RA, Sarrigiannis PG, Beauchamp N, et al. Causes of progressive cerebellar ataxia: prospective evaluation of 1500 patients. J Neurol Neurosurg Psychiatry. 2017;88:301\u20139.", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "73_CR14", "unstructured": "Mitoma H, Hadjivassiliou M, Honnorat J. Guidelines for treatment of immune-mediated cerebellar ataxias. Cerebellum & Ataxias. 2015;2:14.doi: 10.1186/s40673-015-0034-y , 2015.", "DOI": "10.1186/s40673-015-0034-y", "doi-asserted-by": "publisher"}, {"key": "73_CR15", "doi-asserted-by": "crossref", "first-page": "364", "DOI": "10.1007/s12311-014-0634-8", "volume": "14", "author": "K Weier", "year": "2015", "unstructured": "Weier K, Banwell B, Cerasa A, Collins DL, Dogonowski AM, Lassmann H, et al. The role of the cerebellum in multiple sclerosis. Cerebellum. 2015;14:364\u201374.", "journal-title": "Cerebellum"}, {"key": "73_CR16", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1161/01.STR.0000196957.55928.ab", "volume": "37", "author": "JL Saver", "year": "2006", "unstructured": "Saver JL. Tine is brain\u2014quantified. Stroke. 2006;37:263\u20136.", "journal-title": "Stroke"}, {"key": "73_CR17", "doi-asserted-by": "crossref", "first-page": "380", "DOI": "10.1038/nrneurol.2012.99", "volume": "8", "author": "E Lancaster", "year": "2012", "unstructured": "Lancaster E, Dalmau J. Neuronal autoantigens-pathogenesis, associated disorders and antibody testing. Nat Rev Neurol. 2012;8:380\u201392.", "journal-title": "Nat Rev Neurol"}, {"key": "73_CR18", "doi-asserted-by": "crossref", "first-page": "1409", "DOI": "10.1093/brain/awg133", "volume": "126", "author": "S Shams\u2019ili", "year": "2003", "unstructured": "Shams\u2019ili S, Grefkens J, de Leeuw B, et al. Paraneoplastic cerebellar degeneration associated with antineur onal antibodies: analysisi of 50 patients. Brain. 2003;126:1409\u201318.", "journal-title": "Brain"}, {"key": "73_CR19", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1016/0303-8467(95)00006-6", "volume": "97", "author": "K Tanaka", "year": "1995", "unstructured": "Tanaka K, Tanaka M, Igarashi S, Onodera O, Miyatake T, Tsuji S. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice. Clin Neurol Neurosurg. 1995;97:101\u20135.", "journal-title": "Clin Neurol Neurosurg"}, {"key": "73_CR20", "doi-asserted-by": "crossref", "first-page": "1873", "DOI": "10.1212/WNL.45.10.1873", "volume": "45", "author": "PA Sillevis Smitt", "year": "1995", "unstructured": "Sillevis Smitt PA, Manley GT, Posner JB. Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice. Neurology. 1995;45:1873\u20138.", "journal-title": "Neurology"}, {"key": "73_CR21", "first-page": "2819", "volume": "4", "author": "AF Carpentier", "year": "1998", "unstructured": "Carpentier AF, Rosenfeld MR, Delattre JY, Whalen RG, Posner JB, Dalmau J. DNA vaccination with HuD inhibits growth of a neuroblastoma in mice. Clin Cancer Res. 1998;4:2819\u201324.", "journal-title": "Clin Cancer Res"}, {"key": "73_CR22", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1002/1531-8249(200001)47:1<9::AID-ANA5>3.0.CO;2-I", "volume": "47", "author": "ML Albert", "year": "2000", "unstructured": "Albert ML, Austin LM, Darnell RB. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol. 2000;47:9\u201317.", "journal-title": "Ann Neurol"}, {"key": "73_CR23", "doi-asserted-by": "crossref", "first-page": "162", "DOI": "10.1002/1531-8249(199902)45:2<162::AID-ANA5>3.0.CO;2-R", "volume": "45", "author": "B Benyahia", "year": "1999", "unstructured": "Benyahia B, Liblau R, Merle-Beral H, Tourani JM, Dalmau J, Delattre JY. Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. Ann Neurol. 1999;45:162\u20137.", "journal-title": "Ann Neurol"}, {"key": "73_CR24", "doi-asserted-by": "crossref", "first-page": "231", "DOI": "10.1007/s11060-004-1723-1", "volume": "71", "author": "A Rousseau", "year": "2005", "unstructured": "Rousseau A, Benyahia B, Dalmau J, et al. T cell response to Hu-D peptides in patients with anti-Hu syndrome. J Neuro-Oncol. 2005;71:231\u20136.", "journal-title": "J Neuro-Oncol"}, {"key": "73_CR25", "author": "N Gresa-Arribas", "volume": "10", "year": "2015", "unstructured": "Gresa-Arribas N, Ari\u0144o H, Mart\u00ednez-Hern\u00e1ndez F, Sabater L, Saiz A, Dalmau J, et al. Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity. PLoS One. 2015;10:e0121364.", "journal-title": "PLoS One", "DOI": "10.1371/journal.pone.0121364", "doi-asserted-by": "crossref"}, {"key": "73_CR26", "doi-asserted-by": "crossref", "first-page": "690", "DOI": "10.1001/archneur.1985.04060070084021", "volume": "42", "author": "LF Borges", "year": "1985", "unstructured": "Borges LF, Busis NA. Intraneuronal accumulation of myeloma proteins. Arch Neurol. 1985;42:690\u20135.", "journal-title": "Arch Neurol"}, {"key": "73_CR27", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1016/0022-510X(86)90150-4", "volume": "73", "author": "RH Fabian", "year": "1986", "unstructured": "Fabian RH, Ritchie TC. Intraneuronal IgG in the central nervous system. J Neurol Sci. 1986;73:257\u201367.", "journal-title": "J Neurol Sci"}, {"key": "73_CR28", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1016/0022-510X(90)90011-B", "volume": "100", "author": "PS Fishman", "year": "1990", "unstructured": "Fishman PS, Farrand DA, Kristt DA. Internalization of plasma proteins by cerebellar Purkinje cells. J Neurol Sci. 1990;100:43\u20139.", "journal-title": "J Neurol Sci"}, {"key": "73_CR29", "doi-asserted-by": "crossref", "first-page": "82", "DOI": "10.1016/0022-510X(91)90198-G", "volume": "106", "author": "F Graus", "year": "1991", "unstructured": "Graus F, Illa I, Agusti M, Ribalta T, Cruz-Sanchez F, Juarez C. Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model. J Neurol Sci. 1991;106:82\u20137.", "journal-title": "J Neurol Sci"}, {"key": "73_CR30", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1007/BF00309627", "volume": "89", "author": "JE Greenlee", "year": "1995", "unstructured": "Greenlee JE, Burns JB, Rose JW, Jaeckle KA, Clawson S. Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption. Acta Neuropathol. 1995;89:341\u20135.", "journal-title": "Acta Neuropathol"}, {"key": "73_CR31", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1186/1742-2094-6-31", "volume": "6", "author": "KE Hill", "year": "2009", "unstructured": "Hill KE, Clawson SA, Rose JW, Carlson NG, Greenlee JE. Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics. J Neuroinflammation. 2009;6:31.", "journal-title": "J Neuroinflammation"}, {"key": "73_CR32", "doi-asserted-by": "crossref", "first-page": "2087", "DOI": "10.1101/gad.13.16.2087", "volume": "13", "author": "HJ Okano", "year": "1999", "unstructured": "Okano HJ, Park WY, Corradi JP, Darnell RB. The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival. Genes Dev. 1999;13:2087\u201397.", "journal-title": "Genes Dev"}, {"key": "73_CR33", "doi-asserted-by": "crossref", "first-page": "529", "DOI": "10.1016/j.nbd.2003.11.003", "volume": "15", "author": "K Sakai", "year": "2004", "unstructured": "Sakai K, Kitagawa Y, Saiki S, Saiki M, Hirose G. Effect of a paraneoplastic cerebellar degeneration-associated neural protein on B-myb promoter activity. Neurobiol Dis. 2004;15:529\u201333.", "journal-title": "Neurobiol Dis"}, {"key": "73_CR34", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1016/S0016-5085(03)00664-4", "volume": "125", "author": "R Giorgio De", "year": "2003", "unstructured": "De Giorgio R, Bovara M, Barbara G, Canossa M, Sarnelli G, De Ponti F, et al. Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility. Gastroenterology. 2003;125:70\u20139.", "journal-title": "Gastroenterology"}, {"key": "73_CR35", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.1016/S1474-4422(15)00401-9", "volume": "15", "author": "F Graus", "year": "2016", "unstructured": "Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391\u2013404.", "journal-title": "Lancet Neurol"}, {"key": "73_CR36", "first-page": "449", "volume": "11", "author": "SR Irani", "year": "2011", "unstructured": "Irani SR, Vincent A. Autoimmune encephalitis-new awareness, challenging questions. Discov Med. 2011;11:449\u201358.", "journal-title": "Discov Med"}, {"key": "73_CR37", "doi-asserted-by": "crossref", "first-page": "776", "DOI": "10.1016/S1474-4422(10)70137-X", "volume": "9", "author": "M Lai", "year": "2010", "unstructured": "Lai M, Huibers MG, Lancaster E, Graus F, Bataller L, Balice-Gordon R, et al. Investigation of LG1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 2010;9:776\u201385.", "journal-title": "Lancet Neurol"}, {"key": "73_CR38", "doi-asserted-by": "crossref", "first-page": "2734", "DOI": "10.1093/brain/awq213", "volume": "133", "author": "SR Irani", "year": "2010", "unstructured": "Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, et al. Antibodies to Kv1 potassium channel complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia. Brain. 2010;133:2734\u201348.", "journal-title": "Brain"}, {"key": "73_CR39", "doi-asserted-by": "crossref", "first-page": "648", "DOI": "10.1126/science.8036512", "volume": "265", "author": "SW Rogers", "year": "1994", "unstructured": "Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cauley K, Crain B, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen\u2019s encephalitis. Science. 1994;265:648\u201351.", "journal-title": "Science"}, {"key": "73_CR40", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1002/ana.21050", "volume": "61", "author": "J Dalmau", "year": "2007", "unstructured": "Dalmau J, T\u00fcz\u00fcn E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25\u201336.", "journal-title": "Ann Neurol"}, {"key": "73_CR41", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1016/S1474-4422(09)70324-2", "volume": "9", "author": "E Lancaster", "year": "2010", "unstructured": "Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J, et al. Antibodies to GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010;9:67\u201376.", "journal-title": "Lancet Neurol"}, {"key": "73_CR42", "doi-asserted-by": "crossref", "first-page": "424", "DOI": "10.1002/ana.21589", "volume": "65", "author": "M Lai", "year": "2009", "unstructured": "Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009;65:424\u201334.", "journal-title": "Ann Neurol"}, {"key": "73_CR43", "doi-asserted-by": "crossref", "first-page": "1091", "DOI": "10.1016/S1474-4422(08)70224-2", "volume": "7", "author": "J Dalmau", "year": "2008", "unstructured": "Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effect of antibodies. Lancet Neurol. 2008;7:1091\u20138.", "journal-title": "Lancet Neurol"}, {"key": "73_CR44", "doi-asserted-by": "crossref", "first-page": "5866", "DOI": "10.1523/JNEUROSCI.0167-10.2010", "volume": "30", "author": "EG Hughes", "year": "2010", "unstructured": "Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci. 2010;30:5866\u201375.", "journal-title": "J Neurosci"}, {"key": "73_CR45", "doi-asserted-by": "crossref", "first-page": "755", "DOI": "10.1016/0896-6273(95)90219-8", "volume": "14", "author": "RE Twyman", "year": "1995", "unstructured": "Twyman RE, Gahring LC, Spiess J, Rogers SW. Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron. 1995;14:755\u201362.", "journal-title": "Neuron"}, {"key": "73_CR46", "doi-asserted-by": "crossref", "first-page": "2705", "DOI": "10.1073/pnas.0710771105", "volume": "105", "author": "YJ Liao", "year": "2008", "unstructured": "Liao YJ, Safa P, Chen YR, Sobel RA, Boyden ES, Tsien RW. Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo. Proc Natl Acad Sci U S A. 2008;105:2705\u201310.", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "73_CR47", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1056/NEJM200001063420104", "volume": "342", "author": "P Sillevis Smitt", "year": "2000", "unstructured": "Sillevis Smitt P, Kinoshita A, De Leeuw B, Moll W, Coesmans M, Jaarsma D, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med. 2000;342:21\u20137.", "journal-title": "N Engl J Med"}, {"key": "73_CR48", "doi-asserted-by": "crossref", "first-page": "869", "DOI": "10.1038/nn1086", "volume": "6", "author": "H Hirai", "year": "2003", "unstructured": "Hirai H, Launey T, Mikawa S, Torashima T, Yanagihara D, Kasaura T, et al. New role of delta2-glutamate receptors in AMPA receptor trafficking and cerebellar function. Nat Neurosci. 2003;6:869\u201376.", "journal-title": "Nat Neurosci"}, {"key": "73_CR49", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1002/1531-8249(199908)46:2<263::AID-ANA19>3.0.CO;2-0", "volume": "46", "author": "K Ishida", "year": "1999", "unstructured": "Ishida K, Mitoma H, Song SY, Uchihara T, Inaba A, Eguchi S, et al. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol. 1999;46:263\u20137.", "journal-title": "Ann Neurol"}, {"key": "73_CR50", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.1016/S0022-510X(00)00272-0", "volume": "175", "author": "H Mitoma", "year": "2000", "unstructured": "Mitoma H, Song SY, Ishida K, Yamakuni T, Kobayashi T, Mizusawa H. Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamic acid decarboxylase. J Neurol Sci. 2000;175:40\u20134.", "journal-title": "J Neurol Sci"}, {"key": "73_CR51", "doi-asserted-by": "crossref", "first-page": "386", "DOI": "10.1136/jnnp.70.3.386", "volume": "70", "author": "H Takenoshita", "year": "2001", "unstructured": "Takenoshita H, Shizuka-Ikeda M, Mitoma H, Song S, Hagiwara Y, Igeta Y, et al. Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia. J Neurol Neurosurg Psychiatry. 2001;70:386\u20139.", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "73_CR52", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1016/S0022-510X(02)00423-9", "volume": "208", "author": "H Mitoma", "year": "2003", "unstructured": "Mitoma H, Ishida K, Shizuka-Ikeda M, Mizusawa H. Dual impairment of GABAA- and GABAB-receptor-mediated synaptic responses by autoantibodies to glutamic acid decarboxylase. J Neurol Sci. 2003;208:51\u20136.", "journal-title": "J Neurol Sci"}, {"key": "73_CR53", "doi-asserted-by": "crossref", "first-page": "186", "DOI": "10.1016/j.jns.2008.04.019", "volume": "271", "author": "K Ishida", "year": "2008", "unstructured": "Ishida K, Mitoma H, Mizusawa H. Reversibility of cerebellar GABAergic synapse impairment induced by anti-glutamic acid decarboxylase autoantibodies. J Neurol Sci. 2008;271:186\u201390.", "journal-title": "J Neurol Sci"}, {"key": "73_CR54", "doi-asserted-by": "crossref", "first-page": "544", "DOI": "10.1002/ana.21123", "volume": "61", "author": "MU Manto", "year": "2007", "unstructured": "Manto MU, Laute MA, Aguera M, Rogemond V, Pandolfo M, Honnorat J. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol. 2007;61:544\u201351.", "journal-title": "Ann Neurol"}, {"key": "73_CR55", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1186/1750-1172-6-3", "volume": "6", "author": "MU Manto", "year": "2011", "unstructured": "Manto MU, Hampe CS, Rogemond V, Honnorat J. Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia. Orphanet J Rare Dis. 2011;6:3.", "journal-title": "Orphanet J Rare Dis."}, {"key": "73_CR56", "doi-asserted-by": "crossref", "first-page": "82", "DOI": "10.1186/1750-1172-8-82", "volume": "8", "author": "CS Hampe", "year": "2013", "unstructured": "Hampe CS, Petrosini L, De Bartolo P, Caporali P, Cutuli D, Laricchiuta D, et al. Monoclonal antibodies to 65kDa glutamate decarboxylase induce epitope specific effects on motor and cognitive functions in rats. Orphanet J Rare Dis. 2013;8:82.", "journal-title": "Orphanet J Rare Dis"}, {"key": "73_CR57", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.3389/fnbeh.2015.00078", "volume": "9", "author": "M Manto", "year": "2015", "unstructured": "Manto M, Honnorat J, Hampe CS, Guerra-Narbona R, L\u04e7pez-Ramos JC, Delgado-Garcia JM, et al. Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotransmission. Front Behav Neurosci. 2015;9:78.", "journal-title": "Front Behav Neurosci"}, {"key": "73_CR58", "doi-asserted-by": "crossref", "first-page": "2913297", "DOI": "10.1155/2017/2913297", "volume": "2017", "author": "H Mitoma", "year": "2017", "unstructured": "Mitoma H, Manto M, Hampe CS. Pathogenic roles of glutamic acid decarboxylase 65 autoantibodies in cerebellar ataxias. J Immunol Res. 2017;2017:2913297.", "journal-title": "J Immunol Res"}, {"key": "73_CR59", "doi-asserted-by": "crossref", "first-page": "194", "DOI": "10.1002/ana.410440209", "volume": "44", "author": "K Dinkel", "year": "1998", "unstructured": "Dinkel K, Meinck HM, Jury KM, Karges W, Richter W. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol. 1998;44:194\u2013201.", "journal-title": "Ann Neurol"}, {"key": "73_CR60", "doi-asserted-by": "crossref", "first-page": "e108774", "DOI": "10.1371/journal.pone.0108774", "volume": "9", "author": "T Ishikawa", "year": "2014", "unstructured": "Ishikawa T, Tomatsu S, Lee J, Hoffman DS, Kakei S. Releasing dentate nucleus cells from Purkinje cell inhibition generates output from the cerebrocerebellum. PLoS One. 2014;9:e108774.", "journal-title": "PLoS One"}, {"key": "73_CR61", "doi-asserted-by": "crossref", "first-page": "1275", "DOI": "10.1002/j.1460-2075.1991.tb08069.x", "volume": "10", "author": "A Reetz", "year": "1991", "unstructured": "Reetz A, Solimena M, Matteoli M, Folli F, Takei K, De Camilli P. GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion. The EMBO J. 1991;10:1275\u201384.", "journal-title": "The EMBO J"}, {"key": "73_CR62", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1083/jcb.118.2.309", "volume": "118", "author": "S Christgau", "year": "1992", "unstructured": "Christgau S, Aanstoot HJ, Schierbeck H, Begley K, Tullin S, Hejnaes K, et al. Membrane anchoring of the autoantigen GAD65 to microvesicles in pancreatic beta-cells by palmitoylation in the NH2-terminal domain. J Cell Biol. 1992;118:309\u201320.", "journal-title": "J Cell Biol"}, {"key": "73_CR63", "first-page": "75", "volume": "53", "author": "TB Purcell", "year": "2012", "unstructured": "Purcell TB, Sellers AD, Goehring LS. Presumed case of \u201cstiff-horse syndrome\u201d caused by decreased gamma-aminobutyric acid (GABA) production in an American Paint mare. Can Vet J. 2012;53:75\u20138.", "journal-title": "Can Vet J"}, {"key": "73_CR64", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1007/s00726-011-1091-z", "volume": "44", "author": "H Thomas", "year": "2013", "unstructured": "Thomas H, Beck K, Adamczyk M, Aeschlimann P, Langley M, Oita RC, et al. Transglutaminase 6: a protein associated with central nervous system development and motor function. Amino Acids. 2013;44:161\u201377.", "journal-title": "Amino Acids"}, {"key": "73_CR65", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1053/j.gastro.2007.04.070", "volume": "133", "author": "E Cervio", "year": "2007", "unstructured": "Cervio E, Volta U, Verri M, Boschi F, Pastoris O, Granito A, et al. Sera of patients with celiac disease and neurologic disorders evoke a mitochondrial-dependent apoptosis in vitro. Gastroenterology. 2007;133:195\u2013206.", "journal-title": "Gastroenterology"}, {"key": "73_CR66", "doi-asserted-by": "crossref", "first-page": "9698", "DOI": "10.1371/journal.pone.0009698", "volume": "5", "author": "S Boscolo", "year": "2010", "unstructured": "Boscolo S, Lorenzon A, Sblattero D, Florian F, Stebel M, Marzari R, et al. Anti transglutaminase antibodies cause ataxia in mice. PLoS One. 2010;5:9698.", "journal-title": "PLoS One"}, {"key": "73_CR67", "doi-asserted-by": "crossref", "first-page": "5981", "DOI": "10.4049/jimmunol.1300183", "volume": "190", "author": "R Iversen", "year": "2013", "unstructured": "Iversen R, Di Niro R, Stamnaes J, Lundin KE, Wilson PC, Sollid LM. Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells. J Immunol. 2013;190:5981\u201391.", "journal-title": "J Immunol"}, {"key": "73_CR68", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.4331/wjbc.v1.i5.181", "volume": "1", "author": "M Ricotta", "year": "2010", "unstructured": "Ricotta M, Iannuzzi M, Vivo GD, Gentile V. Physio-pathological roles of transglutaminase-catalyzed reactions. World J Biol Chem. 2010;1:181\u20137.", "journal-title": "World J Biol Chem"}, {"key": "73_CR69", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1016/j.jneuroim.2015.03.009", "volume": "281", "author": "P Fouka", "year": "2015", "unstructured": "Fouka P, Alexopoulos H, Akrivou S, Trohatou O, Politis PK, Dalakas MC. GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders. J Neuroimmunol. 2015;281:73\u20137.", "journal-title": "J Neuroimmunol"}, {"key": "73_CR70", "doi-asserted-by": "crossref", "first-page": "452", "DOI": "10.1016/0166-2236(91)90044-U", "volume": "14", "author": "M Solimena", "year": "1991", "unstructured": "Solimena M, De Camilli P. Autoimmunity to glutamic acid decarboxylase (GAD) in Stiff-Man syndrome and insulin-dependent diabetes mellitus. Trends Neurosci. 1991;14:452\u20137.", "journal-title": "Trends Neurosci"}, {"key": "73_CR71", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1038/347151a0", "volume": "340", "author": "S Baekkeskov", "year": "1990", "unstructured": "Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 1990;340:151\u20136.", "journal-title": "Nature"}, {"key": "73_CR72", "doi-asserted-by": "crossref", "first-page": "595", "DOI": "10.1084/jem.180.2.595", "volume": "180", "author": "J Kim", "year": "1994", "unstructured": "Kim J, Namchuk M, Bugawan T, Fu Q, Jaffe M, Shi Y, Aanstoot HJ, et al. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med. 1994;180:595\u2013606.", "journal-title": "J Exp Med"}, {"key": "73_CR73", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.2337/diab.43.1.161", "volume": "43", "author": "E Bj\u00f6rk", "year": "1994", "unstructured": "Bj\u00f6rk E, Velloso LA, K\u00e4mpe O, Karlsson FA. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes. 1994;43:161\u20135.", "journal-title": "Diabetes"}, {"key": "73_CR74", "first-page": "818", "volume": "156", "author": "K Daw", "year": "1996", "unstructured": "Daw K, Ujihara N, Atkinson M, Powers AC. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol. 1996;156:818\u201325.", "journal-title": "J Immunol"}, {"key": "73_CR75", "doi-asserted-by": "crossref", "first-page": "2689", "DOI": "10.2337/diabetes.52.11.2689", "volume": "52", "author": "CJ Padoa", "year": "2003", "unstructured": "Padoa CJ, Banga JP, Madec AM, Ziegler M, Schlosser M, Ortqvist E, et al. Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs. Diabetes. 2003;52:2689\u201395.", "journal-title": "Diabetes"}, {"key": "73_CR76", "doi-asserted-by": "crossref", "first-page": "1293", "DOI": "10.2337/db07-1461", "volume": "57", "author": "G Fenalti", "year": "2008", "unstructured": "Fenalti G, Hampe CS, Arafat Y, Law RH, Banga JP, Mackay IR, et al. COOH-terminal clustering of autoantibody and T-cell determinants on the structure of GAD65 provide insights into the molecular basis of autoreactivity. Diabetes. 2008;57:1293\u2013301.", "journal-title": "Diabetes"}, {"key": "73_CR77", "doi-asserted-by": "crossref", "first-page": "685", "DOI": "10.1093/brain/awg050", "volume": "126", "author": "M Hadjivassiliou", "year": "2003", "unstructured": "Hadjivassiliou M, Gr\u00fcnewald R, Sharrack B, Sanders D, Lobo A, Williamson C, et al. Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics. Brain. 2003;126:685\u201391.", "journal-title": "Brain"}, {"key": "73_CR78", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.1007/s12311-012-0411-5", "volume": "12", "author": "K Nanri", "year": "2013", "unstructured": "Nanri K, Niwa H, Mitoma H, Takei A, Ikeda J, Harada T, et al. Low-titer anti-GAD-antibody-positive cerebellar ataxia. Cerebellum. 2013;12:171\u20135.", "journal-title": "Cerebellum"}, {"key": "73_CR79", "doi-asserted-by": "crossref", "first-page": "655", "DOI": "10.1002/acn3.328", "volume": "3", "author": "A Venkatraman", "year": "2016", "unstructured": "Venkatraman A, Opal P. Paraneoplastic cerebellar degeneration with anti-Yo antibodies-a review. Ann Clin Trans Neurol. 2016;3:655\u201363.", "journal-title": "Ann Clin Trans Neurol"}, {"key": "73_CR80", "doi-asserted-by": "crossref", "first-page": "292", "DOI": "10.1016/j.coi.2006.03.015", "volume": "18", "author": "SB Gauld", "year": "2006", "unstructured": "Gauld SB, Merrell KT, Cambier JC. Silencing autoreactive B cells by anergy: a fresh perspective. Curr Opin Immunol. 2006;18:292\u20137.", "journal-title": "Curr Opin Immunol"}, {"key": "73_CR81", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.1038/nature09370", "volume": "467", "author": "HJ Kim", "year": "2010", "unstructured": "Kim HJ, Verbinnen B, Tang X, Lu L, Cantor H. Inhibition of follicular T helper cells by CD8 + Treg is essential for self tolerance. Nature. 2010;467:328\u201332.", "journal-title": "Nature"}, {"key": "73_CR82", "doi-asserted-by": "crossref", "first-page": "1912", "DOI": "10.1053/j.gastro.2009.09.008", "volume": "137", "author": "D Schuppan", "year": "2009", "unstructured": "Schuppan D, Junker Y, Barisani D. Celiac diseas: from pathogenesis to novel therapies. Gastroenterl. 2009;137:1912\u201333.", "journal-title": "Gastroenterl"}, {"key": "73_CR83", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1016/j.autrev.2016.01.017", "volume": "15", "author": "P Zaenker", "year": "2016", "unstructured": "Zaenker P, Gray ES, Ziman MR. Autoantibody Production in Cancer-The humoral immune response toward autologous antigens in cancer patients. Autoimmun Rev. 2016;15:477\u201383.", "journal-title": "Autoimmun Rev"}, {"key": "73_CR84", "unstructured": "Vojdani A. A potential link between environmental triggers and autoimmunity. Autoimmune Dis. 2014;2014:437231. doi: 10.1155/2014/437231 .", "DOI": "10.1155/2014/437231", "doi-asserted-by": "publisher"}, {"key": "73_CR85", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1016/0092-8674(91)90165-U", "volume": "65", "author": "MBA Oldstone", "year": "1991", "unstructured": "Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell. 1991;65:319\u201331.", "journal-title": "Cell"}, {"key": "73_CR86", "doi-asserted-by": "crossref", "first-page": "1221", "DOI": "10.1136/jnnp.74.9.1221", "volume": "74", "author": "M Hadjivassiliou", "year": "2003", "unstructured": "Hadjivassiliou M, Davies-Jones GAB, Sandres DS, Gr\u00fcnewald RA. Dietary treatment of gluten ataxia. J Neurol Neurosurg Psychiatry. 2003;74:1221\u20134.", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "73_CR87", "doi-asserted-by": "crossref", "first-page": "1300", "DOI": "10.1111/j.1468-1331.2008.02305.x", "volume": "15", "author": "N Souayah", "year": "2008", "unstructured": "Souayah N, Chin RL, Brannagan TH, Latov N, Green PR, Kokoszka A, et al. Effect of intravenous immunoglobulin on cerebellar ataxia and neuropathic pain associated with celiac disease. Eur J Neurol. 2008;15:1300\u20133.", "journal-title": "Eur J Neurol"}, {"key": "73_CR88", "doi-asserted-by": "crossref", "first-page": "739", "DOI": "10.2169/internalmedicine.48.1869", "volume": "48", "author": "K Nanri", "year": "2009", "unstructured": "Nanri K, Okita M, Takeguchi M, Taguchi T, Ishiko T, Saitjo H, et al. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia. Intern Med (Tokyo). 2009;48:739\u201390.", "journal-title": "Intern Med (Tokyo)"}, {"key": "73_CR89", "unstructured": "Hadjivassiliou M, Gr\u00fcnewald RA, Davies-Jones GAB. Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry 2002;72:560-563.", "DOI": "10.1136/jnnp.72.5.560", "doi-asserted-by": "crossref"}, {"key": "73_CR90", "doi-asserted-by": "crossref", "first-page": "494", "DOI": "10.1007/s12311-008-0052-x", "volume": "7", "author": "M Hadjivassiliou", "year": "2008", "unstructured": "Hadjivassiliou M, Sanders DS, Woodroofe N, Williamson C, Gr\u00fcnewald RA. Gluten ataxia. Cerebellum. 2008;7:494\u20138.", "journal-title": "Cerebellum"}, {"key": "73_CR91", "doi-asserted-by": "crossref", "first-page": "1411", "DOI": "10.1136/jnnp.2003.025171", "volume": "75", "author": "PM Candler", "year": "2004", "unstructured": "Candler PM, Hart PE, Barnett M, Weil R, Ress JH. A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. J Neurol Neurosurg Psychiatry. 2004;75:1411\u20135.", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "73_CR92", "doi-asserted-by": "crossref", "first-page": "479", "DOI": "10.1136/jnnp.68.4.479", "volume": "68", "author": "F Keime-Guibert", "year": "2000", "unstructured": "Keime-Guibert F, Graus F, Fleury A, Ren\u0117 R, Honnorat J, Broet P, et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry. 2000;68:479\u201382.", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "73_CR93", "doi-asserted-by": "crossref", "first-page": "489", "DOI": "10.1097/CCO.0000000000000222", "volume": "27", "author": "R H\u04e7ftberger", "year": "2015", "unstructured": "H\u04e7ftberger R, Rosenfeld M, Dalmau J. Update on neurological paraneoplastic syndromes. Curr Opin Oncol. 2015;27:489\u201395.", "journal-title": "Curr Opin Oncol"}, {"key": "73_CR94", "doi-asserted-by": "crossref", "first-page": "408", "DOI": "10.1016/j.neurol.2010.07.032", "volume": "167", "author": "G Demarquay", "year": "2011", "unstructured": "Demarquay G, Honnorat J. Clinical presentation of immune-mediated cerebellar ataxia. Rev Neurol. (Paris). 2011;167:408\u201317.", "journal-title": "Rev Neurol. (Paris)"}, {"key": "73_CR95", "doi-asserted-by": "crossref", "first-page": "396", "DOI": "10.1177/1756285616648940", "volume": "9", "author": "H Mitoma", "year": "2016", "unstructured": "Mitoma H, Manto M. The physiological basis for therapies of cerebellar ataxias. Ther Adv Neurol Disord. 2016;9:396\u2013413.", "journal-title": "Ther Adv Neurol Disord"}, {"key": "73_CR96", "doi-asserted-by": "crossref", "first-page": "272", "DOI": "10.1016/j.pneurobio.2006.02.006", "volume": "78", "author": "M Ito", "year": "2006", "unstructured": "Ito M. Cerebellar circuitry as a neural machine. Prog Neurobiol. 2006;78:272\u2013303.", "journal-title": "Prog Neurobiol"}, {"key": "73_CR97", "doi-asserted-by": "crossref", "first-page": "874", "DOI": "10.1002/cne.22555", "volume": "519", "author": "PN Quy", "year": "2011", "unstructured": "Quy PN, Fujita H, Sakamoto Y, Na J, Sugihara I. Projection patterns of single mossy fiber axons originating from the dorsal column nuclei mapped on the aldolase C compartments in the rat cerebellar cortex. J Comp Neurol. 2011;519:874\u201399.", "journal-title": "J Comp Neurol"}, {"key": "73_CR98", "doi-asserted-by": "crossref", "first-page": "212", "DOI": "10.1016/j.csbj.2015.03.004", "volume": "13", "author": "DG Fujikawa", "year": "2015", "unstructured": "Fujikawa DG. The role of excitotoxic programmed necrosis in a brain injury. Comput Struct Biotechnol J. 2015;13:212\u201322.", "journal-title": "Comput Struct Biotechnol J"}, {"key": "73_CR99", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.2174/1389203711314010004", "volume": "14", "author": "A Suzumura", "year": "2013", "unstructured": "Suzumura A. Neuron-microglia interaction in neuroinflammation. Curr Protein Pept Sci. 2013;14:1.", "journal-title": "Curr Protein Pept Sci"}, {"key": "73_CR100", "doi-asserted-by": "crossref", "first-page": "12105", "DOI": "10.1523/JNEUROSCI.5369-12.2013", "volume": "33", "author": "G Mandolesi", "year": "2013", "unstructured": "Mandolesi G, Musella A, Gentile A, Grasselli G, Haji N, Sepman H, et al. Interleukin-1\u03b2 alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis. J Neurosci. 2013;33:12105\u201321.", "journal-title": "J Neurosci"}, {"key": "73_CR101", "doi-asserted-by": "crossref", "first-page": "1062", "DOI": "10.1111/jnc.13348", "volume": "135", "author": "A Massie", "year": "2015", "unstructured": "Massie A, Boill\u0117e B, Hewett S, Knackstedt L, Lewerenz J. Main path and byways: non-vesicular glutamate release by system xc(\u2212) as an important modifier glutamatergic neurotransmission. J Neurochem. 2015;135:1062\u201379.", "journal-title": "J Neurochem"}, {"key": "73_CR102", "doi-asserted-by": "crossref", "first-page": "861231", "DOI": "10.1155/2014/861231", "volume": "2014", "author": "G Olmos", "year": "2014", "unstructured": "Olmos G, Llad\u014dd J. Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediators Inflamma. 2014;2014:861231.", "journal-title": "Mediators Inflamma"}, {"key": "73_CR103", "first-page": "322", "volume": "9", "author": "JE Yuste", "year": "2015", "unstructured": "Yuste JE, Tarragon E, Campuzano CM. Ros-Bernal. F Implications of glial nitric oxide in neurodegenerative diseases Front Cell Neurosci. 2015;9:322.", "journal-title": "F Implications of glial nitric oxide in neurodegenerative diseases Front Cell Neurosci"}, {"key": "73_CR104", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1136/jnnp.2006.091116", "volume": "78", "author": "K Ishida", "year": "2007", "unstructured": "Ishida K, Mitoma H, Wada Y, Oka T, Shibahara J, Murayana S, et al. Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia. J Neurol Neurosurg Neuropsychiatry. 2007;78:190\u20132.", "journal-title": "J Neurol Neurosurg Neuropsychiatry"}, {"key": "73_CR105", "doi-asserted-by": "crossref", "first-page": "148", "DOI": "10.1016/j.jns.2009.12.006", "volume": "290", "author": "G Piccolo", "year": "2010", "unstructured": "Piccolo G, Tavazzi E, Cavallaro T, Romani A, Sceisi R, Martino G. Clinico-pathological findings in a patient with progressive cerebellar ataxia, autoimmune polyendocrine syndrome, hepatocellular carcinoma and anti-GAD autoantibodies. J Neurol Sci. 2010;290:148\u20139.", "journal-title": "J Neurol Sci"}, {"key": "73_CR106", "doi-asserted-by": "crossref", "first-page": "751", "DOI": "10.1007/s13311-014-0289-7", "volume": "11", "author": "R Chopra", "year": "2014", "unstructured": "Chopra R, Shakkottai VG. The role for alterations in neural activity in the pathogenesis of polyglutamine repeat disorders. Neurotherapeutics. 2014;11:751\u201363.", "journal-title": "Neurotherapeutics"}, {"key": "73_CR107", "unstructured": "Hadjivassiliou M, Rao DG, Gr\u00ecnewald RA, Aeschlimann DP, Sarrigiannis PG, Hoggard N, Aeschlimann P, Mooney PD, Sanders DS. Neurological Dysfunction in Coeliac Disease and Non-Coeliac Gluten Sensitivity. Am J Gastroenterol. 2016;111(4):561\u20137.", "DOI": "10.1038/ajg.2015.434", "doi-asserted-by": "crossref"}, {"key": "73_CR108", "unstructured": "Bushara KO, Goebel SU, Shill H, Goldfarb LG, Hallett M. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol. 2001;49(4):540\u20133.", "DOI": "10.1002/ana.108", "doi-asserted-by": "crossref"}, {"key": "73_CR109", "unstructured": "Verma AK, Gatti S, Galeazzi T, Monachesi C, Padella L, Baldo GD, Annibali R, Lionetti E, Catassi C. Gluten Contamination in Naturally or Labeled Gluten-Free Products Marketed in Italy. Nutrients. 2017;9(2). pii: E115. doi: 10.3390/nu9020115 .", "DOI": "10.3390/nu9020115", "doi-asserted-by": "publisher"}, {"key": "73_CR110", "doi-asserted-by": "crossref", "first-page": "294", "DOI": "10.1016/S1474-4422(02)00135-7", "volume": "1", "author": "R Voltz", "year": "2002", "unstructured": "Voltz R. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol. 2002;1:294\u2013305.", "journal-title": "Lancet Neurol"}], "container-title": ["Cerebellum & Ataxias"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/s40673-017-0073-7.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 3]], "date-time": "2019-10-03T20:12:33Z", "timestamp": 1570133553000}, "score": 80.3389, "issued": {"date-parts": [[2017, 9, 21]]}, "references-count": 110, "journal-issue": {"published-print": {"date-parts": [[2017, 12]]}, "issue": "1"}, "alternative-id": ["73"], "URL": "http://dx.doi.org/10.1186/s40673-017-0073-7", "relation": {"cites": []}, "ISSN": ["2053-8871"], "issn-type": [{"value": "2053-8871", "type": "electronic"}], "article-number": "16"}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T04:28:32Z", "timestamp": 1574742512280}, "reference-count": 63, "publisher": "Springer Science and Business Media LLC", "issue": "1", "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["cerebellum ataxias"], "published-print": {"date-parts": [[2015, 12]]}, "DOI": "10.1186/s40673-015-0034-y", "type": "journal-article", "created": {"date-parts": [[2015, 11, 10]], "date-time": "2015-11-10T12:46:02Z", "timestamp": 1447159562000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 29, "title": ["Guidelines for treatment of immune-mediated cerebellar ataxias"], "prefix": "10.1186", "volume": "2", "author": [{"given": "Hiroshi", "family": "Mitoma", "sequence": "first", "affiliation": []}, {"given": "Marios", "family": "Hadjivassiliou", "sequence": "additional", "affiliation": []}, {"given": "J\u00e9r\u00f4me", "family": "Honnorat", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 11, 10]]}, "reference": [{"key": "34_CR1", "author": "H Mitoma", "year": "2015", "unstructured": "Mitoma H, Adhikari K, Aeschlimann D, Chattopadhyay P, Hadjivassiliou M, Hampe CS, et al. Consensus Paper: Neuroimmune mechanisms of cerebellar ataxias. Cerebellum. 2015. doi: 10.1007/s12311-015-0664-x .", "journal-title": "Cerebellum"}, {"key": "34_CR2", "doi-asserted-by": "crossref", "first-page": "330", "DOI": "10.1001/archneurol.2009.341", "volume": "67", "author": "B Giommeto", "year": "2010", "unstructured": "Giommeto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G, et al. Paraneoplastic neurologic syndromes in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol. 2010;67:330\u20135.", "journal-title": "Arch Neurol."}, {"key": "34_CR3", "first-page": "674", "volume": "38", "author": "B Brouwer", "year": "1919", "unstructured": "Brouwer B. Beitrag zur kenntnis der chronischen diffusen kleinhirnerkrankungen. Neurol Zentralbl. 1919;38:674\u201382.", "journal-title": "Neurol Zentralbl"}, {"key": "34_CR4", "doi-asserted-by": "crossref", "first-page": "731", "DOI": "10.1111/ene.12368", "volume": "21", "author": "F Ducray", "year": "2014", "unstructured": "Ducray F, Demarquay G, Graus F, Decullier E, Antoine J-C, Giometto B, et al. Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experience. Eur J Neurol. 2014;21:731\u20135.", "journal-title": "Eur J Neurol."}, {"key": "34_CR5", "doi-asserted-by": "crossref", "first-page": "1582", "DOI": "10.1016/S0140-6736(98)05342-2", "volume": "352", "author": "M Hadjivassiliou", "year": "1998", "unstructured": "Hadjivassiliou M, Gr\u00fcnewald RA, Chattopadhyay AK, Davies-Jones GA, Gibson A, Jarratt JA, et al. Clinical, radiological, neurophysiological and neuropathological characteristics of gluten ataxia. Lancet. 1998;352:1582\u20135.", "journal-title": "Lancet."}, {"key": "34_CR6", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.1212/WNL.41.2_Part_1.228", "volume": "41", "author": "PJ Shaw", "year": "1991", "unstructured": "Shaw PJ, Walls TJ, Newman PK, Cleland PG, Cartlidge NE. Hashimoto\u2019s encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers-report of 5 cases. Neurology. 1991;41:228\u201333.", "journal-title": "Neurology."}, {"key": "34_CR7", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1001/archneur.58.2.225", "volume": "58", "author": "J Honnorat", "year": "2001", "unstructured": "Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, Andres C, et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies. Study of 14 patients. Arch Neurol. 2001;58:225\u201330.", "journal-title": "Arch Neurol"}, {"key": "34_CR8", "author": "S Jarius", "year": "2015", "unstructured": "Jarius S, Wildemann B. \u2018Medusa-head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII. J Neuroinflammation. 2015. doi: 10.1186/s12974-015-0356-y .", "journal-title": "J Neuroinflammation"}, {"key": "34_CR9", "author": "S Jarius", "year": "2015", "unstructured": "Jarius S, Wildemann B. \u2018Medusa-head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC. J Neuroinflammation. 2015. doi: 10.1186/s12974-015-0357-x .", "journal-title": "J Neuroinflammation"}, {"key": "34_CR10", "author": "S Jarius", "year": "2015", "unstructured": "Jarius S, Wildemann B. \u2018Medusa-head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook. J Neuroinflammation. 2015. doi: 10.1186/s12974-015-0358-9 .", "journal-title": "J Neuroinflammation"}, {"key": "34_CR11", "doi-asserted-by": "crossref", "first-page": "1270", "DOI": "10.1002/mds.22129", "volume": "23", "author": "M Hadjivassiliou", "year": "2008", "unstructured": "Hadjivassiliou M, Boscolo S, Tongiorgi E, Grunewald RA, Sharrack B, Sanders DS, et al. Cerebellar ataxia as a possible organ specific autoimmune disease. Movement Disord. 2008;23:1270\u2013377.", "journal-title": "Movement Disord."}, {"key": "34_CR12", "doi-asserted-by": "crossref", "first-page": "1221", "DOI": "10.1136/jnnp.74.9.1221", "volume": "74", "author": "M Hadjivassiliou", "year": "2003", "unstructured": "Hadjivassiliou M, Davies-Jones GAB, Sandres DS, Gr\u00fcnewald RA. Dietary treatment of gluten ataxia. J Neurol Neurosurg Psychiatry. 2003;74:1221\u20134.", "journal-title": "J Neurol Neurosurg Psychiatry."}, {"key": "34_CR13", "doi-asserted-by": "crossref", "first-page": "827", "DOI": "10.1002/ana.1281", "volume": "50", "author": "K B\u00fcrk", "year": "2001", "unstructured": "B\u00fcrk K, Melms A, Schulz JB, Dichgans J. Effective of intravenous immunoglobin therapy in cerebellar ataxia associated with gluten sensitivity. Ann Neurol. 2001;50:827\u20138.", "journal-title": "Ann Neurol."}, {"key": "34_CR14", "doi-asserted-by": "crossref", "first-page": "1300", "DOI": "10.1111/j.1468-1331.2008.02305.x", "volume": "15", "author": "N Souayah", "year": "2008", "unstructured": "Souayah N, Chin RL, Brannagan TH, Latov N, Green PHR, Kokoszka A, et al. Effect of intravenous immunoglobulin on cerebellar ataxia and neuropathic pain associated with celiac disease. Eur J Neurol. 2008;15:1300\u20133.", "journal-title": "Eur J Neurol."}, {"key": "34_CR15", "doi-asserted-by": "crossref", "first-page": "560", "DOI": "10.1136/jnnp.72.5.560", "volume": "72", "author": "M Hadjivassiliou", "year": "2002", "unstructured": "Hadjivassiliou M, Gr\u00fcnewald RA, Davies-Jones GAB. Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry. 2002;72:560\u20133.", "journal-title": "J Neurol Neurosurg Psychiatry."}, {"key": "34_CR16", "doi-asserted-by": "crossref", "first-page": "494", "DOI": "10.1007/s12311-008-0052-x", "volume": "7", "author": "M Hadjivassiliou", "year": "2008", "unstructured": "Hadjivassiliou M, Sanders DS, Woodroofe N, Williamson C, Gr\u00fcnewald RA. Gluten ataxia. Cerebellum. 2008;7:494\u20138.", "journal-title": "Cerebellum."}, {"key": "34_CR17", "doi-asserted-by": "crossref", "first-page": "783", "DOI": "10.2169/internalmedicine.48.1802", "volume": "48", "author": "K Nanri", "year": "2009", "unstructured": "Nanri K, Okita M, Takeguchi M, Taguchi T, Ishiko T, Saitjo H, et al. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia. Intern Med Tokyo Jpn. 2009;48:783\u201390.", "journal-title": "Intern Med Tokyo Jpn."}, {"key": "34_CR18", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1186/2053-8871-1-11", "volume": "1", "author": "PG Sarrigiannis", "year": "2014", "unstructured": "Sarrigiannis PG, Hoggard N, Sanders DS, Aeschlimann D, Grunewald RA, Unwin ZC, et al. Myoclonic ataxia and refractory coeliac disease. Cerebellum & Ataxias. 2014;1:11.", "journal-title": "Cerebellum & Ataxias."}, {"key": "34_CR19", "doi-asserted-by": "crossref", "first-page": "408", "DOI": "10.1016/j.neurol.2010.07.032", "volume": "167", "author": "G Demarquay", "year": "2011", "unstructured": "Demarquay G, Honnorat J. Clinical presentation of immune-mediated cerebellar ataxia. Rev Neurol (Paris). 2011;167:408\u201317.", "journal-title": "Rev Neurol (Paris)"}, {"key": "34_CR20", "doi-asserted-by": "crossref", "first-page": "294", "DOI": "10.1016/S1474-4422(02)00135-7", "volume": "1", "author": "R Voltz", "year": "2002", "unstructured": "Voltz R. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol. 2002;1:294\u2013305.", "journal-title": "Lancet Neurol."}, {"key": "34_CR21", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1016/S1474-4422(08)70060-7", "volume": "7", "author": "J Dalmau", "year": "2008", "unstructured": "Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol. 2008;7:327\u201340.", "journal-title": "Lancet Neurol."}, {"key": "34_CR22", "doi-asserted-by": "crossref", "first-page": "479", "DOI": "10.1136/jnnp.68.4.479", "volume": "68", "author": "F Keime-Guibert", "year": "2000", "unstructured": "Keime-Guibert F, Graus F, Fleury A, Ren\u0117 R, Honnorat J, Broet P, et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry. 2000;68:479\u201382.", "journal-title": "J Neurol Neurosurg Psychiatry."}, {"key": "34_CR23", "doi-asserted-by": "crossref", "first-page": "1411", "DOI": "10.1136/jnnp.2003.025171", "volume": "75", "author": "PM Candler", "year": "2004", "unstructured": "Candler PM, Hart PE, Barnett M, Weil R, Ress JH. A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. J Neurol Neurosurg Psychiatry. 2004;75:1411\u20135.", "journal-title": "J Neurol Neurosurg Psychiatry."}, {"key": "34_CR24", "doi-asserted-by": "crossref", "first-page": "246", "DOI": "10.1111/j.1749-6632.1998.tb10934.x", "volume": "841", "author": "EJ Dropcho", "year": "1998", "unstructured": "Dropcho EJ. Principles of paraneoplastic syndromes. Ann NY Acad Sci. 1998;841:246\u201361.", "journal-title": "Ann NY Acad Sci."}, {"key": "34_CR25", "doi-asserted-by": "crossref", "first-page": "112", "DOI": "10.1136/jnnp.56.1.112", "volume": "56", "author": "JWB Moll", "year": "1993", "unstructured": "Moll JWB, Henzen-Logmans SC, van Meche FGA, Vecht CH. Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration. J Neurol Neurosurg Psychiatry. 1993;56:112.", "journal-title": "J Neurol Neurosurg Psychiatry."}, {"key": "34_CR26", "doi-asserted-by": "crossref", "first-page": "814", "DOI": "10.1001/archneur.1995.00540320098016", "volume": "52", "author": "E Stark", "year": "1995", "unstructured": "Stark E, Wurster U, Patzold U, Sailer M, Haas J. Immunological and clinical response to immunosuppressive treatment in paraneoplastic cerebellar degeneration. Arch Neurol. 1995;52:814\u20138.", "journal-title": "Arch Neurol."}, {"key": "34_CR27", "doi-asserted-by": "crossref", "first-page": "412", "DOI": "10.1136/jnnp.67.3.412", "volume": "67", "author": "AP Batocchi", "year": "1999", "unstructured": "Batocchi AP, Rosa GDE, Evoli A, Tonali P, Greggi S, Scambia G, et al. Positive response to therapy in a patient with seropositive paraneoplastic cerebellar degeneration and an endometrioid carcinoma of the vesicovaginal septum. J Neurol Neurosurg Psychiatry. 1999;67:412\u20133.", "journal-title": "J Neurol Neurosurg Psychiatry."}, {"key": "34_CR28", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1016/S0022-510X(00)00353-1", "volume": "178", "author": "N Mowzoon", "year": "2000", "unstructured": "Mowzoon N, Bradley AG. Successful immunosuppressant therapy of severe progressive cerebellar degeneration and sensory neuropathy: a case report. J Neurol Sci. 2000;178:63\u20135.", "journal-title": "J Neurol Sci."}, {"key": "34_CR29", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1007/s11060-006-9198-x", "volume": "81", "author": "S Phuphanich", "year": "2007", "unstructured": "Phuphanich S, Brock C. Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody. J Neurooncol. 2007;81:67\u20139.", "journal-title": "J Neurooncol."}, {"key": "34_CR30", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.1016/j.jns.2008.04.020", "volume": "272", "author": "J Th\u00f6ne", "year": "2008", "unstructured": "Th\u00f6ne J, Hohaus A, Lamprecht S, Bickel A, Erbguth F. Effective immunosuppressant therapy with cyclophosphamide and corticosteroids in paraneoplastic cerebellar degeneration. J Neurol Sci. 2008;272:171\u20133.", "journal-title": "J Neurol Sci."}, {"key": "34_CR31", "doi-asserted-by": "crossref", "first-page": "946", "DOI": "10.1007/s00415-010-5859-y", "volume": "258", "author": "J Schessl", "year": "2011", "unstructured": "Schessl J, Schuberth M, Reilich P, Schneiderat P, Strigl-Pill N, Walter MC, et al. Long-term efficiency of intravenously administered immunoglobulin in anti-Yo syndrome with paraneoplastic cerebellar degeneration. J Neurol. 2011;258:946\u20137.", "journal-title": "J Neurol."}, {"key": "34_CR32", "doi-asserted-by": "crossref", "first-page": "705", "DOI": "10.1212/WNL.0b013e31820d62eb", "volume": "76", "author": "C Briani", "year": "2011", "unstructured": "Briani C, Vitaliani R, Grisold W, Honnorat J, Graus F, Antoine JC, et al. Spectrum of paraneoplastic disease associated with lymphoma. Neurology. 2011;76:705\u201310.", "journal-title": "Neurology."}, {"key": "34_CR33", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1007/s11940-012-0215-4", "volume": "15", "author": "JE Greenlee", "year": "2013", "unstructured": "Greenlee JE. Treatment of paraneoplastic cerebellar degeneration. Curr Treat Opinions Neurol. 2013;15:185\u2013200.", "journal-title": "Curr Treat Opinions Neurol."}, {"key": "34_CR34", "doi-asserted-by": "crossref", "first-page": "412", "DOI": "10.1136/jnnp.2007.138016", "volume": "80", "author": "J Honnorat", "year": "2009", "unstructured": "Honnorat J, Cartalat-Carel S, Ricard D, Camdessanche JP, Carpentier AF, Rogemond V, et al. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry. 2009;80:412\u20136.", "journal-title": "J Neurol Neurosurg Psychiatry."}, {"key": "34_CR35", "doi-asserted-by": "crossref", "first-page": "587", "DOI": "10.1016/j.neurol.2014.07.007", "volume": "170", "author": "J Honnorat", "year": "2014", "unstructured": "Honnorat J. Therapeutic approaches in antibody-associated central nervous system pathologies. Rev Neurol (Paris). 2014;170:587\u201394.", "journal-title": "Rev Neurol (Paris)"}, {"key": "34_CR36", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1002/1531-8249(199908)46:2<263::AID-ANA19>3.0.CO;2-0", "volume": "46", "author": "K Ishida", "year": "1999", "unstructured": "Ishida K, Mitoma H, Song SY, Uchihara T, Inaba A, Eguchi S, et al. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol. 1999;46:263\u20137.", "journal-title": "Ann Neurol."}, {"key": "34_CR37", "doi-asserted-by": "crossref", "first-page": "634", "DOI": "10.1016/S1474-4422(03)00534-9", "volume": "2", "author": "G Lauria", "year": "2003", "unstructured": "Lauria G, Pareyson D, Pitzolu G, Bazzigaluppi E. Excellent response to steroid treatment in anti-GAD cerebellar ataxia. Lancet Neurol. 2003;2:634\u20135.", "journal-title": "Lancet Neurol."}, {"key": "34_CR38", "doi-asserted-by": "crossref", "first-page": "616", "DOI": "10.1016/j.revmed.2006.04.006", "volume": "27", "author": "B Birand", "year": "2006", "unstructured": "Birand B, Cabre P, Bonnan M, Olindo S, Smadja D. A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative. Rev Med Interne. 2006;27:616\u20139.", "journal-title": "Rev Med Interne."}, {"key": "34_CR39", "doi-asserted-by": "crossref", "first-page": "1308", "DOI": "10.1212/01.wnl.0000238389.83574.be", "volume": "67", "author": "NR McFarland", "year": "2006", "unstructured": "McFarland NR, Login IS, Verno S, Burns TM. Improvement with corticosteroids and azathioprine in GAD65-associated cerebellar ataxia. Neurology. 2006;67:1308\u20139.", "journal-title": "Neurology."}, {"key": "34_CR40", "doi-asserted-by": "crossref", "first-page": "2263", "DOI": "10.1002/mds.21041", "volume": "21", "author": "JY Kim", "year": "2006", "unstructured": "Kim JY, Chung EJ, Kim JH, Jung KY, Lee WY. ReVaninsponse to steroid treatment in anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff-person syndrome and polyendocrinopathy. Mov Disord. 2006;21:2263\u201372.", "journal-title": "Mov Disord."}, {"key": "34_CR41", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1136/jnnp.2006.089268", "volume": "78", "author": "S Vulliemoz", "year": "2007", "unstructured": "Vulliemoz S, Vanini G, Truffert A, Chizzolini C, Seeck M. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies. J Neurol Neurosurg Psychiatry. 2007;78:187\u20139.", "journal-title": "J Neurol Neurosurg Psychiatry."}, {"key": "34_CR42", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.1016/j.clineuro.2006.01.009", "volume": "109", "author": "CC Chang", "year": "2007", "unstructured": "Chang CC, Eggers SD, Johnson JK, Haman A, Miller BL, Geschwind MD. Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt-Jakob disease. Clin Neurol Neurosurg. 2007;109:54\u20137.", "journal-title": "Clin Neurol Neurosurg."}, {"key": "34_CR43", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1016/j.neurol.2008.02.032", "volume": "164", "author": "M Bonnan", "year": "2008", "unstructured": "Bonnan M, Cabre P, Olindo S, Signate A, Saint-Vil M, Smadja D. Steroid treatment in four cases of anti-GAD cerebellar ataxia. Rev Neurol. 2008;164:427\u201333.", "journal-title": "Rev Neurol."}, {"key": "34_CR44", "doi-asserted-by": "crossref", "first-page": "857", "DOI": "10.1212/WNL.52.4.857", "volume": "52", "author": "M Abele", "year": "1999", "unstructured": "Abele M, Weller M, Mescheriakov S, B\u00fcrk K, Dichgans J, Klockgether T. Cerebellar ataxia with glutamic acid decarboxylase autoantibodies. Neurology. 1999;52:857\u20139.", "journal-title": "Neurology."}, {"key": "34_CR45", "doi-asserted-by": "crossref", "first-page": "386", "DOI": "10.1136/jnnp.70.3.386", "volume": "70", "author": "H Takenoshita", "year": "2001", "unstructured": "Takenoshita H, Shizuka-Ikeda M, Mitoma H, Song SY, Harigaya Y, Igeta Y, et al. Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia. J Neurol Neurosurg Psychiatry. 2001;70:386\u201389.", "journal-title": "J Neurol Neurosurg Psychiatry."}, {"key": "34_CR46", "doi-asserted-by": "crossref", "first-page": "348", "DOI": "10.1007/s004150200019", "volume": "249", "author": "S R\u00fcegg", "year": "2002", "unstructured": "R\u00fcegg S, Stahl M, B\u00fchlmann M, Dupont A, Lyrer PA, Humbel RL, et al. Cerebellar degeneration and polyglandular autoimmune syndrome with anti-glutamic acid decarboxylase antibodies. J Neurol. 2002;249:348\u201350.", "journal-title": "J Neurol."}, {"key": "34_CR47", "doi-asserted-by": "crossref", "first-page": "343", "DOI": "10.1136/jnnp.73.3.343", "volume": "73", "author": "S Matsumoto", "year": "2002", "unstructured": "Matsumoto S, Kusuhara T, Nakajima M, Ouma S, Takahashi M, Yamada T. Acute attacks and brain stem signs in a patient with glutamic acid decarboxylase autoantibodies. J Neurol Neurosurg Psychiatry. 2002;73:343\u201350.", "journal-title": "J Neurol Neurosurg Psychiatry."}, {"key": "34_CR48", "author": "Z Georgieva", "year": "2014", "unstructured": "Georgieva Z, Parton M. Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis. BMJ Case Rep. 2014. doi: 10.1136/bcr-2013-202314 .", "journal-title": "BMJ Case Rep"}, {"key": "34_CR49", "doi-asserted-by": "crossref", "first-page": "318", "DOI": "10.1007/s12311-013-0534-3", "volume": "13", "author": "V Planche", "year": "2014", "unstructured": "Planche V, Marques A, Ulla M, Ruivard M, Durif F. Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies. Cerebellum. 2014;13:318\u201322.", "journal-title": "Cerebellum."}, {"key": "34_CR50", "doi-asserted-by": "crossref", "first-page": "264", "DOI": "10.1159/000369784", "volume": "6", "author": "J Kuchling", "year": "2014", "unstructured": "Kuchling J, Shababi-Klein J, N\u00fcmann A, Gerischer LM, Harms L, Pr\u00fcss H. GAD antibody-associated late-onset cerebellar ataxia in two female siblings. Case Rep Neurol. 2014;6:264\u201370.", "journal-title": "Case Rep Neurol"}, {"key": "34_CR51", "doi-asserted-by": "crossref", "first-page": "1009", "DOI": "10.1001/jamaneurol.2014.1011", "volume": "71", "author": "H Ari\u0144o", "year": "2014", "unstructured": "Ari\u0144o H, Gresa-Arribas N, Blanco Y, Mart\u00ednez-Hern\u00e1ndez E, Sabater L, Petit-Pedrol M, et al. Cerebellar ataxia and glutamic acid decarboxylase antibodies. Immunologic profile and long-term effect of immunotherapy. JAMA Neurol. 2014;71:1009\u201316.", "journal-title": "JAMA Neurol"}, {"key": "34_CR52", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.1007/s12311-012-0411-5", "volume": "12", "author": "K Nanri", "year": "2013", "unstructured": "Nanri K, Niwa H, Mitoma H, Takei A, Ikeda J, Harada T, et al. Low-titer anti-GAD-antibody-positive cerebellar ataxia. Cerebellum. 2013;12:171\u20135.", "journal-title": "Cerebellum."}, {"key": "34_CR53", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1136/jnnp.2007.142745", "volume": "80", "author": "R Virgilio", "year": "2009", "unstructured": "Virgilio R, Corti S, Agazzi P, Santoro D, Lanfranconi S, Candelise L, et al. Effect of steroid treatment in cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies. J Neurol Neurosurg Psychiatry. 2009;80:95\u20136.", "journal-title": "J Neurol Neurosurg Psychiatry."}, {"key": "34_CR54", "author": "V Nociti", "volume": "17", "year": "2010", "unstructured": "Nociti V, Frisullo G, Tartaglione T, Patanella AK, Iorio R, Tonali PA, et al. Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment. Eur J Neurol. 2010;17, e5.", "journal-title": "Eur J Neurol.", "DOI": "10.1111/j.1468-1331.2009.02839.x", "doi-asserted-by": "crossref"}, {"key": "34_CR55", "doi-asserted-by": "crossref", "first-page": "993", "DOI": "10.1590/S0004-282X2011000700030", "volume": "69", "author": "JL Pedroso", "year": "2011", "unstructured": "Pedroso JL, Braga-Neto P, Dutra LA, Barsottini OGP. Cerebellar ataxia associated to anti-glutamic acid decarboxylase autoantibody (anti GAD). Arq Neuropsiquiatr. 2011;69:993.", "journal-title": "Arq Neuropsiquiatr."}, {"key": "34_CR56", "doi-asserted-by": "crossref", "first-page": "175", "DOI": "10.1111/j.1600-0404.2010.01356.x", "volume": "123", "author": "M Hadjivassiliou", "year": "2011", "unstructured": "Hadjivassiliou M, Aeschlimann D, Grunewald RA, Sanders DS, Sharrack B, Woodroofe N. GAD antibody associated neurological illness and its relationship to gluten sensitivity. Acta Neurol Scand. 2011;123:175\u201380.", "journal-title": "Acta Neurol Scand."}, {"key": "34_CR57", "first-page": "202", "volume": "152", "author": "M Manto", "year": "1996", "unstructured": "Manto M, Goldman S, Bodur H. Cerebellar syndrome associated with Hashimoto\u2019s encephalopathy. Rev Neurol (Paris). 1996;152:202\u20134.", "journal-title": "Rev Neurol (Paris)"}, {"key": "34_CR58", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1136/jnnp.71.1.81", "volume": "71", "author": "M Selim", "year": "2001", "unstructured": "Selim M, Drachman DA. Ataxia associated with Hashimoto\u2019s disease: progressive non-familial adult onset cerebellar degeneration with autoimmune thyroiditis. J Neurol Neurosurg Psychiatry. 2001;71:81\u20137.", "journal-title": "J Neurol Neurosurg Psychiatry."}, {"key": "34_CR59", "first-page": "13", "volume": "156", "author": "B Passarella", "year": "2005", "unstructured": "Passarella B, Negro C, Nozzoli C, De Marco V, Rini A. Cerebellar subacute syndrome due to corticosteroid-responsive encephalopathy associated with autoimmune thyroiditis (also called \u2018Hashimoto\u2019s encephalopathy\u2019). Clin Ter. 2005;156:13\u20137.", "journal-title": "Clin Ter."}, {"key": "34_CR60", "doi-asserted-by": "crossref", "first-page": "1705", "DOI": "10.1007/s00415-011-5976-2", "volume": "258", "author": "Y Tang", "year": "2011", "unstructured": "Tang Y, Chu C, Lin MT, Wei G, Zhang X, Da Y, et al. Hashimoto\u2019s encephalopathy mimicking spinocerebellar ataxia. J Neurol. 2011;258:1705\u20137.", "journal-title": "J Neurol."}, {"key": "34_CR61", "doi-asserted-by": "crossref", "first-page": "14", "DOI": "10.1159/000342217", "volume": "69", "author": "A Matsunaga", "year": "2013", "unstructured": "Matsunaga A, Ikawa M, Fujii A, Nakamoto Y, Kuriyama M, Yoneda M. Hashimoto\u2019s encephalopathy as a treatable adult-onset cerebellar ataxia mimicking spinocerebellar degeneration. Eur Neurol. 2013;69:14\u201320.", "journal-title": "Eur Neurol."}, {"key": "34_CR62", "doi-asserted-by": "crossref", "first-page": "196", "DOI": "10.1136/jnnp.2006.093005", "volume": "78", "author": "H Nakagawa", "year": "2007", "unstructured": "Nakagawa H, Yoneda M, Fujii A, Kinomoto K, Kuriyama M. Hashimoto\u2019s encephalopathy presenting with progressive cerebellar ataxia. J Neurol Neurosurg Psychiatry. 2007;78:196\u20137.", "journal-title": "J Neurol Neurosurg Psychiatry."}, {"key": "34_CR63", "author": "H Mitoma", "year": "2014", "unstructured": "Mitoma H, Yoneda M, Saitow F, Suzuki H, Matsunaga A, Ikawa M, et al. Presynaptic dysfunction caused by cerebrospinal fluid from a patient with the ataxic form of Hashimoto\u2019s encephalopathy. Neurol Clin Neurosci. 2014. doi: 10.1111/ncn3.105 .", "journal-title": "Neurol Clin Neurosci"}], "container-title": ["Cerebellum & Ataxias"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/s40673-015-0034-y", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 23]], "date-time": "2017-06-23T23:19:07Z", "timestamp": 1498259947000}, "score": 58.357605, "issued": {"date-parts": [[2015, 11, 10]]}, "references-count": 63, "journal-issue": {"published-print": {"date-parts": [[2015, 12]]}, "issue": "1"}, "alternative-id": ["34"], "URL": "http://dx.doi.org/10.1186/s40673-015-0034-y", "relation": {"cites": []}, "ISSN": ["2053-8871"], "issn-type": [{"value": "2053-8871", "type": "electronic"}], "article-number": "14"}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T18:17:08Z", "timestamp": 1574878628401}, "reference-count": 173, "publisher": "Bentham Science Publishers Ltd.", "issue": "1", "content-domain": {"domain": ["eurekaselect.com"], "crossmark-restriction": true}, "short-container-title": ["CN"], "published-print": {"date-parts": [[2018, 12, 5]]}, "abstract": "<jats:sec>\n<jats:title />\n<jats:p>Immune-mediated cerebellar ataxias (IMCAs), a clinical entity reported for the first time\nin the 1980s, include gluten ataxia (GA), paraneoplastic cerebellar degenerations (PCDs), antiglutamate\ndecarboxylase 65 (GAD) antibody-associated cerebellar ataxia, post-infectious cerebellitis,\nand opsoclonus myoclonus syndrome (OMS). These IMCAs share common features with regard\nto therapeutic approaches. When certain factors trigger immune processes, elimination of the antigen(\ns) becomes a priority: e.g., gluten-free diet in GA and surgical excision of the primary tumor in\nPCDs. Furthermore, various immunotherapeutic modalities (e.g., steroids, immunoglobulins, plasmapheresis,\nimmunosuppressants, rituximab) should be considered alone or in combination to prevent\nthe progression of the IMCAs. There is no evidence of significant differences in terms of response\nand prognosis among the various types of immunotherapies. Treatment introduced at an\nearly stage, when CAs or cerebellar atrophy is mild, is associated with better prognosis. Preservation\nof the \u201ccerebellar reserve\u201d is necessary for the improvement of CAs and resilience of the cerebellar\nnetworks. In this regard, we emphasize the therapeutic principle of \u201cTime is Cerebellum\u201d in\nIMCAs.</jats:p>\n</jats:sec>", "DOI": "10.2174/1570159x16666180917105033", "type": "journal-article", "created": {"date-parts": [[2018, 9, 17]], "date-time": "2018-09-17T11:52:04Z", "timestamp": 1537185124000}, "page": "33-58", "update-policy": "http://dx.doi.org/10.2174/bsp_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges"], "prefix": "10.2174", "volume": "17", "author": [{"given": "Hiroshi", "family": "Mitoma", "sequence": "first", "affiliation": [{"name": "Medical Education Promotion Center, Tokyo Medical University, Tokyo, Japan"}]}, {"given": "Mario", "family": "Manto", "sequence": "additional", "affiliation": [{"name": "Service des Neurosciences, UMons, 7000 Mons, Belgium"}]}, {"given": "Christiane S.", "family": "Hampe", "sequence": "additional", "affiliation": [{"name": "University of Washington, School of Medicine, Seattle, WA 98109, United States"}]}], "member": "965", "reference": [{"key": "ref=1", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1016/B978-0-444-51892-7.00011-5", "volume": "103", "author": "Hadjivassiliou M.", "year": "2012", "unstructured": "Hadjivassiliou M. Handb Clin Neurol, Immune-mediated acquired ataxias.,, 2012, 103,, 189-199,[http://dx.doi.org/10.1016/B978-0-444-51892-7.00011-]. [PMID: 218278].", "journal-title": "Handb Clin Neurol"}, {"key": "ref=2", "doi-asserted-by": "crossref", "first-page": "1582", "DOI": "10.1016/S0140-6736(98)05342-2", "volume": "352", "author": "Hadjivassiliou M.", "year": "1998", "unstructured": "Hadjivassiliou M, Gr\u00fcnewald RA, Chattopadhyay AK, Davies-Jones GA, Gibson A, Jarratt JA, Kandler RH, Lobo A, Powell T, Smith CM. Lancet, Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia.,, 1998, 352,, 1582-1585,[http://dx.doi.org/10.1016/S0140-6736(98)05342-]. [PMID: 9843].", "journal-title": "Lancet"}, {"key": "ref=3", "doi-asserted-by": "crossref", "first-page": "1135", "DOI": "10.1136/jnnp.2003.034447", "volume": "75", "author": "Graus F.", "year": "2004", "unstructured": "Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler Ch, Verschuuren JJ, Vincent A, Voltz R. J Neurol Neurosurg Psychiatry, Recommended diagnostic criteria for paraneoplastic neurological syndromes.,, 2004, 75,, 1135-1140,[http://dx.doi.org/10.1136/jnnp. 2003.034]. [PMID: 15258].", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "ref=4", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1016/S1474-4422(08)70060-7", "volume": "7", "author": "Dalmau J.", "year": "2008", "unstructured": "Dalmau J, Rosenfeld MR. Lancet Neurol, Paraneoplastic syndromes of the CNS.,, 2008, 7,, 327-340,[http://dx.doi.org/10.1016/ S1474-4422(08)70060-]. [PMID: 18339].", "journal-title": "Lancet Neurol"}, {"key": "ref=5", "doi-asserted-by": "crossref", "first-page": "731", "DOI": "10.1111/ene.12368", "volume": "21", "author": "Ducray F.", "year": "2014", "unstructured": "Ducray F, Demarquay G, Graus F, Decullier E, Antoine JC, Giometto B, Psimaras D, Delattre JY, Carpentier AF, Honnorat J. Eur J Neurol, Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experience.,, 2014, 21,, 731-735,[http://dx.doi.org/10.1111/ene.12]. [PMID: 244718].", "journal-title": "Eur J Neurol"}, {"key": "ref=6", "author": "Jarius S.", "year": "2015", "unstructured": "Jarius S, Wildemann B. J Neuroinflammation, Medusa-head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VII.,, 2015, 21,, 731-,", "journal-title": "J Neuroinflammation"}, {"key": "ref=7", "author": "Jarius S.", "year": "2015", "unstructured": "Jarius S, Wildemann B. J Neuroinflammation, Medusa-head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ ARHGAP26 and anti-VGCC.,, 2015, 21,, 731-,", "journal-title": "J Neuroinflammation"}, {"key": "ref=8", "author": "Jarius S.", "year": "2015", "unstructured": "Jarius S, Wildemann B. J Neuroinflammation, Medusa-head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.,, 2015, 21,, 731-,", "journal-title": "J Neuroinflammation"}, {"key": "ref=9", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1001/archneur.58.2.225", "volume": "58", "author": "Honnorat J.", "year": "2001", "unstructured": "Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, Maestre J, Fabien N, Vighetto A, Casamitjana R, Thivolet C, Tavolato B, Antoine J, Trouillas P, Graus F. Arch Neurol, Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.,, 2001, 58,, 225-230,[http:// dx.doi.org/10.1001/archneur.58.2.]. [PMID: 111769].", "journal-title": "Arch Neurol"}, {"key": "ref=10", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1007/s12311-015-0664-x", "volume": "15", "author": "Mitoma H.", "year": "2016", "unstructured": "Mitoma H, Adhikari K, Aeschlimann D, Chattopadhyay P, Hadjivassiliou M, Hampe CS, Honnorat J, Joubert B, Kakei S, Lee J, Manto M, Matsunaga A, Mizusawa H, Nanri K, Shanmugarajah P, Yoneda M, Yuki N. Cerebellum, Consensus Paper: Neuroimmune mechanisms of cerebellar ataxias.,, 2016, 15,, 213-232,[http://dx.doi.org/10.1007/s12311-015-0664-x]. [PMID: 258238].", "journal-title": "Cerebellum"}, {"key": "ref=11", "doi-asserted-by": "crossref", "first-page": "14", "DOI": "10.1186/s40673-015-0034-y", "volume": "2", "author": "Mitoma H.", "year": "2015", "unstructured": "Mitoma H, Hadjivassiliou M, Honnorat J. Cerebellum Ataxias, Guidelines for treatment of immune-mediated cerebellar ataxias.,, 2015, 2,, 14-,[http://dx.doi.org/10.1186/s40673-015-0034-y]. [PMID: 265615].", "journal-title": "Cerebellum Ataxias"}, {"key": "ref=12", "doi-asserted-by": "crossref", "first-page": "396", "DOI": "10.1177/1756285616648940", "volume": "9", "author": "Mitoma H.", "year": "2016", "unstructured": "Mitoma H, Manto M. Ther Adv Neurol Disorder, The physiological basis of therapies for cerebellar ataxias.,, 2016, 9,, 396-413,[http://dx.doi.org/10.1177/17562856166489]. [PMID: 275828].", "journal-title": "Ther Adv Neurol Disorder"}, {"key": "ref=13", "doi-asserted-by": "crossref", "first-page": "2913297", "DOI": "10.1155/2017/2913297", "volume": "2017", "author": "Mitoma H.", "year": "2017", "unstructured": "Mitoma H, Manto M, Hampe CS. J Immunol Res, Pathogenic roles of glutamic acid decarboxylase 65 autoantibodies in cerebellar ataxias.,, 2017, 2017,, 2913297-,[http://dx.doi.org/10.1155/2017/ 2913]. [PMID: 283865].", "journal-title": "J Immunol Res"}, {"key": "ref=14", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1186/s40673-017-0073-7", "volume": "4", "author": "Mitoma H.", "year": "2017", "unstructured": "Mitoma H, Manto M, Hampe CS. Cerebellum Ataxias, Immune-mediated cerebellar ataxias: from bench to bedside.,, 2017, 4,, 16-,[http://dx.doi.org/10.1186/s40673-017-0073-]. [PMID: 289440].", "journal-title": "Cerebellum Ataxias"}, {"key": "ref=15", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1136/jnnp-2016-314863", "volume": "88", "author": "Hadjivassiliou M.", "year": "2017", "unstructured": "Hadjivassiliou M, Martindale J, Shanmugarajah P, Gr\u00fcnewald RA, Sarrigiannis PG, Beauchamp N, Garrard K, Warburton R, Sanders DS, Friend D, Duty S, Taylor J, Hoggard N. J Neurol Neurosurg Psychiatry, Causes of progressive cerebellar ataxia: prospective evaluation of 1500 patients.,, 2017, 88,, 301-309,[http://dx.doi.org/10.1136/jnnp-2016-3148]. [PMID: 27965].", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "ref=16", "author": "Hadjivassiliou M.", "year": "2017", "unstructured": "Hadjivassiliou M. CNS Neurol Disord Drug Targets, Advances in therapies of cerebellar disorders: Immune-mediated ataxias.,, 2017, 88,, 301-,[http://dx.doi.org/10.2174/18715273176661712211105]. [PMID: 292686].", "journal-title": "CNS Neurol Disord Drug Targets"}, {"key": "ref=17", "first-page": "13", "volume": "20", "author": "Charcot J.M.", "year": "1868", "unstructured": "Charcot JM. CR Soc Biol (Paris), S\u00e9ance du 14 mars.,, 1868, 20,, 13-,", "journal-title": "CR Soc Biol (Paris)"}, {"key": "ref=18", "first-page": "674", "volume": "38", "author": "Brouwer B.", "year": "1919", "unstructured": "Brouwer B. Neurol Zentralbl, Beitrag zur Kenntnis der chronischen diffusen Kleinhirnerkrankungen.,, 1919, 38,, 674-682,", "journal-title": "Neurol Zentralbl"}, {"key": "ref=19", "doi-asserted-by": "crossref", "first-page": "1370", "DOI": "10.1002/mds.22129", "volume": "23", "author": "Hadjivassiliou M.", "year": "2008", "unstructured": "Hadjivassiliou M, Boscolo S, Tongiorgi E, Gr\u00fcnewald RA, Sharrack B, Sanders DS, Woodroofe N, Davies-Jones GA. Mov Disord, Cerebellar ataxia as a possible organ-specific autoimmune disease.,, 2008, 23,, 1370-1377,[http://dx.doi.org/10.1002/ mds.22]. [PMID: 18546].", "journal-title": "Mov Disord"}, {"key": "ref=20", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.1212/WNL.41.2_Part_1.228", "volume": "41", "author": "Shaw P.J.", "year": "1991", "unstructured": "Shaw PJ, Walls TJ, Newman PK, Cleland PG, Cartlidge NE. Neurology, Hashimoto\u2019s encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers--report of 5 cases.,, 1991, 41,, 228-233,[http://dx.doi.org/10.1212/ WNL.41.2_Part_1.]. [PMID: 1992].", "journal-title": "Neurology"}, {"key": "ref=21", "doi-asserted-by": "crossref", "first-page": "14", "DOI": "10.1159/000342217", "volume": "69", "author": "Matsunaga A.", "year": "2013", "unstructured": "Matsunaga A, Ikawa M, Fujii A, Nakamoto Y, Kuriyama M, Yoneda M. Eur Neurol, Hashimoto\u2019s encephalopathy as a treatable adult-onset cerebellar ataxia mimicking spinocerebellar degeneration.,, 2013, 69,, 14-20,[http://dx.doi.org/10.1159/000342]. [PMID: 231288].", "journal-title": "Eur Neurol"}, {"key": "ref=22", "author": "Mitoma H.", "year": "2014", "unstructured": "Mitoma H, Yoneda M, Saitow F, Suzuki H, Matsunaga A, Ikawa M, Mizusawa H. Neurol Clin Neurosci, Presynaptic dysfunction caused by CSF from a patient with ataxic form of Hashimoto\u2019s encephalopathy.,, 2014, 69,, 14-,[http://dx.doi.org/10.1111/ ncn3.].", "journal-title": "Neurol Clin Neurosci"}, {"key": "ref=23", "doi-asserted-by": "crossref", "first-page": "1263", "DOI": "10.1007/s00431-014-2391-6", "volume": "173", "author": "Hilberath J.M.", "year": "2014", "unstructured": "Hilberath JM, Schmidt H, Wolf GK. Eur J Pediatr, Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): case report of reversible coma and status epilepticus in an adolescent patient and review of the literature.,, 2014, 173,, 1263-1273,[http://dx.doi.org/10.1007/s00431-014-2391-]. [PMID: 250849].", "journal-title": "Eur J Pediatr"}, {"key": "ref=24", "doi-asserted-by": "crossref", "first-page": "160", "DOI": "10.1186/1742-2094-9-160", "volume": "9", "author": "Melzer N.", "year": "2012", "unstructured": "Melzer N, Golombeck KS, Gross CC, Meuth SG, Wiendl H. J Neuroinflammation, Cytotoxic CD8+ T cells and CD138+ plasma cells prevail in cerebrospinal fluid in non-paraneoplastic cerebellar ataxia with contactin-associated protein-2 antibodies.,, 2012, 9,, 160-,[http://dx.doi.org/10.1186/1742-2094-9-]. [PMID: 22759].", "journal-title": "J Neuroinflammation"}, {"key": "ref=25", "doi-asserted-by": "crossref", "first-page": "e255", "DOI": "10.1212/NXI.0000000000000255", "volume": "3", "author": "Miske R.", "year": "2016", "unstructured": "Miske R, Gross CC, Scharf M, Golombeck KS, Hartwig M, Bhatia U. Neurol Neuroimmunol Neuroinflamm, Neurochondrin is a neural target antigen in autoimmune cerebellar degeneration.,, 2016, 3,, e255-,[http://dx.doi.org/10.1212/NXI.0000000000000]. [PMID: 274585].", "journal-title": "Neurol Neuroimmunol Neuroinflamm"}, {"key": "ref=26", "doi-asserted-by": "crossref", "first-page": "76", "DOI": "10.1016/j.jns.2013.03.002", "volume": "333", "author": "Rostami A.", "year": "2013", "unstructured": "Rostami A, Ciric B. J Neurol Sci, Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.,, 2013, 333,, 76-87,[http://dx.doi.org/10.1016/j.jns.2013.03.00]. [PMID: 235787].", "journal-title": "J Neurol Sci"}, {"key": "ref=27", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1186/s12974-017-0892-8", "volume": "14", "author": "Danikowski K.M.", "year": "2017", "unstructured": "Danikowski KM, Jayaraman S, Prabhakar BS. J Neuroinflammation, Regulatory T cells in multiple sclerosis and myasthenia gravis.,, 2017, 14,, 117-,[http://dx.doi.org/10.1186/s12974-017-0892-]. [PMID: 285996].", "journal-title": "J Neuroinflammation"}, {"key": "ref=28", "doi-asserted-by": "crossref", "first-page": "132", "DOI": "10.1002/ana.21744", "volume": "66", "author": "Friese M.A.", "year": "2009", "unstructured": "Friese MA, Fugger L. Ann Neurol, Pathogenic CD8(+) T cells in multiple sclerosis.,, 2009, 66,, 132-141,[http://dx.doi.org/ 10.1002/ana.217]. [PMID: 19743].", "journal-title": "Ann Neurol"}, {"key": "ref=29", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.1046/j.1365-2249.2002.01931.x", "volume": "129", "author": "Costa M.", "year": "2002", "unstructured": "Costa M, Saiz A, Casamitjana R, Casta\u00f1er MF, Sanmart\u00ed A, Graus F, Jaraquemada D. Clin Exp Immunol, T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity.,, 2002, 129,, 471-478,[http://dx.doi.org/10.1046/j.1365-2249.2002.01931. x]. [PMID: 121978].", "journal-title": "Clin Exp Immunol"}, {"key": "ref=30", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1136/jnnp-2017-316583", "volume": "89", "author": "Iorio R.", "year": "2018", "unstructured": "Iorio R, Damato V, Evoli A, Gessi M, Gaudino S, Di Lazzaro V, Spagni G, Sluijs JA, Hol EM. J Neurol Neurosurg Psychiatry, Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients.,, 2018, 89,, 138-146,[http://dx.doi.org/10.1136/jnnp-2017-3165]. [PMID: 28951].", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "ref=31", "first-page": "437231", "volume": "2014", "author": "Vojdani A.", "year": "2014", "unstructured": "Vojdani A. Autoimmune Dis, A Potential Link between Environmental Triggers and Autoimmunity.,, 2014, 2014,, 437231-,[http://dx. doi.org/10.1155/2014/437]. [PMID: 246887].", "journal-title": "Autoimmune Dis"}, {"key": "ref=32", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1016/j.autrev.2016.01.017", "volume": "15", "author": "Zaenker P.", "year": "2016", "unstructured": "Zaenker P, Gray ES, Ziman MR. Autoimmun Rev, Autoantibody Production in Cancer--The Humoral Immune Response toward Autologous Antigens in Cancer Patients.,, 2016, 15,, 477-483,[http://dx.doi.org/10.1016/j.autrev.2016.01.0]. [PMID: 2682790].", "journal-title": "Autoimmun Rev"}, {"key": "ref=33", "doi-asserted-by": "crossref", "first-page": "8", "DOI": "10.1016/j.canlet.2008.11.009", "volume": "281", "author": "Bei R.", "year": "2009", "unstructured": "Bei R, Masuelli L, Palumbo C, Modesti M, Modesti A. Cancer Lett, A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth.,, 2009, 281,, 8-23,[http:// dx.doi.org/10.1016/j.canlet.2008.11.00]. [PMID: 19091].", "journal-title": "Cancer Lett"}, {"key": "ref=34", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1126/science.1071059", "volume": "296", "author": "Matzinger P.", "year": "2002", "unstructured": "Matzinger P. Science, The danger model: a renewed sense of self.,, 2002, 296,, 301-305,[http://dx.doi.org/10.1126/science. 10710]. [PMID: 119510].", "journal-title": "Science"}, {"key": "ref=35", "first-page": "393", "volume": "11", "author": "de Vlam K.", "year": "1993", "unstructured": "de Vlam K, De Keyser F, Verbruggen G, Vandenbossche M, Vanneuville B, D\u2019Haese D, Veys EM. Clin Exp Rheumatol, Detection and identification of antinuclear autoantibodies in the serum of normal blood donors.,, 1993, 11,, 393-397,[PMID: 84035].", "journal-title": "Clin Exp Rheumatol"}, {"key": "ref=36", "doi-asserted-by": "crossref", "first-page": "2319", "DOI": "10.1002/art.34380", "volume": "64", "author": "Satoh M.", "year": "2012", "unstructured": "Satoh M, Chan EK, Ho LA, Rose KM, Parks CG, Cohn RD, Jusko TA, Walker NJ, Germolec DR, Whitt IZ, Crockett PW, Pauley BA, Chan JY, Ross SJ, Birnbaum LS, Zeldin DC, Miller FW. Arthritis Rheum, Prevalence and sociodemographic correlates of antinuclear antibodies in the United States.,, 2012, 64,, 2319-2327,[http://dx.doi.org/10.1002/art. 34]. [PMID: 222379].", "journal-title": "Arthritis Rheum"}, {"key": "ref=37", "doi-asserted-by": "crossref", "first-page": "e000076", "DOI": "10.1136/bmjdrc-2014-000076", "volume": "3", "author": "S\u00f8rgjerd E.P.", "year": "2015", "unstructured": "S\u00f8rgjerd EP, Thorsby PM, Torjesen PA, Skorpen F, Kval\u00f8y K, Grill V. BMJ Open Diabetes Res Care, Presence of anti-GAD in a non-diabetic population of adults; time dynamics and clinical influence: results from the HUNT study.,, 2015, 3,, e000076-,[http://dx.doi.org/10.1136/bmjdrc-2014-0000]. [PMID: 261575].", "journal-title": "BMJ Open Diabetes Res Care"}, {"key": "ref=38", "doi-asserted-by": "crossref", "first-page": "1195", "DOI": "10.1590/S1807-59322009001200009", "volume": "64", "author": "Caglar E.", "year": "2009", "unstructured": "Caglar E, Ugurlu S, Ozenoglu A, Can G, Kadioglu P, Dobrucali A. Clinics (S\u00e3o Paulo), Autoantibody frequency in celiac disease.,, 2009, 64,, 1195-1200,[http://dx.doi.org/10.1590/S1807-5932200900120000]. [PMID: 2003770].", "journal-title": "Clinics (S\u00e3o Paulo)"}, {"key": "ref=39", "doi-asserted-by": "crossref", "first-page": "663", "DOI": "10.4158/EP12318.OR", "volume": "19", "author": "Hampe C.S.", "year": "2013", "unstructured": "Hampe CS, Maitland ME, Gilliam LK, Phan TH, Sweet IR, Radtke JR, Bota V, Ransom BR, Hirsch IB. Endocr Pract, High titers of autoantibodies to glutamate decarboxylase in type 1 diabetes patients: epitope analysis and inhibition of enzyme activity.,, 2013, 19,, 663-668,[http://dx.doi.org/10.4158/EP12318. OR]. [PMID: 23512].", "journal-title": "Endocr Pract"}, {"key": "ref=40", "doi-asserted-by": "crossref", "first-page": "247", "DOI": "10.1111/cei.12026", "volume": "171", "author": "Ch\u00e9ramy M.", "year": "2013", "unstructured": "Ch\u00e9ramy M, Hampe CS, Ludvigsson J, Casas R. Clin Exp Immunol, Characteristics of in-vitro phenotypes of glutamic acid decarboxylase 65 autoantibodies in high-titre individuals.,, 2013, 171,, 247-254,[http://dx.doi.org/10.1111/cei.120]. [PMID: 23379].", "journal-title": "Clin Exp Immunol"}, {"key": "ref=41", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.2169/internalmedicine.9190-17", "volume": "57", "author": "Nakamura Y.", "year": "2018", "unstructured": "Nakamura Y, Nakajima H, Hosokawa T, Yamane K, Ishida S, Kimura F. Intern Med, Acute cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies mimicking miller fisher syndrome.,, 2018, 57,, 269-271,[http://dx.doi.org/10.2169/ internalmedicine.9190-]. [PMID: 29093].", "journal-title": "Intern Med"}, {"key": "ref=42", "doi-asserted-by": "crossref", "first-page": "2553", "DOI": "10.1093/brain/awn183", "volume": "131", "author": "Saiz A.", "year": "2008", "unstructured": "Saiz A, Blanco Y, Sabater L, Gonz\u00e1lez F, Bataller L, Casamitjana R, Rami\u00f3-Torrent\u00e0 L, Graus F. Brain, Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.,, 2008, 131,, 2553-2563,[http://dx.doi.org/10.1093/brain/awn]. [PMID: 186877].", "journal-title": "Brain"}, {"key": "ref=43", "doi-asserted-by": "crossref", "first-page": "386", "DOI": "10.1136/jnnp.70.3.386", "volume": "70", "author": "Takenoshita H.", "year": "2001", "unstructured": "Takenoshita H, Shizuka-Ikeda M, Mitoma H, Song S, Harigaya Y, Igeta Y, Yaguchi M, Ishida K, Shoji M, Tanaka M, Mizusawa H, Okamoto K. J Neurol Neurosurg Psychiatry, Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia.,, 2001, 70,, 386-389,[http://dx.doi.org/10.1136/jnnp.70.3.]. [PMID: 111818].", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "ref=44", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1186/1750-1172-6-3", "volume": "6", "author": "Manto M.U.", "year": "2011", "unstructured": "Manto MU, Hampe CS, Rogemond V, Honnorat J. Orphanet J Rare Dis, Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia.,, 2011, 6,, 3-,[http://dx.doi.org/10.1186/1750-1172-6-]. [PMID: 212948].", "journal-title": "Orphanet J Rare Dis"}, {"key": "ref=45", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1186/1742-2094-6-31", "volume": "6", "author": "Hill K.E.", "year": "2009", "unstructured": "Hill KE, Clawson SA, Rose JW, Carlson NG, Greenlee JE. J Neuroinflammation, Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics.,, 2009, 6,, 31-,[http://dx.doi.org/10.1186/1742-2094-6-]. [PMID: 1987460].", "journal-title": "J Neuroinflammation"}, {"key": "ref=46", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1016/S0167-5699(96)90258-3", "volume": "17", "author": "Alarcon-Segovia D.", "year": "1996", "unstructured": "Alarcon-Segovia D, Ruiz-Arg\u00fcelles A, Llorente L. Immunol Today, Broken dogma: penetration of autoantibodies into living cells.,, 1996, 17,, 163-164,[PMID: 8871].", "journal-title": "Immunol Today"}, {"key": "ref=47", "doi-asserted-by": "crossref", "first-page": "997", "DOI": "10.1097/NEN.0b013e3181f0c82b", "volume": "69", "author": "Greenlee J.E.", "year": "2010", "unstructured": "Greenlee JE, Clawson SA, Hill KE, Wood BL, Tsunoda I, Carlson NG. J Neuropathol Exp Neurol, Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures.,, 2010, 69,, 997-1007,[http://dx.doi.org/10.1097/NEN.0b013e3181 f0c82b]. [PMID: 20838].", "journal-title": "J Neuropathol Exp Neurol"}, {"key": "ref=48", "doi-asserted-by": "crossref", "first-page": "e0123446", "DOI": "10.1371/journal.pone.0123446", "volume": "10", "author": "Greenlee J.E.", "year": "2015", "unstructured": "Greenlee JE, Clawson SA, Hill KE, Wood B, Clardy SL, Tsunoda I, Carlson NG. PLoS One, Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.,, 2015, 10,, e0123446-,[http://dx.doi.org/10. 1371/journal.pone.0123]. [PMID: 25885].", "journal-title": "PLoS One"}, {"key": "ref=49", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1007/BF00309627", "volume": "89", "author": "Greenlee J.E.", "year": "1995", "unstructured": "Greenlee JE, Burns JB, Rose JW, Jaeckle KA, Clawson S. Acta Neuropathol, Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption.,, 1995, 89,, 341-345,[http://dx.doi.org/10.1007/ BF003096]. [PMID: 76107].", "journal-title": "Acta Neuropathol"}, {"key": "ref=50", "doi-asserted-by": "crossref", "first-page": "690", "DOI": "10.1001/archneur.1985.04060070084021", "volume": "42", "author": "Borges L.F.", "year": "1985", "unstructured": "Borges LF, Busis NA. Arch Neurol, Intraneuronal accumulation of myeloma proteins.,, 1985, 42,, 690-694,[http://dx.doi.org/ 10.1001/archneur.1985.040600700840]. [PMID: 39259].", "journal-title": "Arch Neurol"}, {"key": "ref=51", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1016/0022-510X(86)90150-4", "volume": "73", "author": "Fabian R.H.", "year": "1986", "unstructured": "Fabian RH, Ritchie TC. J Neurol Sci, Intraneuronal IgG in the central nervous system.,, 1986, 73,, 257-267,[http://dx.doi.org/10. 1016/0022-510X(86)90150-]. [PMID: 352280].", "journal-title": "J Neurol Sci"}, {"key": "ref=52", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1016/0022-510X(90)90011-B", "volume": "100", "author": "Fishman P.S.", "year": "1990", "unstructured": "Fishman PS, Farrand DA, Kristt DA. J Neurol Sci, Internalization of plasma proteins by cerebellar Purkinje cells.,, 1990, 100,, 43-49,[http://dx.doi.org/10.1016/0022-510X(90)90011-B]. [PMID: 1708].", "journal-title": "J Neurol Sci"}, {"key": "ref=53", "doi-asserted-by": "crossref", "first-page": "82", "DOI": "10.1016/0022-510X(91)90198-G", "volume": "106", "author": "Graus F.", "year": "1991", "unstructured": "Graus F, Illa I, Agusti M, Ribalta T, Cruz-Sanchez F, Juarez C. J Neurol Sci, Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model.,, 1991, 106,, 82-87,[http://dx.doi.org/10.1016/0022-510X(91)90198-G]. [PMID: 1779].", "journal-title": "J Neurol Sci"}, {"key": "ref=54", "doi-asserted-by": "crossref", "first-page": "82", "DOI": "10.1186/1750-1172-8-82", "volume": "8", "author": "Hampe C.S.", "year": "2013", "unstructured": "Hampe CS, Petrosini L, De Bartolo P, Caporali P, Cutuli D, Laricchiuta D, Foti F, Radtke JR, Vidova V, Honnorat J, Manto M. Orphanet J Rare Dis, Monoclonal antibodies to 65kDa glutamate decarboxylase induce epitope specific effects on motor and cognitive functions in rats.,, 2013, 8,, 82-,[http://dx.doi. org/10.1186/1750-1172-8-]. [PMID: 237386].", "journal-title": "Orphanet J Rare Dis"}, {"key": "ref=55", "doi-asserted-by": "crossref", "first-page": "2093", "DOI": "10.1093/cercor/bht060", "volume": "24", "author": "Vega-Flores G.", "year": "2014", "unstructured": "Vega-Flores G, Rubio SE, Jurado-Parras MT, G\u00f3mez-Climent M\u00c1, Hampe CS, Manto M, Soriano E, Pascual M, Gruart A, Delgado-Garc\u00eda JM. Cereb Cortex, The GABAergic septohippocampal pathway is directly involved in internal processes related to operant reward learning.,, 2014, 24,, 2093-2107,[http://dx.doi.org/10.1093/cercor/bht0]. [PMID: 23479].", "journal-title": "Cereb Cortex"}, {"key": "ref=56", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.3389/fnbeh.2015.00078", "volume": "9", "author": "Manto M.", "year": "2015", "unstructured": "Manto M, Honnorat J, Hampe CS, Guerra-Narbona R, L\u00f3pez-Ramos JC, Delgado-Garc\u00eda JM, Saitow F, Suzuki H, Yanagawa Y, Mizusawa H, Mitoma H. Front Behav Neurosci, Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotransmission and affect motor learning and behavioral functions.,, 2015, 9,, 78-,[http:// dx.doi.org/10.3389/fnbeh.2015.000]. [PMID: 258705].", "journal-title": "Front Behav Neurosci"}, {"key": "ref=57", "doi-asserted-by": "crossref", "first-page": "1221", "DOI": "10.1136/jnnp.74.9.1221", "volume": "74", "author": "Hadjivassiliou M.", "year": "2003", "unstructured": "Hadjivassiliou M, Davies-Jones GAB, Sanders DS, Gr\u00fcnewald RA. J Neurol Neurosurg Psychiatry, Dietary treatment of gluten ataxia.,, 2003, 74,, 1221-1224,[http://dx.doi.org/ 10.1136/jnnp.74.9.1]. [PMID: 129339].", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "ref=58", "doi-asserted-by": "crossref", "first-page": "1300", "DOI": "10.1111/j.1468-1331.2008.02305.x", "volume": "15", "author": "Souayah N.", "year": "2008", "unstructured": "Souayah N, Chin RL, Brannagan TH, Latov N, Green PHR, Kokoszka A, Sander HW. Eur J Neurol, Effect of intravenous immunoglobulin on cerebellar ataxia and neuropathic pain associated with celiac disease.,, 2008, 15,, 1300-1303,[http://dx.doi.org/10.1111/j.1468-1331.2008.02305.x]. [PMID: 190495].", "journal-title": "Eur J Neurol"}, {"key": "ref=59", "doi-asserted-by": "crossref", "first-page": "560", "DOI": "10.1136/jnnp.72.5.560", "volume": "72", "author": "Hadjivassiliou M.", "year": "2002", "unstructured": "Hadjivassiliou M, Gr\u00fcnewald RA, Davies-Jones GAB. J Neurol Neurosurg Psychiatry, Gluten sensitivity as a neurological illness.,, 2002, 72,, 560-563,[http://dx.doi.org/10.1136/jnnp.72.5.5]. [PMID: 119710].", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "ref=60", "doi-asserted-by": "crossref", "first-page": "494", "DOI": "10.1007/s12311-008-0052-x", "volume": "7", "author": "Hadjivassiliou M.", "year": "2008", "unstructured": "Hadjivassiliou M, Sanders DS, Woodroofe N, Williamson C, Gr\u00fcnewald RA. Cerebellum, Gluten ataxia.,, 2008, 7,, 494-498,[http://dx.doi.org/10.1007/s12311-008-0052-x]. [PMID: 187879].", "journal-title": "Cerebellum"}, {"key": "ref=61", "doi-asserted-by": "crossref", "first-page": "705", "DOI": "10.1212/WNL.0000000000004237", "volume": "89", "author": "Hadjivassiliou M.", "year": "2017", "unstructured": "Hadjivassiliou M, Gr\u00fcnewald RA, Sanders DS, Shanmugarajah P, Hoggard N. Neurology, Effect of gluten-free diet on cerebellar MR spectroscopy in gluten ataxia.,, 2017, 89,, 705-709,[http://dx.doi.org/10.1212/WNL.0000000000004]. [PMID: 287245].", "journal-title": "Neurology"}, {"key": "ref=62", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1186/2053-8871-1-11", "volume": "1", "author": "Sarrigiannis P.G.", "year": "2014", "unstructured": "Sarrigiannis PG, Hoggard N, Aeschlimann D, Sanders DS, Gr\u00fcnewald RA, Unwin ZC, Hadjivassiliou M. Cerebellum Ataxias, Myoclonus ataxia and refractory coeliac disease.,, 2014, 1,, 11-,[http://dx.doi.org/10.1186/2053-8871-1-]. [PMID: 263310].", "journal-title": "Cerebellum Ataxias"}, {"key": "ref=63", "doi-asserted-by": "crossref", "first-page": "1912", "DOI": "10.1053/j.gastro.2009.09.008", "volume": "137", "author": "Schuppan D.", "year": "2009", "unstructured": "Schuppan D, Junker Y, Barisani D. Gastroenterology, Celiac disease: from pathogenesis to novel therapies.,, 2009, 137,, 1912-1933,[http://dx.doi.org/10.1053/j.gastro.2009.09.00]. [PMID: 197666].", "journal-title": "Gastroenterology"}, {"key": "ref=64", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1007/s00726-011-1091-z", "volume": "44", "author": "Thomas H.", "year": "2013", "unstructured": "Thomas H, Beck K, Adamczyk M, Aeschlimann P, Langley M, Oita RC, Thiebach L, Hils M, Aeschlimann D. Amino Acids, Transglutaminase 6: a protein associated with central nervous system development and motor function.,, 2013, 44,, 161-177,[http://dx.doi.org/10.1007/s00726-011-1091-z]. [PMID: 21984].", "journal-title": "Amino Acids"}, {"key": "ref=65", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1053/j.gastro.2007.04.070", "volume": "133", "author": "Cervio E.", "year": "2007", "unstructured": "Cervio E, Volta U, Verri M, Boschi F, Pastoris O, Granito A, Barbara G, Parisi C, Felicani C, Tonini M, De Giorgio R. Gastroenterology, Sera of patients with celiac disease and neurologic disorders evoke a mitochondrial-dependent apoptosis in vitro.,, 2007, 133,, 195-206,[http://dx.doi.org/10.1053/j.gastro.2007. 04.0]. [PMID: 17631].", "journal-title": "Gastroenterology"}, {"key": "ref=66", "doi-asserted-by": "crossref", "first-page": "e9698", "DOI": "10.1371/journal.pone.0009698", "volume": "5", "author": "Boscolo S.", "year": "2010", "unstructured": "Boscolo S, Lorenzon A, Sblattero D, Florian F, Stebel M, Marzari R, Not T, Aeschlimann D, Ventura A, Hadjivassiliou M, Tongiorgi E. PLoS One, Anti transglutaminase antibodies cause ataxia in mice.,, 2010, 5,, e9698-,[http://dx.doi.org/10.1371/ journal.pone.00096]. [PMID: 203006].", "journal-title": "PLoS One"}, {"key": "ref=67", "doi-asserted-by": "crossref", "first-page": "5981", "DOI": "10.4049/jimmunol.1300183", "volume": "190", "author": "Iversen R.", "year": "2013", "unstructured": "Iversen R, Di Niro R, Stamnaes J, Lundin KE, Wilson PC, Sollid LM. J Immunol, Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells.,, 2013, 190,, 5981-5991,[http://dx.doi.org/10.4049/jimmunol.1300]. [PMID: 23690].", "journal-title": "J Immunol"}, {"key": "ref=68", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.4331/wjbc.v1.i5.181", "volume": "1", "author": "Ricotta M.", "year": "2010", "unstructured": "Ricotta M, Iannuzzi M, Vivo GD, Gentile V. World J Biol Chem, Physio-pathological roles of transglutaminase-catalyzed reactions.,, 2010, 1,, 181-187,[http://dx.doi.org/10.4331/wjbc. v1.i5.]. [PMID: 2154100].", "journal-title": "World J Biol Chem"}, {"key": "ref=69", "doi-asserted-by": "crossref", "first-page": "489", "DOI": "10.1097/CCO.0000000000000222", "volume": "27", "author": "H\u00f6ftberger R.", "year": "2015", "unstructured": "H\u00f6ftberger R, Rosenfeld MR, Dalmau J. Curr Opin Oncol, Update on neurological paraneoplastic syndromes.,, 2015, 27,, 489-495,[http://dx.doi.org/10.1097/CCO.0000000000000]. [PMID: 263356].", "journal-title": "Curr Opin Oncol"}, {"key": "ref=70", "doi-asserted-by": "crossref", "first-page": "408", "DOI": "10.1016/j.neurol.2010.07.032", "volume": "167", "author": "Demarquay G.", "year": "2011", "unstructured": "Demarquay G, Honnorat J. Rev Neurol (Paris), Clinical presentation of immune-mediated cerebellar ataxia.,, 2011, 167,, 408-417,[http://dx.doi.org/10.1016/j.neurol.2010.07.0]. [PMID: 210557].", "journal-title": "Rev Neurol (Paris)"}, {"key": "ref=71", "doi-asserted-by": "crossref", "first-page": "294", "DOI": "10.1016/S1474-4422(02)00135-7", "volume": "1", "author": "Voltz R.", "year": "2002", "unstructured": "Voltz R. Lancet Neurol, Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy.,, 2002, 1,, 294-305,[http://dx.doi.org/10.1016/S1474-4422(02)00135-]. [PMID: 12849].", "journal-title": "Lancet Neurol"}, {"key": "ref=72", "doi-asserted-by": "crossref", "first-page": "1931", "DOI": "10.1212/WNL.42.10.1931", "volume": "42", "author": "Peterson K.", "year": "1992", "unstructured": "Peterson K, Rosenblum MK, Kotanides H, Posner JB. Neurology, Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients.,, 1992, 42,, 1931-1937,[http://dx.doi.org/10.1212/WNL.42.10.19]. [PMID: 14075].", "journal-title": "Neurology"}, {"key": "ref=73", "doi-asserted-by": "crossref", "first-page": "713", "DOI": "10.1212/WNL.55.5.713", "volume": "55", "author": "Rojas I.", "year": "2000", "unstructured": "Rojas I, Graus F, Keime-Guibert F, Re\u00f1\u00e9 R, Delattre JY, Ram\u00f3n JM, Dalmau J, Posner JB. Neurology, Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies.,, 2000, 55,, 713-715,[http://dx.doi.org/10.1212/WNL. 55.5.7]. [PMID: 109807].", "journal-title": "Neurology"}, {"key": "ref=74", "doi-asserted-by": "crossref", "first-page": "1411", "DOI": "10.1136/jnnp.2003.025171", "volume": "75", "author": "Candler P.M.", "year": "2004", "unstructured": "Candler PM, Hart PE, Barnett M, Weil R, Rees JH. J Neurol Neurosurg Psychiatry, A follow up study of patients with paraneoplastic neurological disease in the United Kingdom.,, 2004, 75,, 1411-1415,[http://dx.doi.org/10.1136/jnnp.2003.025]. [PMID: 153776].", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "ref=75", "doi-asserted-by": "crossref", "first-page": "479", "DOI": "10.1136/jnnp.68.4.479", "volume": "68", "author": "Keime-Guibert F.", "year": "2000", "unstructured": "Keime-Guibert F, Graus F, Fleury A, Ren\u00e9 R, Honnorat J, Broet P, Delattre JY. J Neurol Neurosurg Psychiatry, Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.,, 2000, 68,, 479-482,[http://dx.doi.org/10.1136/jnnp.68.4.]. [PMID: 10727].", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "ref=76", "doi-asserted-by": "crossref", "first-page": "1409", "DOI": "10.1093/brain/awg133", "volume": "126", "author": "Shams\u2019ili S.", "year": "2003", "unstructured": "Shams\u2019ili S, Grefkens J, de Leeuw B, van den Bent M, Hooijkaas H, van der Holt B, Vecht C, Sillevis Smitt P. Brain, Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.,, 2003, 126,, 1409-1418,[http://dx.doi.org/10.1093/brain/awg]. [PMID: 127640].", "journal-title": "Brain"}, {"key": "ref=77", "doi-asserted-by": "crossref", "first-page": "112", "DOI": "10.1136/jnnp.56.1.112", "volume": "56", "author": "Moll J.W.B.", "year": "1993", "unstructured": "Moll JWB, Henzen-Logmans SC, Van der Mech\u00e9 FG, Vecht CH. J Neurol Neurosurg Psychiatry, Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration.,, 1993, 56,, 112-,[http://dx.doi.org/10.1136/ jnnp.56.1.]. [PMID: 8429].", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "ref=78", "doi-asserted-by": "crossref", "first-page": "814", "DOI": "10.1001/archneur.1995.00540320098016", "volume": "52", "author": "Stark E.", "year": "1995", "unstructured": "Stark E, Wurster U, Patzold U, Sailer M, Haas J. Arch Neurol, Immunological and clinical response to immunosuppressive treatment in paraneoplastic cerebellar degeneration.,, 1995, 52,, 814-818,[http://dx.doi.org/10.1001/archneur.1995.005403200980]. [PMID: 76396].", "journal-title": "Arch Neurol"}, {"key": "ref=79", "doi-asserted-by": "crossref", "first-page": "2153", "DOI": "10.1002/(SICI)1097-0142(19961115)78:10<2153::AID-CNCR16>3.0.CO;2-Y", "volume": "78", "author": "David Y.B.", "year": "1996", "unstructured": "David YB, Warner E, Levitan M, Sutton DM, Malkin MG, Dalmau JO. Cancer, Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin. A case report.,, 1996, 78,, 2153-2156,[http://dx.doi.org/10.1002/(SICI)1097-0142(19961115)78:10<2153:AID-CNCR16>3.0.CO;2-Y]. [PMID: 8918].", "journal-title": "Cancer"}, {"key": "ref=80", "doi-asserted-by": "crossref", "first-page": "299", "DOI": "10.1007/s004150050350", "volume": "246", "author": "Blaes F.", "year": "1999", "unstructured": "Blaes F, Strittmatter M, Merkelbach S, Jost V, Klotz M, Schimrigk K, Hamann GF. J Neurol, Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders.,, 1999, 246,, 299-303,[http://dx.doi.org/10.1007/s004150050]. [PMID: 103676].", "journal-title": "J Neurol"}, {"key": "ref=81", "doi-asserted-by": "crossref", "first-page": "412", "DOI": "10.1136/jnnp.67.3.412", "volume": "67", "author": "Batocchi A.P.", "year": "1999", "unstructured": "Batocchi AP, De Rosa G, Evoli A, Tonali P, Greggi S, Scambia G, Salerno G, Tonali P. J Neurol Neurosurg Psychiatry, Positive response to therapy in a patient with a seropositive paraneoplastic cerebellar degeneration and an endometrioid carcinoma of the vesicovaginal septum.,, 1999, 67,, 412-413,[http://dx. doi.org/10.1136/jnnp.67.3.]. [PMID: 105770].", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "ref=82", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1016/S0022-510X(00)00353-1", "volume": "178", "author": "Mowzoon N.", "year": "2000", "unstructured": "Mowzoon N, Bradley WG. J Neurol Sci, Successful immunosuppressant therapy of severe progressive cerebellar degeneration and sensory neuropathy: a case report.,, 2000, 178,, 63-65,[http:// dx.doi.org/10.1016/S0022-510X(00)00353-]. [PMID: 11018].", "journal-title": "J Neurol Sci"}, {"key": "ref=83", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1007/s00415-005-0882-0", "volume": "253", "author": "Shams\u2019ili S.", "year": "2006", "unstructured": "Shams\u2019ili S, de Beukelaar J, Gratama JW, Hooijkaas H, van den Bent M, van \u2019t Veer M, Sillevis Smitt P. J Neurol, An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes.,, 2006, 253,, 16-20,[http://dx.doi.org/ 10.1007/s00415-005-0882-0]. [PMID: 1644460].", "journal-title": "J Neurol"}, {"key": "ref=84", "doi-asserted-by": "crossref", "first-page": "90", "DOI": "10.1111/j.1744-9987.2006.00348.x", "volume": "10", "author": "Taniguchi Y.", "year": "2006", "unstructured": "Taniguchi Y, Tanji C, Kawai T, Saito H, Marubayashi S, Yorioka N. Ther Apher Dial, A case report of plasmapheresis in paraneoplastic cerebellar ataxia associated with anti-Tr antibody.,, 2006, 10,, 90-93,[http://dx.doi.org/10.1111/j.1744-9987. 2006.00348.x]. [PMID: 16556].", "journal-title": "Ther Apher Dial"}, {"key": "ref=85", "doi-asserted-by": "crossref", "first-page": "1960", "DOI": "10.1080/10428190600678082", "volume": "47", "author": "Geromin A.", "year": "2006", "unstructured": "Geromin A, Candoni A, Marcon G, Ferrari S, Sperotto A, De Luca S, Fanin R. Leuk Lymphoma, Paraneoplastic cerebellar degeneration associated with anti-neuronal anti-Tr antibodies in a patient with Hodgkin\u2019s disease.,, 2006, 47,, 1960-1963,[http:// dx.doi.org/10.1080/104281906006780]. [PMID: 170650].", "journal-title": "Leuk Lymphoma"}, {"key": "ref=86", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1007/s11060-006-9198-x", "volume": "81", "author": "Phuphanich S.", "year": "2007", "unstructured": "Phuphanich S, Brock C. J Neurooncol, Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody.,, 2007, 81,, 67-69,[http://dx.doi.org/10. 1007/s11060-006-9198-x]. [PMID: 16773].", "journal-title": "J Neurooncol"}, {"key": "ref=87", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.1016/j.jns.2008.04.020", "volume": "272", "author": "Th\u00f6ne J.", "year": "2008", "unstructured": "Th\u00f6ne J, Hohaus A, Lamprecht S, Bickel A, Erbguth F. J Neurol Sci, Effective immunosuppressant therapy with cyclophosphamide and corticosteroids in paraneoplastic cerebellar degeneration.,, 2008, 272,, 171-173,[http://dx.doi.org/10.1016/j.jns.2008. 04.0]. [PMID: 18632].", "journal-title": "J Neurol Sci"}, {"key": "ref=88", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1007/s11060-007-9479-z", "volume": "86", "author": "Esposito M.", "year": "2008", "unstructured": "Esposito M, Penza P, Orefice G, Pagano A, Parente E, Abbadessa A, Bonavita V. J Neurooncol, Successful treatment of paraneoplastic cerebellar degeneration with Rituximab.,, 2008, 86,, 363-364,[http://dx.doi.org/10.1007/s11060-007-9479-z]. [PMID: 179240].", "journal-title": "J Neurooncol"}, {"key": "ref=89", "doi-asserted-by": "crossref", "first-page": "946", "DOI": "10.1007/s00415-010-5859-y", "volume": "258", "author": "Schessl J.", "year": "2011", "unstructured": "Schessl J, Schuberth M, Reilich P, Schneiderat P, Strigl-Pill N, Walter MC, Schlotter-Weigel B, Schoser B. J Neurol, Long-term efficiency of intravenously administered immunoglobulin in anti-Yo syndrome with paraneoplastic cerebellar degeneration.,, 2011, 258,, 946-947,[http://dx.doi.org/10.1007/s00415-010-5859-y]. [PMID: 21174].", "journal-title": "J Neurol"}, {"key": "ref=90", "doi-asserted-by": "crossref", "first-page": "1387", "DOI": "10.2169/internalmedicine.51.7019", "volume": "51", "author": "Shimazu Y.", "year": "2012", "unstructured": "Shimazu Y, Minakawa EN, Nishikori M, Ihara M, Hashi Y, Matsuyama H, Hishizawa M, Yoshida S, Kitano T, Kondo T, Ishikawa T, Takahashi R, Takaori-Kondo A. Intern Med, A case of follicular lymphoma associated with paraneoplastic cerebellar degeneration.,, 2012, 51,, 1387-1392,[http://dx.doi.org/ 10.2169/internalmedicine.51.70]. [PMID: 226878].", "journal-title": "Intern Med"}, {"key": "ref=91", "doi-asserted-by": "crossref", "first-page": "986", "DOI": "10.1002/pbc.23314", "volume": "58", "author": "Yeo K.K.", "year": "2012", "unstructured": "Yeo KK, Walter AW, Miller RE, Dalmau J. Pediatr Blood Cancer, Rituximab as potential therapy for paraneoplastic cerebellar degeneration in pediatric Hodgkin disease.,, 2012, 58,, 986-987,[http://dx.doi.org/10.1002/pbc.23]. [PMID: 225329].", "journal-title": "Pediatr Blood Cancer"}, {"key": "ref=92", "doi-asserted-by": "crossref", "first-page": "231", "DOI": "10.1016/j.jnci.2013.07.001", "volume": "25", "author": "Lakshmaiah K.C.", "year": "2013", "unstructured": "Lakshmaiah KC, Viveka BK, Anil KN, Saini ML, Sinha S, Saini KS. J Egypt Natl Canc Inst, Gastric diffuse large B cell lymphoma presenting as paraneoplastic cerebellar degeneration: case report and review of literature.,, 2013, 25,, 231-235,[http://dx.doi.org/10.1016/j.jnci.2013.07.00]. [PMID: 242070].", "journal-title": "J Egypt Natl Canc Inst"}, {"key": "ref=93", "doi-asserted-by": "crossref", "first-page": "355", "DOI": "10.4103/0972-2327.138528", "volume": "17", "author": "Bhargava A.", "year": "2014", "unstructured": "Bhargava A, Bhushan B, Kasundra GM, Shubhakaran K, Pujar GS, Banakar B. Ann Indian Acad Neurol, Response to abdominal hysterectomy with bilateral salpingo-oophorectomy in postmenopausal woman with anti-yo antibody mediated paraneoplastic cerebellar degeneration.,, 2014, 17,, 355-357,[http://dx.doi.org/ 10.4103/0972-2327.1385]. [PMID: 25221].", "journal-title": "Ann Indian Acad Neurol"}, {"key": "ref=94", "doi-asserted-by": "crossref", "first-page": "421", "DOI": "10.1016/j.jocn.2014.06.103", "volume": "22", "author": "Mitchell A.N.", "year": "2015", "unstructured": "Mitchell AN, Bakhos CT, Zimmerman EA. J Clin Neurosci, Anti-Ri-associated paraneoplastic brainstem cerebellar syndrome with coexisting limbic encephalitis in a patient with mixed large cell neuroendocrine lung carcinoma.,, 2015, 22,, 421-423,[http://dx.doi.org/10.1016/j.jocn.2014.06.]. [PMID: 254430].", "journal-title": "J Clin Neurosci"}, {"key": "ref=95", "doi-asserted-by": "crossref", "first-page": "324", "DOI": "10.1186/s12885-016-2349-3", "volume": "16", "author": "Zhu Y.", "year": "2016", "unstructured": "Zhu Y, Chen S, Chen S, Song J, Chen F, Guo H, Shang Z, Wang Y, Zhou C, Shi B. BMC Cancer, An uncommon manifestation of paraneoplastic cerebellar degeneration in a patient with high grade urothelial, carcinoma with squamous differentiation: A case report and literature review.,, 2016, 16,, 324-,[http://dx. doi.org/10.1186/s12885-016-2349-]. [PMID: 27209].", "journal-title": "BMC Cancer"}, {"key": "ref=96", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1007/s00381-016-3284-y", "volume": "33", "author": "Gungor S.", "year": "2017", "unstructured": "Gungor S, Kilic B, Arslan M, Ozgen U, Dalmau J. Childs Nerv Syst, Hodgkin\u2019s lymphoma associated with paraneoplastic cerebellar degeneration in children: a case report and review of the literature.,, 2017, 33,, 509-512,[http://dx.doi.org/10.1007/s00381-016-3284-y]. [PMID: 277965].", "journal-title": "Childs Nerv Syst"}, {"key": "ref=97", "author": "Berzero G.", "year": "", "unstructured": "Berzero G, Karantoni E, Dehais C, Ducray F, Thomas L, Picard G. Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies, , J. Neurol. Neurosurg. Psychiatry, 2017. pii: jnnp-2017-316904,", "journal-title": "Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies"}, {"key": "ref=98", "doi-asserted-by": "crossref", "first-page": "380", "DOI": "10.1038/nrneurol.2012.99", "volume": "8", "author": "Lancaster E.", "year": "2012", "unstructured": "Lancaster E, Dalmau J. Nat Rev Neurol, Neuronal autoantigens--pathogenesis, associated disorders and antibody testing.,, 2012, 8,, 380-390,[http://dx.doi.org/10.1038/nrneurol.2012.]. [PMID: 227106].", "journal-title": "Nat Rev Neurol"}, {"key": "ref=99", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1016/0303-8467(95)00006-6", "volume": "97", "author": "Tanaka K.", "year": "1995", "unstructured": "Tanaka K, Tanaka M, Igarashi S, Onodera O, Miyatake T, Tsuji S. Clin Neurol Neurosurg, Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.,, 1995, 97,, 101-105,[http://dx.doi.org/10.1016/0303-8467(95)00006-]. [PMID: 77889].", "journal-title": "Clin Neurol Neurosurg"}, {"key": "ref=100", "doi-asserted-by": "crossref", "first-page": "1873", "DOI": "10.1212/WNL.45.10.1873", "volume": "45", "author": "Sillevis Smitt P.A.", "year": "1995", "unstructured": "Sillevis Smitt PA, Manley GT, Posner JB. Neurology, Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice.,, 1995, 45,, 1873-1878,[http://dx.doi.org/10.1212/WNL.45.10.18]. [PMID: 74779].", "journal-title": "Neurology"}, {"key": "ref=101", "first-page": "2819", "volume": "4", "author": "Carpentier A.F.", "year": "1998", "unstructured": "Carpentier AF, Rosenfeld MR, Delattre JY, Whalen RG, Posner JB, Dalmau J. Clin Cancer Res, DNA vaccination with HuD inhibits growth of a neuroblastoma in mice.,, 1998, 4,, 2819-2824,[PMID: 98297].", "journal-title": "Clin Cancer Res"}, {"key": "ref=102", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1002/1531-8249(200001)47:1<9::AID-ANA5>3.0.CO;2-I", "volume": "47", "author": "Albert M.L.", "year": "2000", "unstructured": "Albert ML, Austin LM, Darnell RB. Ann Neurol, Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration.,, 2000, 47,, 9-17,[http://dx.doi.org/10.1002/1531-8249(200001)47:1<9:AID-ANA5 >3.0.CO;2-I]. [PMID: 106320].", "journal-title": "Ann Neurol"}, {"key": "ref=103", "doi-asserted-by": "crossref", "first-page": "162", "DOI": "10.1002/1531-8249(199902)45:2<162::AID-ANA5>3.0.CO;2-R", "volume": "45", "author": "Benyahia B.", "year": "1999", "unstructured": "Benyahia B, Liblau R, Merle-B\u00e9ral H, Tourani JM, Dalmau J, Delattre JY. Ann Neurol, Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies.,, 1999, 45,, 162-167,[http://dx.doi.org/10.1002/1531-8249(199902) 45:2<162:AID-ANA5>3.0.CO;2-R]. [PMID: 99896].", "journal-title": "Ann Neurol"}, {"key": "ref=104", "doi-asserted-by": "crossref", "first-page": "231", "DOI": "10.1007/s11060-004-1723-1", "volume": "71", "author": "Rousseau A.", "year": "2005", "unstructured": "Rousseau A, Benyahia B, Dalmau J, Connan F, Guillet JG, Delattre JY, Choppin J. J Neurooncol, T cell response to Hu-D peptides in patients with anti-Hu syndrome.,, 2005, 71,, 231-236,[http://dx.doi.org/10.1007/s11060-004-1723-]. [PMID: 157359].", "journal-title": "J Neurooncol"}, {"key": "ref=105", "doi-asserted-by": "crossref", "first-page": "655", "DOI": "10.1002/acn3.328", "volume": "3", "author": "Venkatraman A.", "year": "2016", "unstructured": "Venkatraman A, Opal P. Ann Clin Transl Neurol, Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review.,, 2016, 3,, 655-663,[http://dx.doi.org/10.1002/acn3.]. [PMID: 27606].", "journal-title": "Ann Clin Transl Neurol"}, {"key": "ref=106", "doi-asserted-by": "crossref", "first-page": "e1260212", "DOI": "10.1080/2162402X.2016.1260212", "volume": "6", "author": "Gebauer C.", "year": "2016", "unstructured": "Gebauer C, Pignolet B, Yshii L, Maur\u00e9 E, Bauer J, Liblau R. OncoImmunology, CD4+ and CD8+ T cells are both needed to induce paraneoplastic neurological disease in a mouse model.,, 2016, 6,, e1260212-,[http://dx.doi.org/10.1080/2162402X.2016.1260]. [PMID: 283448].", "journal-title": "OncoImmunology"}, {"key": "ref=107", "doi-asserted-by": "crossref", "first-page": "2087", "DOI": "10.1101/gad.13.16.2087", "volume": "13", "author": "Okano H.J.", "year": "1999", "unstructured": "Okano HJ, Park WY, Corradi JP, Darnell RB. Genes Dev, The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival.,, 1999, 13,, 2087-2097,[http://dx.doi.org/10.1101/gad.13. 16.20]. [PMID: 104657].", "journal-title": "Genes Dev"}, {"key": "ref=108", "doi-asserted-by": "crossref", "first-page": "529", "DOI": "10.1016/j.nbd.2003.11.003", "volume": "15", "author": "Sakai K.", "year": "2004", "unstructured": "Sakai K, Kitagawa Y, Saiki S, Saiki M, Hirose G. Neurobiol Dis, Effect of a paraneoplastic cerebellar degeneration-associated neural protein on B-myb promoter activity.,, 2004, 15,, 529-533,[http://dx.doi.org/10.1016/j.nbd.2003.11.00]. [PMID: 15056].", "journal-title": "Neurobiol Dis"}, {"key": "ref=109", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1002/ana.10392", "volume": "53", "author": "Fukuda T.", "year": "2003", "unstructured": "Fukuda T, Motomura M, Nakao Y, Shiraishi H, Yoshimura T, Iwanaga K, Tsujihata M, Eguchi K. Ann Neurol, Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome.,, 2003, 53,, 21-28,[http://dx.doi.org/10.1002/ana.10]. [PMID: 125098].", "journal-title": "Ann Neurol"}, {"key": "ref=110", "doi-asserted-by": "crossref", "first-page": "2705", "DOI": "10.1073/pnas.0710771105", "volume": "105", "author": "Liao Y.J.", "year": "2008", "unstructured": "Liao YJ, Safa P, Chen YR, Sobel RA, Boyden ES, Tsien RW. Proc Natl Acad Sci USA, Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo.,, 2008, 105,, 2705-2710,[http://dx.doi.org/10.1073/pnas.0710771]. [PMID: 18272].", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "ref=111", "doi-asserted-by": "crossref", "first-page": "1009", "DOI": "10.1001/jamaneurol.2014.1011", "volume": "71", "author": "Ari\u00f1o H.", "year": "2014", "unstructured": "Ari\u00f1o H, Gresa-Arribas N, Blanco Y, Mart\u00ednez-Hern\u00e1ndez E, Sabater L, Petit-Pedrol M, Rouco I, Bataller L, Dalmau JO, Saiz A, Graus F. JAMA Neurol, Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy.,, 2014, 71,, 1009-1016,[http://dx. doi.org/10.1001/jamaneurol.2014.10]. [PMID: 24934].", "journal-title": "JAMA Neurol"}, {"key": "ref=112", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1002/1531-8249(199908)46:2<263::AID-ANA19>3.0.CO;2-0", "volume": "46", "author": "Ishida K.", "year": "1999", "unstructured": "Ishida K, Mitoma H, Song SY, Uchihara T, Inaba A, Eguchi S, Kobayashi T, Mizusawa H. Ann Neurol, Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase.,, 1999, 46,, 263-267,[http://dx. doi.org/10.1002/1531-8249(199908)46:2<263:AID-ANA19>3.0.CO;2-0]. [PMID: 104438].", "journal-title": "Ann Neurol"}, {"key": "ref=113", "doi-asserted-by": "crossref", "first-page": "857", "DOI": "10.1212/WNL.52.4.857", "volume": "52", "author": "Abele M.", "year": "1999", "unstructured": "Abele M, Weller M, Mescheriakov S, B\u00fcrk K, Dichgans J, Klockgether T. Neurology, Cerebellar ataxia with glutamic acid decarboxylase autoantibodies.,, 1999, 52,, 857-859,[http://dx.doi. org/10.1212/WNL.52.4.8]. [PMID: 100787].", "journal-title": "Neurology"}, {"key": "ref=114", "doi-asserted-by": "crossref", "first-page": "968", "DOI": "10.2169/internalmedicine.40.968", "volume": "40", "author": "Kono S.", "year": "2001", "unstructured": "Kono S, Miyajima H, Sugimoto M, Suzuki Y, Takahashi Y, Hishida A. Intern Med, Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer.,, 2001, 40,, 968-971,[http://dx.doi.org/10.2169/internalmedicine. 40.9]. [PMID: 115799].", "journal-title": "Intern Med"}, {"key": "ref=115", "doi-asserted-by": "crossref", "first-page": "348", "DOI": "10.1007/s004150200019", "volume": "249", "author": "R\u00fcegg S.", "year": "2002", "unstructured": "R\u00fcegg S, Stahl M, B\u00fchlmann M, Dupont A, Lyrer PA, Humbel RL, Steck AJ. J Neurol, Cerebellar degeneration and polyglandular autoimmune syndrome with anti-glutamic acid decarboxylase antibodies.,, 2002, 249,, 348-350,[http://dx.doi.org/10. 1007/s0041502000]. [PMID: 119935].", "journal-title": "J Neurol"}, {"key": "ref=116", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1136/jnnp.73.3.345", "volume": "73", "author": "Matsumoto S.", "year": "2002", "unstructured": "Matsumoto S, Kusuhara T, Nakajima M, Ouma S, Takahashi M, Yamada T. J Neurol Neurosurg Psychiatry, Acute attacks and brain stem signs in a patient with glutamic acid decarboxylase autoantibodies.,, 2002, 73,, 345-346,[http://dx.doi.org/10.1136/ jnnp.73.3.]. [PMID: 12185].", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "ref=117", "doi-asserted-by": "crossref", "first-page": "634", "DOI": "10.1016/S1474-4422(03)00534-9", "volume": "2", "author": "Lauria G.", "year": "2003", "unstructured": "Lauria G, Pareyson D, Pitzolu MG, Bazzigaluppi E. Lancet Neurol, Excellent response to steroid treatment in anti-GAD cerebellar ataxia.,, 2003, 2,, 634-635,[http://dx.doi.org/10.1016/S1474-4422(03)00534-]. [PMID: 145055].", "journal-title": "Lancet Neurol"}, {"key": "ref=118", "author": "Birand B.", "year": "", "unstructured": "Birand B, Cabre P, Bonnan M, Olindo S, Smadja D. Lancet Neurol, ,, , 2,, 634-,[A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative]. Rev. Med. Interne, 2006, 27(8), 616-619. [http://dx.doi.org/10.1016/j.revmed.2006.04.00]. [PMID: 167977]."}, {"key": "ref=119", "doi-asserted-by": "crossref", "first-page": "1308", "DOI": "10.1212/01.wnl.0000238389.83574.be", "volume": "67", "author": "McFarland N.R.", "year": "2006", "unstructured": "McFarland NR, Login IS, Vernon S, Burns TM. Neurology, Improvement with corticosteroids and azathioprine in GAD65-associated cerebellar ataxia.,, 2006, 67,, 1308-1309,[http://dx. doi.org/10.1212/01.wnl.0000238389.83574.be]. [PMID: 170307].", "journal-title": "Neurology"}, {"key": "ref=120", "doi-asserted-by": "crossref", "first-page": "2263", "DOI": "10.1002/mds.21041", "volume": "21", "author": "Kim J.Y.", "year": "2006", "unstructured": "Kim JY, Chung EJ, Kim JH, Jung KY, Lee WY. Mov Disord, Response to steroid treatment in anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff person syndrome and polyendocrinopathy.,, 2006, 21,, 2263-2264,[http://dx.doi. org/10.1002/mds.210]. [PMID: 1701390].", "journal-title": "Mov Disord"}, {"key": "ref=121", "doi-asserted-by": "crossref", "first-page": "1068", "DOI": "10.1212/01.wnl.0000237558.83349.d0", "volume": "67", "author": "Rakocevic G.", "year": "2006", "unstructured": "Rakocevic G, Raju R, Semino-Mora C, Dalakas MC. Neurology, Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies.,, 2006, 67,, 1068-1070,[http://dx.doi.org/ 10.1212/01.wnl.0000237558.83349.d0]. [PMID: 170009].", "journal-title": "Neurology"}, {"key": "ref=122", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1136/jnnp.2006.089268", "volume": "78", "author": "Vulliemoz S.", "year": "2007", "unstructured": "Vulliemoz S, Vanini G, Truffert A, Chizzolini C, Seeck M. J Neurol Neurosurg Psychiatry, Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.,, 2007, 78,, 187-189,[http://dx.doi.org/10.1136/jnnp.2006.089]. [PMID: 172297].", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "ref=123", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.1016/j.clineuro.2006.01.009", "volume": "109", "author": "Chang C.C.", "year": "2007", "unstructured": "Chang CC, Eggers SD, Johnson JK, Haman A, Miller BL, Geschwind MD. Clin Neurol Neurosurg, Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt-Jakob disease.,, 2007, 109,, 54-57,[http://dx.doi.org/10.1016/j.clineuro.2006.01.00]. [PMID: 16621].", "journal-title": "Clin Neurol Neurosurg"}, {"key": "ref=124", "author": "Bonnan M.", "year": "", "unstructured": "Bonnan M, Cabre P, Olindo S, Signate A, Saint-Vil M, Smadja D. Clin Neurol Neurosurg, ,, , 109,, 54-,[Steroid treatment in four cases of anti-GAD cerebellar ataxia]. Rev. Neurol. (Paris), 2008, 164(5), 427-433 [http://dx.doi. org/10.1016/j.neurol.2008.02.0]. [PMID: 185558]."}, {"key": "ref=125", "doi-asserted-by": "crossref", "first-page": "bcr2013202314", "DOI": "10.1136/bcr-2013-202314", "volume": "2014", "author": "Georgieva Z.", "year": "2014", "unstructured": "Georgieva Z, Parton M. BMJ Case Rep, Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis.,, 2014, 2014,, bcr2013202314-,[http://dx.doi.org/10.1136/ bcr-2013-202]. [PMID: 244196].", "journal-title": "BMJ Case Rep"}, {"key": "ref=126", "doi-asserted-by": "crossref", "first-page": "318", "DOI": "10.1007/s12311-013-0534-3", "volume": "13", "author": "Planche V.", "year": "2014", "unstructured": "Planche V, Marques A, Ulla M, Ruivard M, Durif F. Cerebellum, Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies.,, 2014, 13,, 318-322,[http://dx.doi.org/10.1007/s12311-013-0534-]. [PMID: 24218].", "journal-title": "Cerebellum"}, {"key": "ref=127", "doi-asserted-by": "crossref", "first-page": "264", "DOI": "10.1159/000369784", "volume": "6", "author": "Kuchling J.", "year": "2014", "unstructured": "Kuchling J, Shababi-Klein J, N\u00fcmann A, Gerischer LM, Harms L, Pr\u00fcss H. Case Rep Neurol, GAD antibody-associated late-onset cerebellar ataxia in two female siblings.,, 2014, 6,, 264-270,[http://dx.doi.org/10.1159/0003697]. [PMID: 255660].", "journal-title": "Case Rep Neurol"}, {"key": "ref=128", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1016/j.jneuroim.2015.03.009", "volume": "281", "author": "Fouka P.", "year": "2015", "unstructured": "Fouka P, Alexopoulos H, Akrivou S, Trohatou O, Politis PK, Dalakas MC. J Neuroimmunol, GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders.,, 2015, 281,, 73-77,[http://dx.doi.org/10.1016/j.jneuroim. 2015.03.00]. [PMID: 25867].", "journal-title": "J Neuroimmunol"}, {"key": "ref=129", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1136/jnnp.2006.091116", "volume": "78", "author": "Ishida K.", "year": "2007", "unstructured": "Ishida K, Mitoma H, Wada Y, Oka T, Shibahara J, Saito Y, Murayama S, Mizusawa H. J Neurol Neurosurg Psychiatry, Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia.,, 2007, 78,, 190-192,[http://dx.doi.org/10.1136/jnnp.2006.091]. [PMID: 1711900].", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "ref=130", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.1016/S0022-510X(00)00272-0", "volume": "175", "author": "Mitoma H.", "year": "2000", "unstructured": "Mitoma H, Song SY, Ishida K, Yamakuni T, Kobayashi T, Mizusawa H. J Neurol Sci, Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase.,, 2000, 175,, 40-44,[http://dx.doi.org/10.1016/S0022-510X (00)00272-0]. [PMID: 10785].", "journal-title": "J Neurol Sci"}, {"key": "ref=131", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1016/S0022-510X(02)00423-9", "volume": "208", "author": "Mitoma H.", "year": "2003", "unstructured": "Mitoma H, Ishida K, Shizuka-Ikeda M, Mizusawa H. J Neurol Sci, Dual impairment of GABAA- and GABAB-receptor-mediated synaptic responses by autoantibodies to glutamic acid decarboxylase.,, 2003, 208,, 51-56,[http://dx.doi.org/10.1016/ S0022-510X(02)00423-]. [PMID: 126397].", "journal-title": "J Neurol Sci"}, {"key": "ref=132", "doi-asserted-by": "crossref", "first-page": "186", "DOI": "10.1016/j.jns.2008.04.019", "volume": "271", "author": "Ishida K.", "year": "2008", "unstructured": "Ishida K, Mitoma H, Mizusawa H. J Neurol Sci, Reversibility of cerebellar GABAergic synapse impairment induced by anti-glutamic acid decarboxylase autoantibodies.,, 2008, 271,, 186-190,[http://dx.doi.org/10.1016/j.jns.2008.04.0]. [PMID: 185346].", "journal-title": "J Neurol Sci"}, {"key": "ref=133", "doi-asserted-by": "crossref", "first-page": "1275", "DOI": "10.1002/j.1460-2075.1991.tb08069.x", "volume": "10", "author": "Reetz A.", "year": "1991", "unstructured": "Reetz A, Solimena M, Matteoli M, Folli F, Takei K, De Camilli P. EMBO J, GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion.,, 1991, 10,, 1275-1284,[http://dx.doi.org/10.1002/ j.1460-2075.1991.tb08069.x]. [PMID: 2022].", "journal-title": "EMBO J"}, {"key": "ref=134", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1083/jcb.118.2.309", "volume": "118", "author": "Christgau S.", "year": "1992", "unstructured": "Christgau S, Aanstoot HJ, Schierbeck H, Begley K, Tullin S, Hejnaes K, Baekkeskov S. J Cell Biol, Membrane anchoring of the autoantigen GAD65 to microvesicles in pancreatic beta-cells by palmitoylation in the NH2-terminal domain.,, 1992, 118,, 309-320,[http://dx.doi.org/10.1083/jcb.118.2.]. [PMID: 1321].", "journal-title": "J Cell Biol"}, {"key": "ref=135", "doi-asserted-by": "crossref", "first-page": "e108774", "DOI": "10.1371/journal.pone.0108774", "volume": "9", "author": "Ishikawa T.", "year": "2014", "unstructured": "Ishikawa T, Tomatsu S, Tsunoda Y, Lee J, Hoffman DS, Kakei S. PLoS One, Releasing dentate nucleus cells from Purkinje cell inhibition generates output from the cerebrocerebellum.,, 2014, 9,, e108774-,[http://dx.doi.org/10.1371/journal.pone.01087]. [PMID: 252797].", "journal-title": "PLoS One"}, {"key": "ref=136", "doi-asserted-by": "crossref", "first-page": "544", "DOI": "10.1002/ana.21123", "volume": "61", "author": "Manto M.U.", "year": "2007", "unstructured": "Manto MU, Laute MA, Aguera M, Rogemond V, Pandolfo M, Honnorat J. Ann Neurol, Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases.,, 2007, 61,, 544-551,[http://dx.doi.org/10.1002/ana.21]. [PMID: 17600].", "journal-title": "Ann Neurol"}, {"key": "ref=137", "doi-asserted-by": "crossref", "first-page": "623", "DOI": "10.1002/mus.23234", "volume": "45", "author": "Rakocevic G.", "year": "2012", "unstructured": "Rakocevic G, Floeter MK. Muscle Nerve, Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes.,, 2012, 45,, 623-634,[http://dx.doi.org/10.1002/mus.23]. [PMID: 224990].", "journal-title": "Muscle Nerve"}, {"key": "ref=138", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1016/B978-0-444-51892-7.00007-3", "volume": "103", "author": "Blumkin L.", "year": "2012", "unstructured": "Blumkin L, Pranzatelli MR. Handb Clin Neurol, Acquired ataxias, infectious and para-infectious.,, 2012, 103,, 137-146,[http://dx.doi.org/10.1016/B978-0-444-51892-7.00007-]. [PMID: 218278].", "journal-title": "Handb Clin Neurol"}, {"key": "ref=139", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.3928/00904481-20140325-13", "volume": "43", "author": "Sivaswamy L.", "year": "2014", "unstructured": "Sivaswamy L. Pediatr Ann, Approach to acute ataxia in childhood: diagnosis and evaluation.,, 2014, 43,, 153-159,[http://dx.doi. org/10.3928/00904481-20140325-]. [PMID: 247165].", "journal-title": "Pediatr Ann"}, {"key": "ref=140", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1080/14734220260418457", "volume": "1", "author": "Sawaishi Y.", "year": "2002", "unstructured": "Sawaishi Y, Takada G. Cerebellum, Acute cerebellitis.,, 2002, 1,, 223-228,[http://dx.doi.org/10.1080/14734220260418]. [PMID: 128799].", "journal-title": "Cerebellum"}, {"key": "ref=141", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1007/BF00838440", "volume": "240", "author": "Klockgether T.", "year": "1993", "unstructured": "Klockgether T, D\u00f6ller G, W\u00fcllner U, Petersen D, Dichgans J. J Neurol, Cerebellar encephalitis in adults.,, 1993, 240,, 17-20,[http://dx.doi.org/10.1007/BF00838]. [PMID: 83808].", "journal-title": "J Neurol"}, {"key": "ref=142", "doi-asserted-by": "crossref", "first-page": "673", "DOI": "10.1002/ana.410350607", "volume": "35", "author": "Connolly A.M.", "year": "1994", "unstructured": "Connolly AM, Dodson WE, Prensky AL, Rust RS. Ann Neurol, Course and outcome of acute cerebellar ataxia.,, 1994, 35,, 673-679,[http://dx.doi.org/10.1002/ana.41035060]. [PMID: 8210].", "journal-title": "Ann Neurol"}, {"key": "ref=143", "doi-asserted-by": "crossref", "first-page": "488", "DOI": "10.1016/0387-7604(94)90015-9", "volume": "16", "author": "Hayashi T.", "year": "1994", "unstructured": "Hayashi T, Ichiyama T, Kobayashi K. Brain Dev, A case of acute cerebellar ataxia with an MRI abnormality.,, 1994, 16,, 488-490,[PMID: 769500].", "journal-title": "Brain Dev"}, {"key": "ref=144", "doi-asserted-by": "crossref", "first-page": "1506", "DOI": "10.1212/WNL.44.8.1506", "volume": "44", "author": "Ito H.", "year": "1994", "unstructured": "Ito H, Sayama S, Irie S, Kanazawa N, Saito T, Kowa H, Haga S, Ikeda K. Neurology, Antineuronal antibodies in acute cerebellar ataxia following Epstein-Barr virus infection.,, 1994, 44,, 1506-1507,[http://dx.doi.org/10.1212/WNL.44.8.150]. [PMID: 8058].", "journal-title": "Neurology"}, {"key": "ref=145", "doi-asserted-by": "crossref", "first-page": "417", "DOI": "10.1001/jamaneurol.2015.4607", "volume": "73", "author": "Armangu\u00e9 T.", "year": "2016", "unstructured": "Armangu\u00e9 T, Sabater L, Torres-Vega E, Mart\u00ednez-Hern\u00e1ndez E, Ari\u00f1o H, Petit-Pedrol M, Planagum\u00e0 J, Bataller L, Dalmau J, Graus F. JAMA Neurol, Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies.,, 2016, 73,, 417-424,[http://dx.doi.org/ 10.1001/jamaneurol.2015.460]. [PMID: 268566].", "journal-title": "JAMA Neurol"}, {"key": "ref=146", "doi-asserted-by": "crossref", "first-page": "1598", "DOI": "10.1001/archneurol.2012.1173", "volume": "69", "author": "Klaas J.P.", "year": "2012", "unstructured": "Klaas JP, Ahlskog JE, Pittock SJ, Matsumoto JY, Aksamit AJ, Bartleson JD, Kumar R, McEvoy KF, McKeon A. Arch Neurol, Adult-onset opsoclonus-myoclonus syndrome.,, 2012, 69,, 1598-1607,[http://dx.doi.org/10.1001/archneurol.2012.1]. [PMID: 22986].", "journal-title": "Arch Neurol"}, {"key": "ref=147", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.1093/brain/124.2.437", "volume": "124", "author": "Bataller L.", "year": "2001", "unstructured": "Bataller L, Graus F, Saiz A, Vilchez JJ. Brain, Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus.,, 2001, 124,, 437-443,[http://dx.doi.org/10.1093/brain/ 124.2.]. [PMID: 111575].", "journal-title": "Brain"}, {"key": "ref=148", "doi-asserted-by": "crossref", "first-page": "238", "DOI": "10.1002/mds.22941", "volume": "25", "author": "Pranzatelli M.R.", "year": "2010", "unstructured": "Pranzatelli MR, Tate ED, Swan JA, Travelstead AL, Colliver JA, Verhulst SJ, Crosley CJ, Graf WD, Joseph SA, Kelfer HM, Raju GP. Mov Disord, B cell depletion therapy for new-onset opsoclonus-myoclonus.,, 2010, 25,, 238-242,[http://dx.doi.org/10.1002/mds.229]. [PMID: 20063].", "journal-title": "Mov Disord"}, {"key": "ref=149", "doi-asserted-by": "crossref", "first-page": "1526", "DOI": "10.1212/WNL.62.9.1526", "volume": "62", "author": "Pranzatelli M.R.", "year": "2004", "unstructured": "Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Moticka EJ, Franz DN, Nigro MA, Parke JT, Stumpf DA, Verhulst SJ. Neurology, B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes.,, 2004, 62,, 1526-1532,[http://dx.doi.org/10.1212/WNL.62.9 15]. [PMID: 151366].", "journal-title": "Neurology"}, {"key": "ref=150", "first-page": "239", "volume": "2", "author": "Young C.A.", "year": "1993", "unstructured": "Young CA, MacKenzie JM, Chadwick DW, Williams IR. Eur J Med, Opsoclonus-myoclonus syndrome: an autopsy study of three cases.,, 1993, 2,, 239-241,[PMID: 82610].", "journal-title": "Eur J Med"}, {"key": "ref=151", "doi-asserted-by": "crossref", "first-page": "322", "DOI": "10.1159/000117241", "volume": "36", "author": "Mitoma H.", "year": "1996", "unstructured": "Mitoma H, Orimo S, Sodeyama N, Tamaki M. Eur Neurol, Paraneoplastic opsoclonus-myoclonus syndrome and neurofibrosarcoma.,, 1996, 36,, 322-,[PMID: 88647].", "journal-title": "Eur Neurol"}, {"key": "ref=152", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1016/S0022-510X(01)00564-0", "volume": "189", "author": "Wong A.M.F.", "year": "2001", "unstructured": "Wong AMF, Musallam S, Tomlinson RD, Shannon P, Sharpe JA. J Neurol Sci, Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlates.,, 2001, 189,, 71-81,[http://dx.doi.org/10.1016/S0022-510X(01)00564-0]. [PMID: 11535].", "journal-title": "J Neurol Sci"}, {"key": "ref=153", "doi-asserted-by": "crossref", "first-page": "98", "DOI": "10.1111/dmcn.13262", "volume": "59", "author": "Chekroud A.M.", "year": "2017", "unstructured": "Chekroud AM, Anand G, Yong J, Pike M, Bridge H. Dev Med Child Neurol, Altered functional brain connectivity in children and young people with opsoclonus-myoclonus syndrome.,, 2017, 59,, 98-104,[http://dx.doi.org/10.1111/dmcn.13]. [PMID: 276589].", "journal-title": "Dev Med Child Neurol"}, {"key": "ref=154", "doi-asserted-by": "crossref", "first-page": "703", "DOI": "10.1002/ana.410370603", "volume": "37", "author": "Ugawa Y.", "year": "1995", "unstructured": "Ugawa Y, Uesaka Y, Terao Y, Hanajima R, Kanazawa I. Ann Neurol, Magnetic stimulation over the cerebellum in humans.,, 1995, 37,, 703-713,[http://dx.doi.org/10.1002/ana.41037060]. [PMID: 77788].", "journal-title": "Ann Neurol"}, {"key": "ref=155", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1186/s40673-016-0054-2", "volume": "3", "author": "Ferrucci R.", "year": "2016", "unstructured": "Ferrucci R, Bocci T, Cortese F, Ruggiero F, Priori A. Cerebellum Ataxias, Cerebellar transcranial direct current stimulation in neurological disease.,, 2016, 3,, 16-,[http://dx.doi.org/10. 1186/s40673-016-0054-]. [PMID: 2759500].", "journal-title": "Cerebellum Ataxias"}, {"key": "ref=156", "doi-asserted-by": "crossref", "first-page": "272", "DOI": "10.1016/j.pneurobio.2006.02.006", "volume": "78", "author": "Ito M.", "year": "2006", "unstructured": "Ito M. Prog Neurobiol, Cerebellar circuitry as a neuronal machine.,, 2006, 78,, 272-303,[http://dx.doi.org/10.1016/j.pneurobio. 2006.02.00]. [PMID: 167597].", "journal-title": "Prog Neurobiol"}, {"key": "ref=157", "first-page": "305", "volume": "2", "author": "Voogd J.", "year": "1988", "unstructured": "Voogd J, Glickstein M. Trends Neurosci, The anatomy of the cerebellum.,, 1988, 2,, 305-371,[PMID: 97359].", "journal-title": "Trends Neurosci"}, {"key": "ref=158", "first-page": "116", "volume": "6", "author": "D\u2019Angelo E.", "year": "2013", "unstructured": "D\u2019Angelo E, Casali S. Front Neural Circuits, Seeking a unified framework for cerebellar function and dysfunction: from circuit operations to cognition.,, 2013, 6,, 116-,[http://dx.doi.org/10.3389/ fncir.2012.00]. [PMID: 233358].", "journal-title": "Front Neural Circuits"}, {"key": "ref=159", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1007/s12311-011-0331-9", "volume": "11", "author": "Manto M.", "year": "2012", "unstructured": "Manto M, Bower JM, Conforto AB, Delgado-Garc\u00eda JM, da Guarda SN, Gerwig M, Habas C, Hagura N, Ivry RB, Mari\u00ebn P, Molinari M, Naito E, Nowak DA, Oulad Ben Taib N, Pelisson D, Tesche CD, Tilikete C, Timmann D. Cerebellum, Consensus paper: roles of the cerebellum in motor control--the diversity of ideas on cerebellar involvement in movement.,, 2012, 11,, 457-487,[http://dx.doi.org/10.1007/s12311-011-0331-]. [PMID: 22161].", "journal-title": "Cerebellum"}, {"key": "ref=160", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1007/BF00364149", "volume": "57", "author": "Kawato M.", "year": "1987", "unstructured": "Kawato M, Furukawa K, Suzuki R. Biol Cybern, A hierarchical neural-network model for control and learning of voluntary movement.,, 1987, 57,, 169-185,[http://dx.doi.org/10.1007/ BF00364]. [PMID: 3676].", "journal-title": "Biol Cybern"}, {"key": "ref=161", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1016/j.neuron.2011.02.044", "volume": "70", "author": "Schonewille M.", "year": "2011", "unstructured": "Schonewille M, Gao Z, Boele HJ, Veloz MF, Amerika WE, Simek AA, De Jeu MT, Steinberg JP, Takamiya K, Hoebeek FE, Linden DJ, Huganir RL, De Zeeuw CI. Neuron, Reevaluating the role of LTD in cerebellar motor learning.,, 2011, 70,, 43-50,[http://dx.doi.org/10.1016/j.neuron.2011.02.0]. [PMID: 21482].", "journal-title": "Neuron"}, {"key": "ref=162", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1002/(SICI)1096-9861(19990816)411:1<97::AID-CNE8>3.0.CO;2-O", "volume": "411", "author": "Wu H.S.", "year": "1999", "unstructured": "Wu HS, Sugihara I, Shinoda Y. J Comp Neurol, Projection patterns of single mossy fibers originating from the lateral reticular nucleus in the rat cerebellar cortex and nuclei.,, 1999, 411,, 97-118,[http://dx.doi.org/10.1002/(SICI)1096-9861(19990816)411:1 <97:AID-CNE8>3.0.CO;2-O]. [PMID: 10404].", "journal-title": "J Comp Neurol"}, {"key": "ref=163", "doi-asserted-by": "crossref", "first-page": "1303", "DOI": "10.1046/j.0953-816x.2001.01499.x", "volume": "13", "author": "Ekerot C.F.", "year": "2001", "unstructured": "Ekerot CF, J\u00f6rntell H. Eur J Neurosci, Parallel fibre receptive fields of Purkinje cells and interneurons are climbing fibre-specific.,, 2001, 13,, 1303-1310,[http://dx.doi.org/10.1046/j.0953-816x.2001.01499.x]. [PMID: 112987].", "journal-title": "Eur J Neurosci"}, {"key": "ref=164", "author": "Colin F.", "unstructured": "Colin F, Ris L, Godaux E, , Cambridge University Press,, Cambridge, , Neuroanatomy of the cerebellum. The cerebellum and its disorders; Manto, M., 2002,6-29", "journal-title": "Neuroanatomy of the cerebellum The cerebellum and its disorders; Manto, M"}, {"key": "ref=165", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.2174/1389203711314010004", "volume": "14", "author": "Suzumura A.", "year": "2013", "unstructured": "Suzumura A. Curr Protein Pept Sci, Neuron-microglia interaction in neuroinflammation.,, 2013, 14,, 16-20,[http://dx.doi.org/10. 2174/138920371131401000]. [PMID: 235447].", "journal-title": "Curr Protein Pept Sci"}, {"key": "ref=166", "doi-asserted-by": "crossref", "first-page": "6549", "DOI": "10.4049/jimmunol.178.10.6549", "volume": "178", "author": "Domercq M.", "year": "2007", "unstructured": "Domercq M, S\u00e1nchez-G\u00f3mez MV, Sherwin C, Etxebarria E, Fern R, Matute C. J Immunol, System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes.,, 2007, 178,, 6549-6556,[http://dx.doi.org/10.4049/jimmunol. 178.10.65]. [PMID: 174758].", "journal-title": "J Immunol"}, {"key": "ref=167", "doi-asserted-by": "crossref", "first-page": "12105", "DOI": "10.1523/JNEUROSCI.5369-12.2013", "volume": "33", "author": "Mandolesi G.", "year": "2013", "unstructured": "Mandolesi G, Musella A, Gentile A, Grasselli G, Haji N, Sepman H, Fresegna D, Bullitta S, De Vito F, Musumeci G, Di Sanza C, Strata P, Centonze D. J Neurosci, Interleukin-1\u03b2 alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis.,, 2013, 33,, 12105-12121,[http:// dx.doi.org/10.1523/JNEUROSCI.5369-12.20]. [PMID: 238646].", "journal-title": "J Neurosci"}, {"key": "ref=168", "doi-asserted-by": "crossref", "first-page": "861231", "DOI": "10.1155/2014/861231", "volume": "2014", "author": "Olmos G.", "year": "2014", "unstructured": "Olmos G, Llad\u00f3 J. Mediators Inflamm, Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity.,, 2014, 2014,, 861231-,[http://dx.doi.org/10.1155/2014/861]. [PMID: 24966].", "journal-title": "Mediators Inflamm"}, {"key": "ref=169", "doi-asserted-by": "crossref", "first-page": "322", "DOI": "10.3389/fncel.2015.00322", "volume": "9", "author": "Yuste J.E.", "year": "2015", "unstructured": "Yuste JE, Tarragon E, Campuzano CM, Ros-Bernal F. Front Cell Neurosci, Implications of glial nitric oxide in neurodegenerative diseases.,, 2015, 9,, 322-,[http://dx.doi.org/10.3389/fncel. 2015.00]. [PMID: 263476].", "journal-title": "Front Cell Neurosci"}, {"key": "ref=170", "doi-asserted-by": "crossref", "first-page": "212", "DOI": "10.1016/j.csbj.2015.03.004", "volume": "13", "author": "Fujikawa D.G.", "year": "2015", "unstructured": "Fujikawa DG. Comput Struct Biotechnol J, The role of excitotoxic programmed necrosis in acute brain injury.,, 2015, 13,, 212-221,[http://dx.doi.org/10.1016/j.csbj.2015.03.00]. [PMID: 258930].", "journal-title": "Comput Struct Biotechnol J"}, {"key": "ref=171", "doi-asserted-by": "crossref", "first-page": "751", "DOI": "10.1007/s13311-014-0289-7", "volume": "11", "author": "Chopra R.", "year": "2014", "unstructured": "Chopra R, Shakkottai VG. Neurotherapeutics, The role for alterations in neuronal activity in the pathogenesis of polyglutamine repeat disorders.,, 2014, 11,, 751-763,[http://dx.doi.org/10.1007/ s13311-014-0289-]. [PMID: 249866].", "journal-title": "Neurotherapeutics"}, {"key": "ref=172", "doi-asserted-by": "crossref", "first-page": "150056", "DOI": "10.1098/rsob.150056", "volume": "5", "author": "Watson L.M.", "year": "2015", "unstructured": "Watson LM, Wong MM, Becker EB. Open Biol, Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia.,, 2015, 5,, 150056-,[http://dx.doi.org/10.1098/rsob. 1500]. [PMID: 26136].", "journal-title": "Open Biol"}, {"key": "ref=173", "doi-asserted-by": "crossref", "first-page": "387", "DOI": "10.1007/s12311-018-0925-6", "volume": "17", "author": "Mitoma H.", "year": "2018", "unstructured": "Mitoma H, Manto M, Hampe CS. Cerebellum, Time is cerebellum.,, 2018, 17,, 387-391,[http://dx.doi.org/10.1007/s12311-018-0925-]. [PMID: 29460].", "journal-title": "Cerebellum"}], "container-title": ["Current Neuropharmacology"], "language": "en", "link": [{"URL": "http://eurekaselect.com/article/download/165484", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 7, 17]], "date-time": "2019-07-17T18:24:21Z", "timestamp": 1563387861000}, "score": 51.81615, "issued": {"date-parts": [[2018, 12, 5]]}, "references-count": 173, "journal-issue": {"published-print": {"date-parts": [[2018, 12, 5]]}, "issue": "1"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/1570159x16666180917105033", "relation": {"cites": []}, "ISSN": ["1570-159X"], "issn-type": [{"value": "1570-159X", "type": "print"}], "assertion": [{"value": "Peer Reviewed", "order": 0, "name": "review_status", "label": "Review Status", "group": {"name": "peer_review_details", "label": "Peer Review Details"}}, {"value": "Single blind", "order": 1, "name": "review_process", "label": "Review Process", "group": {"name": "peer_review_details", "label": "Peer Review Details"}}, {"value": "Checked with iThenticate", "order": 0, "name": "screening_status", "label": "Screening Status", "group": {"name": "plagiarism_screening", "label": "Plagiarism Screening"}}, {"value": "2018-03-11", "order": 0, "name": "received", "label": "Received", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2018-07-06", "order": 1, "name": "revised", "label": "Revised", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2018-09-03", "order": 2, "name": "accepted", "label": "Accepted", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2018-12-05", "order": 3, "name": "published", "label": "Published", "group": {"name": "publication_history", "label": "Publication History"}}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T22:22:19Z", "timestamp": 1574806939974}, "publisher-location": "Singapore", "reference-count": 39, "publisher": "Springer Singapore", "isbn-type": [{"value": "9789811007170", "type": "print"}, {"value": "9789811007194", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 1, 1]], "date-time": "2016-01-01T00:00:00Z", "timestamp": 1451606400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2016]]}, "DOI": "10.1007/978-981-10-0719-4_12", "type": "book-chapter", "created": {"date-parts": [[2016, 6, 7]], "date-time": "2016-06-07T05:15:03Z", "timestamp": 1465276503000}, "page": "127-135", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Potentiating Immune System by Hyperthermia"], "prefix": "10.1007", "author": [{"given": "Hiroshi", "family": "Terunuma", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 6, 8]]}, "reference": [{"key": "12_CR1", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1080/08830180801911743", "volume": "27", "author": "H Terunuma", "year": "2008", "unstructured": "Terunuma H, Deng X, Dewan Z, et al. Potential role of NK cells in the induction of immune responses: Implications for NK cell-based immunotherapy for cancers and viral infections. Int Rev Immunol. 2008;27:93\u2013110.", "journal-title": "Int Rev Immunol"}, {"key": "12_CR2", "doi-asserted-by": "crossref", "first-page": "230", "DOI": "10.1038/cmi.2013.10", "volume": "10", "author": "M Cheng", "year": "2013", "unstructured": "Cheng M, Chen Y, Xiao W, et al. NK cell-based immunotherapy for malignant diseases. Cell Mol Immunol. 2013;10:230\u201352.", "journal-title": "Cell Mol Immunol"}, {"key": "12_CR3", "doi-asserted-by": "crossref", "first-page": "1322", "DOI": "10.1189/jlb.1106699", "volume": "82", "author": "JR Ostberg", "year": "2007", "unstructured": "Ostberg JR, Dayanc BE, Yuan M, et al. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells. J Leukoc Biol. 2007;82:1322\u201331.", "journal-title": "J Leukoc Biol"}, {"key": "12_CR4", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.3191/thermalmed.28.1", "volume": "28", "author": "H Terunuma", "year": "2012", "unstructured": "Terunuma H, Deng X, Toki A, et al. Effects of hyperthermia on the host immune system: from NK cell-based science to clinical application. Therm Med. 2012;28:1\u20139.", "journal-title": "Therm Med"}, {"key": "12_CR5", "first-page": "93", "volume": "10", "author": "S Farjadian", "year": "2013", "unstructured": "Farjadian S, Norouzian M, Younesi V, et al. Hyperthermia increases natural killer cell cytotoxicity against SW-872 liposarcoma cell line. Iran J Immunol. 2013;10:93\u2013102.", "journal-title": "Iran J Immunol"}, {"key": "12_CR6", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1007/BF00188611", "volume": "39", "author": "PK Srivastava", "year": "1994", "unstructured": "Srivastava PK, Udono H, Blachere NE, Li Z. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics. 1994;39:93\u20138.", "journal-title": "Immunogenetics"}, {"key": "12_CR7", "doi-asserted-by": "crossref", "first-page": "593", "DOI": "10.1038/ni1201", "volume": "6", "author": "RJ Binder", "year": "2005", "unstructured": "Binder RJ, Srivastava PK. Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells. Nat Immunol. 2005;6:593\u20139.", "journal-title": "Nat Immunol"}, {"key": "12_CR8", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.3191/thermalmed.23.171", "volume": "23", "author": "T Takahashi", "year": "2007", "unstructured": "Takahashi T. Effects of hyperthermia and modification of thermosensitivity. Therm Med. 2007;23:171\u20139.", "journal-title": "Therm Med"}, {"key": "12_CR9", "doi-asserted-by": "crossref", "first-page": "1459", "DOI": "10.1007/s00262-006-0146-6", "volume": "55", "author": "Y Kida", "year": "2006", "unstructured": "Kida Y, Tsuji-Kawahara S, Ostapenko V, et al. Increased liver temperature efficiently auguments human cellular immune response: T-cell activation and possible monocyte translocation. Cancer Immunol Immunother. 2006;55:1459\u201369.", "journal-title": "Cancer Immunol Immunother"}, {"key": "12_CR10", "doi-asserted-by": "crossref", "first-page": "84", "DOI": "10.1016/j.cyto.2007.07.184", "volume": "39", "author": "TD Vardam", "year": "2007", "unstructured": "Vardam TD, Zhou L, Appenheimer MM, et al. Regulation of a lymphocyte-endothelial-IL-6 trans-signaling axis by fever-range thermal stress: hot spot of immune surveillance. Cytokine. 2007;39:84\u201396.", "journal-title": "Cytokine"}, {"key": "12_CR11", "first-page": "1035", "volume": "60", "author": "CH Chen", "year": "2000", "unstructured": "Chen CH, Wang TL, Hung CF, et al. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res. 2000;60:1035\u201342.", "journal-title": "Cancer Res"}, {"key": "12_CR12", "first-page": "222", "volume": "61", "author": "C Castelli", "year": "2001", "unstructured": "Castelli C, Ciupitu AM, Rini F, et al. Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells. Cancer Res. 2001;61:222\u20137.", "journal-title": "Cancer Res"}, {"key": "12_CR13", "doi-asserted-by": "crossref", "first-page": "624", "DOI": "10.1002/ijc.21061", "volume": "116", "author": "K Tanaka", "year": "2005", "unstructured": "Tanaka K, Ito A, Kobayashi T, et al. Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticle. Int J Cancer. 2005;116:624\u201333.", "journal-title": "Int J Cancer"}, {"key": "12_CR14", "doi-asserted-by": "crossref", "first-page": "1105", "DOI": "10.1093/intimm/dxp095", "volume": "21", "author": "S Sakaguchi", "year": "2009", "unstructured": "Sakaguchi S, Wing K, Onishi Y, et al. Regulatory T cells: how do they suppress immune responses? Int Immunol. 2009;21:1105\u201311.", "journal-title": "Int Immunol"}, {"key": "12_CR15", "doi-asserted-by": "crossref", "first-page": "1582", "DOI": "10.4049/jimmunol.176.3.1582", "volume": "176", "author": "MJ Smyth", "year": "2006", "unstructured": "Smyth MJ, Teng MWL, Swann J, et al. CD4\u2009+\u2009CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol. 2006;176:1582\u20137.", "journal-title": "J Immunol"}, {"key": "12_CR16", "author": "B Shang", "year": "2015", "unstructured": "Shang B, Liu Y, Jiang S, Liu Y. Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis. Sci Rep. 2015. doi: 10.1038/srep15179 .", "journal-title": "Sci Rep"}, {"key": "12_CR17", "doi-asserted-by": "crossref", "first-page": "2418", "DOI": "10.1002/ijc.22551", "volume": "120", "author": "J Guo", "year": "2007", "unstructured": "Guo J, Zhu J, Sheng X, et al. Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma. Int J Cancer. 2007;120:2418\u201325.", "journal-title": "Int J Cancer"}, {"key": "12_CR18", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.3191/thermalmedicine.23.41", "volume": "23", "author": "H Terunuma", "year": "2007", "unstructured": "Terunuma H, Wada A, Deng X, et al. Mild hyperthermia modulates the relative frequency of lymphocyte cell subpopulations: an increase in a cytolytic NK cell subset and a decrease in a regulatory T cell subset. Therm Med. 2007;23:41\u20137.", "journal-title": "Therm Med"}, {"key": "12_CR19", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1080/02656730701858297", "volume": "24", "author": "BE Dayanc", "year": "2008", "unstructured": "Dayanc BE, Beachy SH, Ostberg JR, Repasky EA. Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses. Int J Hyperthermia. 2008;24:41\u201356.", "journal-title": "Int J Hyperthermia"}, {"key": "12_CR20", "unstructured": "Kokura S, Okayama T, Adachi S, et al. The effects of hyperthermia on immune surveillance in tumor. Thermal Med. 2011;27 Supplement:79."}, {"key": "12_CR21", "doi-asserted-by": "crossref", "first-page": "R585", "DOI": "10.1152/ajpregu.00014.2005", "volume": "290", "author": "D Atanackovic", "year": "2006", "unstructured": "Atanackovic D, Pollok K, Faltz C, et al. Patients with solid tumors treated with high-temperature whole body hyperthermia show a redistribution of na\u00efve/memory T-cell subtypes. Am J Physiol Regul Integr Comp Physiol. 2006;290:R585\u201394.", "journal-title": "Am J Physiol Regul Integr Comp Physiol"}, {"key": "12_CR22", "doi-asserted-by": "crossref", "first-page": "486", "DOI": "10.1016/j.intimp.2014.07.036", "volume": "22", "author": "X Deng", "year": "2014", "unstructured": "Deng X, Terunuma H, Terunuma A, et al. Ex vivo-expanded natural killer cells kill cancer cells more effectively than ex vivo expanded \u03b3\u03b4T cells or \u03b1\u03b2T cells. Int Immunopharmacol. 2014;22:486\u201391.", "journal-title": "Int Immunopharmacol"}, {"key": "12_CR23", "doi-asserted-by": "crossref", "first-page": "487", "DOI": "10.1016/0167-5699(95)80033-6", "volume": "16", "author": "S Ferrone", "year": "1995", "unstructured": "Ferrone S, Marincola FM. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today. 1995;16:487\u201394.", "journal-title": "Immunol Today"}, {"key": "12_CR24", "doi-asserted-by": "crossref", "first-page": "8304", "DOI": "10.1158/1078-0432.CCR-04-2588", "volume": "11", "author": "A Facoetti", "year": "2005", "unstructured": "Facoetti A, Nano R, Zelini P, et al. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors. Clin Cancer Res. 2005;11:8304\u201311.", "journal-title": "Clin Cancer Res"}, {"key": "12_CR25", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1034/j.1399-0039.1999.540304.x", "volume": "54", "author": "M Feenstra", "year": "1999", "unstructured": "Feenstra M, Veltkamp M, van Kuik J, et al. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck sequamous cell carcinomas. Tissue Antigens. 1999;54:235\u201345.", "journal-title": "Tissue Antigens"}, {"key": "12_CR26", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1007/s00262-002-0296-0", "volume": "51", "author": "I Maleno", "year": "2002", "unstructured": "Maleno I, Lopez-Nevot MA, Cabrera T, et al. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21. Cancer Immunol Immunother. 2002;51:389\u201396.", "journal-title": "Cancer Immunol Immunother"}, {"key": "12_CR27", "doi-asserted-by": "crossref", "first-page": "248", "DOI": "10.1002/ijc.21163", "volume": "117", "author": "Z Madjd", "year": "2005", "unstructured": "Madjd Z, SpendloveI PSE, et al. Total loss of MHC class I is an independent indicator of good prognosis in breast cancer. Int J Cancer. 2005;117:248\u201355.", "journal-title": "Int J Cancer"}, {"key": "12_CR28", "doi-asserted-by": "crossref", "first-page": "148", "DOI": "10.1038/bjc.1996.28", "volume": "73", "author": "P Korkolopoulou", "year": "1996", "unstructured": "Korkolopoulou P, Kaklamanis L, Pezzella F, et al. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. Br J Cancer. 1996;73:148\u201353.", "journal-title": "Br J Cancer"}, {"key": "12_CR29", "first-page": "627", "volume": "221", "author": "G Kutomi", "year": "2007", "unstructured": "Kutomi G, Tamura Y, Torigoe SN. Effective immunotherapy by HSP-cancer peptide complex and immune escape of HLA class I antigen down regulation. Igaku No Ayumi (Japanese). 2007;221:627\u201330.", "journal-title": "Igaku No Ayumi (Japanese)"}, {"key": "12_CR30", "doi-asserted-by": "crossref", "first-page": "127", "DOI": "10.1111/j.1365-2249.2006.03289.x", "volume": "148", "author": "H Pandha", "year": "2007", "unstructured": "Pandha H, Rigg A, John J, Lemoine N. Loss of expression of antigen-presenting molecules in human pancreatic cancer and pancreatic cancer cell lines. Clin Exp Immunol. 2007;148:127\u201335.", "journal-title": "Clin Exp Immunol"}, {"key": "12_CR31", "doi-asserted-by": "crossref", "first-page": "605", "DOI": "10.1002/jso.21029", "volume": "97", "author": "S Ishigami", "year": "2008", "unstructured": "Ishigami S, Natsugoe S, Nakajo A, et al. HLA-class I expression in gastric cancer. J Surg Oncol. 2008;97:605\u20138.", "journal-title": "J Surg Oncol"}, {"key": "12_CR32", "doi-asserted-by": "crossref", "first-page": "6", "DOI": "10.1002/ijc.21303", "volume": "118", "author": "NFS Watson", "year": "2006", "unstructured": "Watson NFS, Ramage JM, Madjd Z, et al. Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis. Int J Cancer. 2006;118:6\u201310.", "journal-title": "Int J Cancer"}, {"key": "12_CR33", "doi-asserted-by": "crossref", "first-page": "1269", "DOI": "10.1016/j.juro.2006.11.082", "volume": "177", "author": "H Kitamura", "year": "2007", "unstructured": "Kitamura H, Honma I, Torigoe T, et al. Down-regulation of HLA class I antigens is independent prognostic factor for clear cell renal cell carcinoma. J Urol. 2007;177:1269\u201372.", "journal-title": "J Urol"}, {"key": "12_CR34", "doi-asserted-by": "crossref", "first-page": "605", "DOI": "10.1002/ijc.20499", "volume": "113", "author": "JM Romero", "year": "2005", "unstructured": "Romero JM, Jimenez P, Cabrera T, et al. Coordinated downregulation of the antigen presentation machinery and HLA class I/\u03b22-microglobulin complex is responsible for HLA-ABC loss in bladder cancer. Int J Cancer. 2005;113:605\u201310.", "journal-title": "Int J Cancer"}, {"key": "12_CR35", "doi-asserted-by": "crossref", "first-page": "692", "DOI": "10.1016/j.juro.2007.03.109", "volume": "178", "author": "H Kitamura", "year": "2007", "unstructured": "Kitamura H, Torigoe T, Asanuma H, et al. Down-regulation of HLA class I antigens in prostate cancer tissues and up-regulation by histone deacetylase inhibition. J Urol. 2007;178:692\u20136.", "journal-title": "J Urol"}, {"key": "12_CR36", "doi-asserted-by": "crossref", "first-page": "1245", "DOI": "10.1016/j.juro.2014.11.057", "volume": "193", "author": "RS Djajadiningrat", "year": "2015", "unstructured": "Djajadiningrat RS, Horenblas S, Heideman DA, et al. Classic and nonclassic HLA class I expression in penile cancer and relation to HPV status and clinical outcome. J Urol. 2015;193:1245\u201351.", "journal-title": "J Urol"}, {"key": "12_CR37", "doi-asserted-by": "crossref", "first-page": "961", "DOI": "10.1084/jem.191.6.961", "volume": "191", "author": "LA Koopman", "year": "2000", "unstructured": "Koopman LA, Corver WE, van der Slik AR, et al. Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer. J Exp Med. 2000;191:961\u201375.", "journal-title": "J Exp Med"}, {"key": "12_CR38", "doi-asserted-by": "crossref", "first-page": "1828", "DOI": "10.1002/ijc.27449", "volume": "131", "author": "RA Jong De", "year": "2012", "unstructured": "De Jong RA, Boerma A, Boezen HM, et al. Loss of HLA class I and mismatch repair protein expression in sporadic endometrioid endometrial carcinomas. Int J Cancer. 2012;131:1828\u201336.", "journal-title": "Int J Cancer"}, {"key": "12_CR39", "doi-asserted-by": "crossref", "first-page": "1374", "DOI": "10.1111/j.1349-7006.2006.00317.x", "volume": "97", "author": "T Tsukahara", "year": "2006", "unstructured": "Tsukahara T, Kawaguchi S, Torigoe T, et al. Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5. Cancer Sci. 2006;97:1374\u201380.", "journal-title": "Cancer Sci"}], "container-title": ["Hyperthermic Oncology from Bench to Bedside"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-981-10-0719-4_12", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 24]], "date-time": "2017-06-24T15:51:50Z", "timestamp": 1498319510000}, "score": 39.656715, "issued": {"date-parts": [[2016]]}, "ISBN": ["9789811007170", "9789811007194"], "references-count": 39, "URL": "http://dx.doi.org/10.1007/978-981-10-0719-4_12", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T20:42:59Z", "timestamp": 1574800979490}, "reference-count": 83, "publisher": "SAGE Publications", "issue": "5", "license": [{"URL": "http://journals.sagepub.com/page/policies/text-and-data-mining-license", "start": {"date-parts": [[2016, 5, 22]], "date-time": "2016-05-22T00:00:00Z", "timestamp": 1463875200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["journals.sagepub.com"], "crossmark-restriction": true}, "short-container-title": ["Ther Adv Neurol Disord"], "published-print": {"date-parts": [[2016, 9]]}, "DOI": "10.1177/1756285616648940", "type": "journal-article", "created": {"date-parts": [[2016, 5, 23]], "date-time": "2016-05-23T03:09:30Z", "timestamp": 1463972970000}, "page": "396-413", "update-policy": "http://dx.doi.org/10.1177/sage-journals-update-policy", "source": "Crossref", "is-referenced-by-count": 9, "title": ["The physiological basis of therapies for cerebellar ataxias"], "prefix": "10.1177", "volume": "9", "author": [{"given": "Hiroshi", "family": "Mitoma", "sequence": "first", "affiliation": [{"name": "Department of Medical Education, Tokyo Medical University, 6-7-1 Nishi-shinjyuku, Shinjyuku-ku, Tokyo, 160-0023, Japan"}]}, {"given": "Mario", "family": "Manto", "sequence": "additional", "affiliation": [{"name": "Unit\u00e9 d\u2019Etude du Mouvement (UEM), FNRS, Neurologie ULB-Erasme, Brussels, Belgium Universit\u00e9 de Mons, Mons, Belgium"}]}], "member": "179", "published-online": {"date-parts": [[2016, 5, 22]]}, "reference": [{"key": "bibr1-1756285616648940", "DOI": "10.1523/JNEUROSCI.3582-09.2010", "doi-asserted-by": "publisher"}, {"key": "bibr2-1756285616648940", "DOI": "10.1161/01.STR.12.6.723", "doi-asserted-by": "publisher"}, {"key": "bibr3-1756285616648940", "DOI": "10.1212/WNL.31.3.304", "doi-asserted-by": "publisher"}, {"key": "bibr4-1756285616648940", "DOI": "10.1097/00001756-200604240-00009", "doi-asserted-by": "publisher"}, {"key": "bibr5-1756285616648940", "DOI": "10.1002/mds.26356", "doi-asserted-by": "publisher"}, {"key": "bibr6-1756285616648940", "DOI": "10.1007/s12311\u2013015\u20130687\u20133.", "doi-asserted-by": "publisher"}, {"key": "bibr7-1756285616648940", "DOI": "10.1002/cne.901090102", "doi-asserted-by": "publisher"}, {"key": "bibr8-1756285616648940", "DOI": "10.1016/S0024-3205(01)01384-4", "doi-asserted-by": "publisher"}, {"key": "bibr9-1756285616648940", "DOI": "10.1016/j.brs.2012.12.004", "doi-asserted-by": "publisher"}, {"key": "bibr10-1756285616648940", "DOI": "10.1007/s00415-012-6764-3", "doi-asserted-by": "publisher"}, {"key": "bibr11-1756285616648940", "DOI": "10.1136/jnnp.60.5.515", "doi-asserted-by": "publisher"}, {"key": "bibr12-1756285616648940", "author": "Dow R.", "year": "1958", "volume-title": "The Physiology and Pathology of the Cerebellum"}, {"key": "bibr13-1756285616648940", "DOI": "10.1523/JNEUROSCI.2184-09.2009", "doi-asserted-by": "publisher"}, {"key": "bibr14-1756285616648940", "DOI": "10.1016/B978-0-444-63356-9.00003-0", "doi-asserted-by": "publisher"}, {"key": "bibr15-1756285616648940", "DOI": "10.1007/s00415-013-7029-5", "doi-asserted-by": "publisher"}, {"key": "bibr16-1756285616648940", "DOI": "10.1152/jn.00297.2002", "doi-asserted-by": "publisher"}, {"key": "bibr17-1756285616648940", "DOI": "10.1136/jnnp.2004.045716", "doi-asserted-by": "publisher"}, {"key": "bibr18-1756285616648940", "author": "Greenberg M.", "year": "2006", "edition": "6", "volume-title": "Handbook of Neurosurgery"}, {"key": "bibr19-1756285616648940", "DOI": "10.1177/1073858414559409", "doi-asserted-by": "publisher"}, {"key": "bibr20-1756285616648940", "DOI": "10.1007/s12311-013-0514-7", "doi-asserted-by": "publisher"}, {"key": "bibr21-1756285616648940", "DOI": "10.3389/fnsys.2014.00009", "doi-asserted-by": "publisher"}, {"key": "bibr22-1756285616648940", "DOI": "10.1056/NEJMoa0804656", "doi-asserted-by": "publisher"}, {"key": "bibr23-1756285616648940", "DOI": "10.1016/j.jns.2006.02.002", "doi-asserted-by": "publisher"}, {"key": "bibr24-1756285616648940", "DOI": "10.1007/s12311-013-0531-6", "doi-asserted-by": "publisher"}, {"key": "bibr25-1756285616648940", "DOI": "10.1002/mds.23222", "doi-asserted-by": "publisher"}, {"key": "bibr26-1756285616648940", "DOI": "10.1212/WNL.0b013e3181c33adf", "doi-asserted-by": "publisher"}, {"key": "bibr27-1756285616648940", "DOI": "10.1371/journal.pone.0108774", "doi-asserted-by": "publisher"}, {"key": "bibr28-1756285616648940", "DOI": "10.1016/j.pneurobio.2006.02.006", "doi-asserted-by": "publisher"}, {"key": "bibr29-1756285616648940", "DOI": "10.1016/S0074-7742(08)60370-0", "doi-asserted-by": "publisher"}, {"key": "bibr30-1756285616648940", "DOI": "10.1016/S0079-6123(08)63359-2", "doi-asserted-by": "publisher"}, {"key": "bibr31-1756285616648940", "DOI": "10.1007/s004150050344", "doi-asserted-by": "publisher"}, {"key": "bibr32-1756285616648940", "DOI": "10.1152/jn.00645.2011", "doi-asserted-by": "publisher"}, {"key": "bibr33-1756285616648940", "DOI": "10.1093/brain/awm126", "doi-asserted-by": "publisher"}, {"key": "bibr34-1756285616648940", "DOI": "10.1001/archneur.62.4.537", "doi-asserted-by": "publisher"}, {"key": "bibr35-1756285616648940", "DOI": "10.1093/brain/awm172", "doi-asserted-by": "publisher"}, {"key": "bibr36-1756285616648940", "DOI": "10.1212/01.WNL.0000118287.68294.E5", "doi-asserted-by": "publisher"}, {"key": "bibr37-1756285616648940", "DOI": "10.1007/BF00364149", "doi-asserted-by": "publisher"}, {"key": "bibr38-1756285616648940", "author": "Keren Z.", "volume": "7", "first-page": "6", "year": "2009", "journal-title": "Pediatr Endocrinol Rev"}, {"key": "bibr39-1756285616648940", "DOI": "10.1016/j.neuroscience.2009.04.045", "doi-asserted-by": "publisher"}, {"key": "bibr40-1756285616648940", "DOI": "10.1016/j.jneuroim.2015.04.013", "doi-asserted-by": "publisher"}, {"key": "bibr41-1756285616648940", "author": "Manto M.", "first-page": "97", "year": "2002", "volume-title": "The Cerebellum and its Disorders"}, {"key": "bibr42-1756285616648940", "DOI": "10.1007/s12311-008-0063-7", "doi-asserted-by": "publisher"}, {"key": "bibr43-1756285616648940", "DOI": "10.1007/s12311-011-0331-9", "doi-asserted-by": "publisher"}, {"key": "bibr44-1756285616648940", "DOI": "10.1196/annals.1325.065", "doi-asserted-by": "publisher"}, {"key": "bibr45-1756285616648940", "author": "Matsushita K.", "volume": "22", "first-page": "4388", "year": "2002", "journal-title": "J Neurosci", "DOI": "10.1523/JNEUROSCI.22-11-04388.2002", "doi-asserted-by": "crossref"}, {"key": "bibr46-1756285616648940", "DOI": "10.1007/BF00869770", "doi-asserted-by": "publisher"}, {"key": "bibr47-1756285616648940", "DOI": "10.1186/s40673-015-0034-y", "doi-asserted-by": "publisher"}, {"key": "bibr48-1756285616648940", "DOI": "10.1007/s12311\u2013015\u20130664-x", "doi-asserted-by": "publisher"}, {"key": "bibr49-1756285616648940", "DOI": "10.1177/1545968311425918", "doi-asserted-by": "publisher"}, {"key": "bibr50-1756285616648940", "DOI": "10.1161/STR.0b013e3181ec611b", "doi-asserted-by": "publisher"}, {"key": "bibr51-1756285616648940", "DOI": "10.1186/s13023-014-0179-4", "doi-asserted-by": "publisher"}, {"key": "bibr52-1756285616648940", "DOI": "10.1016/j.ncl.2014.07.010", "doi-asserted-by": "publisher"}, {"key": "bibr53-1756285616648940", "DOI": "10.1016/j.nbd.2014.06.012", "doi-asserted-by": "publisher"}, {"key": "bibr54-1756285616648940", "DOI": "10.1111/j.1460-9568.2007.05998.x", "doi-asserted-by": "publisher"}, {"key": "bibr55-1756285616648940", "DOI": "10.1016/S1474-4422(07)70194-1", "doi-asserted-by": "publisher"}, {"key": "bibr56-1756285616648940", "DOI": "10.1093/brain/awh532", "doi-asserted-by": "publisher"}, {"key": "bibr57-1756285616648940", "DOI": "10.1212/WNL.0b013e3181d31e23", "doi-asserted-by": "publisher"}, {"key": "bibr58-1756285616648940", "DOI": "10.1016/S1474-4422(15)00201-X", "doi-asserted-by": "publisher"}, {"key": "bibr59-1756285616648940", "author": "Rowland L.", "year": "2005", "edition": "11", "volume-title": "Merritt\u2019s Neurology"}, {"key": "bibr60-1756285616648940", "DOI": "10.1080/14734220260418457", "doi-asserted-by": "publisher"}, {"key": "bibr61-1756285616648940", "author": "Scalzo S.", "volume": "86", "first-page": "1362", "year": "2015", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "bibr62-1756285616648940", "DOI": "10.1007/s00415-012-6595-2", "doi-asserted-by": "publisher"}, {"key": "bibr63-1756285616648940", "DOI": "10.1074/jbc.R110.118679", "doi-asserted-by": "publisher"}, {"key": "bibr64-1756285616648940", "DOI": "10.1212/WNL.0b013e318225ab07", "doi-asserted-by": "publisher"}, {"key": "bibr65-1756285616648940", "DOI": "10.1212/01.WNL.0000125691.74109.53", "doi-asserted-by": "publisher"}, {"key": "bibr66-1756285616648940", "DOI": "10.1016/S0079-6123(08)00676-6", "doi-asserted-by": "publisher"}, {"key": "bibr67-1756285616648940", "DOI": "10.1212/01.WNL.0000078893.41040.56", "doi-asserted-by": "publisher"}, {"key": "bibr68-1756285616648940", "DOI": "10.1007/s00415-013-7016-x", "doi-asserted-by": "publisher"}, {"key": "bibr69-1756285616648940", "DOI": "10.1007/BF00231730", "doi-asserted-by": "publisher"}, {"key": "bibr70-1756285616648940", "DOI": "10.1016/j.jns.2010.01.021", "doi-asserted-by": "publisher"}, {"key": "bibr71-1756285616648940", "DOI": "10.1002/ana.410370603", "doi-asserted-by": "publisher"}, {"key": "bibr72-1756285616648940", "DOI": "10.1007/s11064-011-0496-0", "doi-asserted-by": "publisher"}, {"key": "bibr73-1756285616648940", "DOI": "10.1046/j.0953-816x.2000.01447.x", "doi-asserted-by": "publisher"}, {"key": "bibr74-1756285616648940", "DOI": "10.1126/scitranslmed.3010101", "doi-asserted-by": "publisher"}, {"key": "bibr75-1756285616648940", "DOI": "10.1038/nn1648", "doi-asserted-by": "publisher"}, {"key": "bibr76-1756285616648940", "DOI": "10.1007/s12311-014-0634-8", "doi-asserted-by": "publisher"}, {"key": "bibr77-1756285616648940", "DOI": "10.1161/01.str.0000441965.15164.d6", "doi-asserted-by": "publisher"}, {"key": "bibr78-1756285616648940", "DOI": "10.1523/JNEUROSCI.2915-04.2004", "doi-asserted-by": "publisher"}, {"key": "bibr79-1756285616648940", "author": "Womack M.", "volume": "23", "first-page": "2600", "year": "2003", "journal-title": "J Neurosci", "DOI": "10.1523/JNEUROSCI.23-07-02600.2003", "doi-asserted-by": "crossref"}, {"key": "bibr80-1756285616648940", "DOI": "10.1034/j.1600-0404.2001.00299.x", "doi-asserted-by": "publisher"}, {"key": "bibr81-1756285616648940", "DOI": "10.1002/ana.410410621", "doi-asserted-by": "publisher"}, {"key": "bibr82-1756285616648940", "author": "Zee D.", "volume": "46", "first-page": "878", "year": "1981", "journal-title": "J Neurophysiol", "DOI": "10.1152/jn.1981.46.4.878", "doi-asserted-by": "crossref"}, {"key": "bibr83-1756285616648940", "DOI": "10.1212/WNL.0b013e318247cc7a", "doi-asserted-by": "publisher"}], "container-title": ["Therapeutic Advances in Neurological Disorders"], "language": "en", "link": [{"URL": "http://journals.sagepub.com/doi/pdf/10.1177/1756285616648940", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://journals.sagepub.com/doi/full-xml/10.1177/1756285616648940", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://journals.sagepub.com/doi/pdf/10.1177/1756285616648940", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 8]], "date-time": "2019-09-08T13:36:36Z", "timestamp": 1567949796000}, "score": 39.610962, "issued": {"date-parts": [[2016, 5, 22]]}, "references-count": 83, "journal-issue": {"published-online": {"date-parts": [[2016, 5, 22]]}, "published-print": {"date-parts": [[2016, 9]]}, "issue": "5"}, "alternative-id": ["10.1177/1756285616648940"], "URL": "http://dx.doi.org/10.1177/1756285616648940", "relation": {"cites": []}, "ISSN": ["1756-2856", "1756-2864"], "issn-type": [{"value": "1756-2856", "type": "print"}, {"value": "1756-2864", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T08:46:19Z", "timestamp": 1574757979893}, "reference-count": 70, "publisher": "Hindawi Limited", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2017, 1, 1]], "date-time": "2017-01-01T00:00:00Z", "timestamp": 1483228800000}, "delay-in-days": 0, "content-version": "unspecified"}], "funder": [{"name": "FNRS-Belgium", "award": []}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Immunology Research"], "published-print": {"date-parts": [[2017]]}, "abstract": "<jats:p>Reports suggesting a pathogenic role of autoantibodies directed against glutamic acid decarboxylase 65 (GAD65Abs) in cerebellar ataxias (CAs) are reviewed, and debatable issues such as internalization of antibodies by neurons and roles of epitopes are discussed. GAD65 is one of two enzymes that catalyze the conversion of glutamate to the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). A pathogenic role of GAD65Ab in CAs is suggested by in vivo and in vitro studies. (1) Intracerebellar administration of cerebrospinal fluid (CSF) immunoglobulins (IgGs) obtained from GAD65Ab-positive CA patients impairs cerebellar modulation of motor control in rats. (2) CSF IgGs act on terminals of GABAergic neurons and decrease the release of GABA in cerebellar slices from rats and mice. (3) Absorption of GAD65Ab by recombinant GAD65 diminishes the above effects, and monoclonal human GAD65Ab (b78) mimic the effects of CSF IgGs in vivo and in vitro. Studies using GAD65-KO mice confirm that the target molecule is GAD65. (4) Notably, the effects of GAD65Ab depend on the epitope specificity of the monoclonal GAD65Ab. Taken together, these results indicate that epitope-specific GAD65Ab-induced impairment of GABA release is involved in the pathogenesis of GAD65Ab-positive CA and support the early detection of GAD65Ab-associated CA to initiate immunotherapy before irreversible neuronal death in the cerebellum.</jats:p>", "DOI": "10.1155/2017/2913297", "type": "journal-article", "created": {"date-parts": [[2017, 3, 12]], "date-time": "2017-03-12T21:00:38Z", "timestamp": 1489352438000}, "page": "1-12", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias"], "prefix": "10.1155", "volume": "2017", "author": [{"ORCID": "http://orcid.org/0000-0003-0513-1811", "authenticated-orcid": true, "given": "Hiroshi", "family": "Mitoma", "sequence": "first", "affiliation": [{"name": "Medical Education Promotion Center, Tokyo Medical University, Tokyo, Japan"}]}, {"ORCID": "http://orcid.org/0000-0001-6034-4380", "authenticated-orcid": true, "given": "Mario", "family": "Manto", "sequence": "additional", "affiliation": [{"name": "Unit\u00e9 d\u2019Etude du Mouvement (UEM), GRIM, FNRS, ULB Erasme, 1070 Bruxelles, Belgium"}]}, {"given": "Christiane S.", "family": "Hampe", "sequence": "additional", "affiliation": [{"name": "School of Medicine, University of Washington, Seattle, WA 98109, USA"}]}], "member": "98", "reference": [{"key": "1", "DOI": "10.1007/s12311-011-0331-9", "doi-asserted-by": "publisher"}, {"key": "2", "DOI": "10.1007/s12311-015-0664-x", "doi-asserted-by": "publisher"}, {"key": "3", "DOI": "10.1186/s40673-015-0034-y", "doi-asserted-by": "publisher"}, {"key": "4", "DOI": "10.1002/mds.22129", "doi-asserted-by": "publisher"}, {"key": "5", "DOI": "10.1016/j.nrl.2013.06.018", "doi-asserted-by": "publisher"}, {"key": "6", "DOI": "10.1177/1756285616648940", "doi-asserted-by": "publisher"}, {"key": "7", "DOI": "10.3389/fnbeh.2015.00078", "doi-asserted-by": "publisher"}, {"key": "8", "DOI": "10.1038/nrneurol.2012.99", "doi-asserted-by": "publisher"}, {"key": "9", "DOI": "10.1212/WNL.52.4.857", "doi-asserted-by": "publisher"}, {"key": "10", "DOI": "10.1212/WNL.49.4.1026", "doi-asserted-by": "publisher"}, {"key": "11", "DOI": "10.1001/archneur.58.2.225", "doi-asserted-by": "publisher"}, {"key": "12", "DOI": "10.1507/endocrj.48.261", "doi-asserted-by": "publisher"}, {"key": "13", "DOI": "10.1016/j.diabet.2008.02.002", "doi-asserted-by": "publisher"}, {"key": "14", "DOI": "10.1016/S0140-6736(13)62409-5", "doi-asserted-by": "publisher"}, {"key": "15", "DOI": "10.1007/s12311-013-0534-3", "doi-asserted-by": "publisher"}, {"key": "16", "DOI": "10.1001/jamaneurol.2014.1011", "doi-asserted-by": "publisher"}, {"key": "17", "DOI": "10.1111/j.1468-1331.2009.02839.x", "doi-asserted-by": "publisher"}, {"key": "18", "DOI": "10.1001/jamaneurol.2015.0749", "doi-asserted-by": "publisher"}, {"key": "19", "DOI": "10.4049/jimmunol.175.11.7755", "doi-asserted-by": "publisher"}, {"key": "20", "volume": "10", "issue": "5", "first-page": "1275", "year": "1991", "journal-title": "EMBO Journal", "DOI": "10.1002/j.1460-2075.1991.tb08069.x", "doi-asserted-by": "crossref"}, {"key": "21", "DOI": "10.1083/jcb.118.2.309", "doi-asserted-by": "publisher"}, {"key": "22", "DOI": "10.1242/jcs.01030", "doi-asserted-by": "publisher"}, {"key": "23", "DOI": "10.1186/s40673-015-0033-z", "doi-asserted-by": "publisher"}, {"key": "24", "DOI": "10.1371/journal.pone.0108774", "doi-asserted-by": "publisher"}, {"key": "25", "DOI": "10.1002/ana.21123", "doi-asserted-by": "publisher"}, {"key": "26", "DOI": "10.1186/1750-1172-6-3", "doi-asserted-by": "publisher"}, {"key": "27", "DOI": "10.1113/jphysiol.2005.088229", "doi-asserted-by": "publisher"}, {"key": "28", "DOI": "10.1046/j.1471-4159.2002.00857.x", "doi-asserted-by": "publisher"}, {"key": "29", "DOI": "10.1016/S0169-328X(01)00069-9", "doi-asserted-by": "publisher"}, {"key": "30", "DOI": "10.1136/jnnp.70.3.386", "doi-asserted-by": "publisher"}, {"key": "31", "DOI": "10.1016/S0022-510X(00)00272-0", "doi-asserted-by": "publisher"}, {"key": "32", "DOI": "10.1136/jnnp.70.3.386", "doi-asserted-by": "publisher"}, {"key": "33", "DOI": "10.1016/s0022-510x(02)00423-9", "doi-asserted-by": "publisher"}, {"key": "34", "DOI": "10.1016/j.jns.2008.04.019", "doi-asserted-by": "publisher"}, {"key": "35", "DOI": "10.1186/1750-1172-8-82", "doi-asserted-by": "publisher"}, {"key": "36", "DOI": "10.1016/0166-2236(91)90044-U", "doi-asserted-by": "publisher"}, {"key": "37", "volume": "340", "issue": "6289", "first-page": "151", "year": "1990", "journal-title": "Nature"}, {"key": "38", "DOI": "10.1084/jem.180.2.595", "doi-asserted-by": "publisher"}, {"key": "39", "DOI": "10.2337/diab.43.1.161", "doi-asserted-by": "publisher"}, {"key": "40", "volume": "156", "issue": "2", "first-page": "818", "year": "1996", "journal-title": "Journal of Immunology"}, {"key": "41", "DOI": "10.1002/ana.410440209", "doi-asserted-by": "publisher"}, {"key": "42", "DOI": "10.1084/jem.178.6.2097", "doi-asserted-by": "publisher"}, {"key": "43", "DOI": "10.2337/diabetes.52.11.2689", "doi-asserted-by": "publisher"}, {"key": "44", "DOI": "10.2337/db07-1461", "doi-asserted-by": "publisher"}, {"key": "45", "DOI": "10.1371/journal.pone.0121364", "doi-asserted-by": "publisher"}, {"key": "46", "DOI": "10.1186/1742-2094-6-31", "doi-asserted-by": "publisher"}, {"key": "47", "DOI": "10.1001/archneur.1985.04060070084021", "doi-asserted-by": "publisher"}, {"key": "48", "DOI": "10.1016/0022-510X(86)90150-4", "doi-asserted-by": "publisher"}, {"key": "49", "DOI": "10.1016/0022-510X(90)90011-B", "doi-asserted-by": "publisher"}, {"key": "50", "DOI": "10.1016/0022-510X(91)90198-G", "doi-asserted-by": "publisher"}, {"key": "51", "DOI": "10.1007/BF00309627", "doi-asserted-by": "publisher"}, {"key": "52", "DOI": "10.1093/cercor/bht060", "doi-asserted-by": "publisher"}, {"key": "53", "DOI": "10.1093/brain/awq253", "doi-asserted-by": "publisher"}, {"key": "54", "DOI": "10.1016/j.jneuroim.2015.03.009", "doi-asserted-by": "publisher"}, {"key": "55", "DOI": "10.1016/j.jim.2004.09.015", "doi-asserted-by": "publisher"}, {"key": "56", "DOI": "10.1080/08916930701619565", "doi-asserted-by": "publisher"}, {"key": "57", "DOI": "10.1136/jnnp.2006.091116", "doi-asserted-by": "publisher"}, {"key": "58", "DOI": "10.1016/j.jns.2009.12.006", "doi-asserted-by": "publisher"}, {"key": "59", "DOI": "10.1002/(sici)1097-4547(19981001)54:160;17::aid-jnr362;3.0.co;2-k", "doi-asserted-by": "publisher"}, {"key": "60", "DOI": "10.1016/j.csbj.2015.03.004", "doi-asserted-by": "publisher"}, {"key": "61", "DOI": "10.1016/s1570-9639(02)00455-7", "doi-asserted-by": "publisher"}, {"key": "62", "DOI": "10.1016/s0092-8674(00)81779-1", "doi-asserted-by": "publisher"}, {"key": "63", "DOI": "10.1017/S1740925X11000123", "doi-asserted-by": "publisher"}, {"key": "64", "DOI": "10.2174/1389203711314010004", "doi-asserted-by": "publisher"}, {"key": "65", "DOI": "10.1523/JNEUROSCI.5369-12.2013", "doi-asserted-by": "publisher"}, {"key": "66", "DOI": "10.1155/2014/861231", "doi-asserted-by": "publisher"}, {"key": "67", "DOI": "10.3389/fncel.2015.00322", "doi-asserted-by": "publisher"}, {"key": "68", "DOI": "10.1002/1098-1136(200010)32:162;1::aid-glia1062;3.0.co;2-w", "doi-asserted-by": "publisher"}, {"key": "69", "DOI": "10.1186/1750-1172-5-31", "doi-asserted-by": "publisher"}, {"key": "70", "DOI": "10.1111/jnc.13348", "doi-asserted-by": "publisher"}], "container-title": ["Journal of Immunology Research"], "language": "en", "link": [{"URL": "http://downloads.hindawi.com/journals/jir/2017/2913297.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://downloads.hindawi.com/journals/jir/2017/2913297.xml", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://downloads.hindawi.com/journals/jir/2017/2913297.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 19]], "date-time": "2019-09-19T16:57:14Z", "timestamp": 1568912234000}, "score": 35.95543, "issued": {"date-parts": [[2017]]}, "references-count": 70, "alternative-id": ["2913297", "2913297"], "URL": "http://dx.doi.org/10.1155/2017/2913297", "relation": {"cites": []}, "ISSN": ["2314-8861", "2314-7156"], "issn-type": [{"value": "2314-8861", "type": "print"}, {"value": "2314-7156", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T04:17:34Z", "timestamp": 1574741854659}, "reference-count": 5, "publisher": "Springer Science and Business Media LLC", "issue": "1", "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["cerebellum ataxias"], "published-print": {"date-parts": [[2015, 12]]}, "DOI": "10.1186/s40673-015-0033-z", "type": "journal-article", "created": {"date-parts": [[2015, 11, 6]], "date-time": "2015-11-06T12:23:28Z", "timestamp": 1446812608000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Overlooked Holmes\u2019 clinical signs: reevaluation by recent physiological findings"], "prefix": "10.1186", "volume": "2", "author": [{"given": "Takahiro", "family": "Ishikawa", "sequence": "first", "affiliation": []}, {"given": "Shinji", "family": "Kakei", "sequence": "additional", "affiliation": []}, {"given": "Hiroshi", "family": "Mitoma", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 11, 6]]}, "reference": [{"key": "33_CR1", "doi-asserted-by": "crossref", "first-page": "461", "DOI": "10.1093/brain/40.4.461", "volume": "40", "author": "G Holmes", "year": "1917", "unstructured": "Holmes G. The symptoms of acute cerebellar injuries due to gunshot injuries. Brain. 1917;40:461\u2013535.", "journal-title": "Brain"}, {"key": "33_CR2", "unstructured": "Bodranghien F, Bastian A, Casali C, Hallet M, Louis ED, Manto M, et al. Consensus paper: Revisiting the symptoms and signs of cerebellar syndrome. Cerebellum. 2015; doi: 10.1007//s12311-015-0687-3 ."}, {"key": "33_CR3", "unstructured": "Luciani L. Il cervelletto: nuovi studi di fisiologia normale e pathologica. Le Monnier 1891."}, {"key": "33_CR4", "doi-asserted-by": "crossref", "first-page": "112", "DOI": "10.1016/S0166-2236(96)10077-1", "volume": "20", "author": "M Ermanno", "year": "1997", "unstructured": "Ermanno M, Petrosini L. Luciani\u2019s work on the cerebellum a century later. Trends Neurosci. 1997;20:112\u20136.", "journal-title": "Trends Neurosci"}, {"key": "33_CR5", "doi-asserted-by": "crossref", "first-page": "e108774", "DOI": "10.1371/journal.pone.0108774", "volume": "9", "author": "T Ishikawa", "year": "2014", "unstructured": "Ishikawa T, Tomatsu S, Lee J, Hoffman DS, Kakei S. Releasing dentate nucleus cells from Purkinje cell inhibition generates output from the cerebrocerebellum. PLoS One. 2014;9:e108774.", "journal-title": "PLoS One"}], "container-title": ["Cerebellum & Ataxias"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/s40673-015-0033-z", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 23]], "date-time": "2017-06-23T23:05:39Z", "timestamp": 1498259139000}, "score": 34.610462, "issued": {"date-parts": [[2015, 11, 6]]}, "references-count": 5, "journal-issue": {"published-print": {"date-parts": [[2015, 12]]}, "issue": "1"}, "alternative-id": ["33"], "URL": "http://dx.doi.org/10.1186/s40673-015-0033-z", "relation": {"cites": []}, "ISSN": ["2053-8871"], "issn-type": [{"value": "2053-8871", "type": "electronic"}], "article-number": "13"}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T19:25:53Z", "timestamp": 1574105153009}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1996, 1, 1]], "date-time": "1996-01-01T00:00:00Z", "timestamp": 820454400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuroscience Research"], "published-print": {"date-parts": [[1996, 1]]}, "DOI": "10.1016/0168-0102(96)88636-6", "type": "journal-article", "created": {"date-parts": [[2002, 12, 27]], "date-time": "2002-12-27T19:20:46Z", "timestamp": 1041016846000}, "page": "S31", "source": "Crossref", "is-referenced-by-count": 0, "title": ["207 Aminergic long-term potentiation of cerebellar GABA-mediated inhibitory transmission through camp dependent mechanism"], "prefix": "10.1016", "volume": "25", "author": [{"given": "Hiroshi", "family": "Mitoma", "sequence": "first", "affiliation": []}, {"given": "Shiro", "family": "Konishi", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuroscience Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0168010296886366?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0168010296886366?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T14:58:00Z", "timestamp": 1555599480000}, "score": 34.483192, "issued": {"date-parts": [[1996, 1]]}, "references-count": 0, "alternative-id": ["0168010296886366"], "URL": "http://dx.doi.org/10.1016/0168-0102(96)88636-6", "ISSN": ["0168-0102"], "issn-type": [{"value": "0168-0102", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T21:46:50Z", "timestamp": 1575496010011}, "publisher-location": "Cham", "reference-count": 57, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783030195144", "type": "print"}, {"value": "9783030195151", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2019, 1, 1]], "date-time": "2019-01-01T00:00:00Z", "timestamp": 1546300800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "published-print": {"date-parts": [[2019]]}, "DOI": "10.1007/978-3-030-19515-1_19", "type": "book-chapter", "created": {"date-parts": [[2019, 8, 13]], "date-time": "2019-08-13T09:02:45Z", "timestamp": 1565686965000}, "page": "599-620", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Autoimmune Ataxias"], "prefix": "10.1007", "author": [{"given": "Marios", "family": "Hadjivassiliou", "sequence": "first", "affiliation": []}, {"given": "Hiroshi", "family": "Mitoma", "sequence": "additional", "affiliation": []}, {"given": "Mario", "family": "Manto", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2019, 8, 14]]}, "reference": [{"key": "19_CR1", "doi-asserted-by": "publisher", "first-page": "301", "DOI": "10.1136/jnnp-2016-314863", "volume": "88", "author": "M Hadjivassiliou", "year": "2016", "unstructured": "Hadjivassiliou M, Martindale J, Shanmugarajah P, et al. Causes of progressive cerebellar ataxia: prospective evaluation of 1500 patients. J Neurol Neurosurg Psychiatry. 2016;88:301. \n                    https://doi.org/10.1136/jnnp-2016-314863\n                    \n                  .", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "19_CR2", "first-page": "8", "volume": "9", "author": "M Hadjivassiliou", "year": "2010", "unstructured": "Hadjivassiliou M. Primary autoimmune cerebellar ataxia (PACA). Adv Clin Neurosci Rehabil. 2010;9:8\u201311.", "journal-title": "Adv Clin Neurosci Rehabil"}, {"key": "19_CR3", "doi-asserted-by": "publisher", "first-page": "1582", "DOI": "10.1016/S0140-6736(98)05342-2", "volume": "352", "author": "M Hadjivassiliou", "year": "1998", "unstructured": "Hadjivassiliou M, Grunewald RA, Chattopadhyay AK, et al. Clinical, radiological, neurophysiological and neuropathological characteristics of gluten ataxia. Lancet. 1998;352:1582\u20135.", "journal-title": "Lancet"}, {"key": "19_CR4", "unstructured": "Sarrigiannis PG, Hoggard N, Aeschlimann D, et al. Myoclonus ataxia and refractory coeliac disease. Cerebellum Ataxias. 2014. \n                    www.cerebellumandataxias.com/content/1/1/11", "DOI": "10.1186/2053-8871-1-11", "doi-asserted-by": "crossref"}, {"key": "19_CR5", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1212/WNL.0000000000004237", "volume": "89", "author": "M Hadjivassiliou", "year": "2017", "unstructured": "Hadjivassiliou M, Grunewald RA, Sanders DS, Shanmugarajah P, Hoggard N. Effect of gluten-free diet on MR spectroscopy in gluten ataxia. Neurology. 2017;89:1\u20135.", "journal-title": "Neurology"}, {"key": "19_CR6", "doi-asserted-by": "publisher", "first-page": "797", "DOI": "10.1038/nm0797-797", "volume": "3", "author": "W Dietrich", "year": "1997", "unstructured": "Dietrich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997;3:797\u2013801.", "journal-title": "Nat Med"}, {"key": "19_CR7", "doi-asserted-by": "publisher", "first-page": "747", "DOI": "10.1084/jem.20011299", "volume": "195", "author": "M S\u00e1rdy", "year": "2002", "unstructured": "S\u00e1rdy M, K\u00e1rp\u00e1ti S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase3) is the autoantigen of dermatitis herpetiformis. J Exp Med. 2002;195:747\u201357.", "journal-title": "J Exp Med"}, {"key": "19_CR8", "doi-asserted-by": "publisher", "first-page": "332", "DOI": "10.1002/ana.21450", "volume": "64", "author": "M Hadjivassiliou", "year": "2008", "unstructured": "Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, Aeschlimann D. Autoantibodies in gluten ataxia recognise a novel neuronal transglutaminase. Ann Neurol. 2008;64:332\u201343.", "journal-title": "Ann Neurol"}, {"key": "19_CR9", "doi-asserted-by": "publisher", "first-page": "318", "DOI": "10.1016/S1474-4422(09)70290-X", "volume": "9", "author": "M Hadjivassiliou", "year": "2010", "unstructured": "Hadjivassiliou M, Sanders DS, Grunewald RA, Woodroofe N, Boscolo S, Aeschlimann D. Gluten sensitivity: from gut to brain. Lancet Neurol. 2010;9:318\u201330.", "journal-title": "Lancet Neurol"}, {"key": "19_CR10", "doi-asserted-by": "publisher", "first-page": "1444", "DOI": "10.3390/nu10101444", "volume": "10", "author": "M Hadjivassiliou", "year": "2018", "unstructured": "Hadjivassiliou M, Grunewald RA, Sanders DS, et al. The significance of low titre antigliadin antibodies in the diagnosis of gluten ataxia. Nutrients. 2018;10:1444. \n                    https://doi.org/10.3390/nu10101444\n                    \n                  .", "journal-title": "Nutrients"}, {"key": "19_CR11", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1212/WNL.0b013e3182919070", "volume": "80", "author": "M Hadjivassiliou", "year": "2013", "unstructured": "Hadjivassiliou M, Aeschlimann P, Sanders DS, et al. Transglutaminase 6 antibodies in the diagnosis of gluten ataxia. Neurology. 2013;80:1\u20136.", "journal-title": "Neurology"}, {"key": "19_CR12", "unstructured": "Hadjivassiliou M, Sanders DS, Aeschlimann D. The neuroimmunology of gluten intolerance. In: Constantinescu C, et al., editors. Neuro-immuno-gastroenterology: Springer; 2016. Springer. International Publishing Switzerland", "DOI": "10.1007/978-3-319-28609-9_15", "doi-asserted-by": "crossref"}, {"key": "19_CR13", "doi-asserted-by": "publisher", "first-page": "827", "DOI": "10.1002/ana.1281", "volume": "50", "author": "K B\u00fcrk", "year": "2001", "unstructured": "B\u00fcrk K, Melms A, Schulz JB, Dichgans J. Effectiveness of intravenous immunoglobulin therapy in cerebellar ataxia associated with gluten sensitivity. Ann Neurol. 2001;50:827\u20138.", "journal-title": "Ann Neurol"}, {"key": "19_CR14", "doi-asserted-by": "publisher", "first-page": "1300", "DOI": "10.1111/j.1468-1331.2008.02305.x", "volume": "15", "author": "N Souayah", "year": "2008", "unstructured": "Souayah N, Chin RL, Brannagan TH, et al. Effect of intravenous immunoglobulin on cerebellar ataxia and neuropathic pain associated with celiac disease. Eur J Neurol. 2008;15:1300\u20133.", "journal-title": "Eur J Neurol"}, {"key": "19_CR15", "doi-asserted-by": "publisher", "first-page": "783", "DOI": "10.2169/internalmedicine.48.1802", "volume": "48", "author": "K Nanri", "year": "2009", "unstructured": "Nanri K, Okita M, Takeguchi M, et al. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia. Intern Med. 2009;48:783\u201390.", "journal-title": "Intern Med"}, {"issue": "9", "key": "19_CR16", "doi-asserted-by": "publisher", "first-page": "1221", "DOI": "10.1136/jnnp.74.9.1221", "volume": "74", "author": "M Hadjivassiliou", "year": "2003", "unstructured": "Hadjivassiliou M, Davies-Jones GAB, Sanders DS, Grunewald RA. Dietary treatment of gluten ataxia. J Neurol Neurosurg Psychiatry. 2003;74(9):1221\u20134.", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "19_CR17", "doi-asserted-by": "publisher", "first-page": "561", "DOI": "10.1038/ajg.2015.434", "volume": "111", "author": "M Hadjivassiliou", "year": "2016", "unstructured": "Hadjivassiliou M, Rao DG, Grunewald RA, et al. Neurological dysfunction in coeliac disease and non-coeliac gluten sensitivity. Am J Gastroenterol. 2016;111:561. \n                    https://doi.org/10.1038/ajg.2015.434\n                    \n                  .", "journal-title": "Am J Gastroenterol"}, {"key": "19_CR18", "doi-asserted-by": "publisher", "first-page": "187", "DOI": "10.1016/0163-7258(95)00016-A", "volume": "67", "author": "DIB Kerr", "year": "1995", "unstructured": "Kerr DIB, Ong J. GABA receptors. Pharmacol Ther. 1995;67:187\u2013246.", "journal-title": "Pharmacol Ther"}, {"key": "19_CR19", "first-page": "211", "volume": "7", "author": "M Solimena", "year": "1998", "unstructured": "Solimena M, Piccolo G, Martino G. Autoantibodies directed against gabaminergic nerve terminals in a patient with idiopathic late-onset cerebellar ataxia and type 1 diabetes mellitus. Clin Neuropathol. 1998;7.(Suppl:211.", "journal-title": "Clin Neuropathol"}, {"key": "19_CR20", "doi-asserted-by": "publisher", "first-page": "148", "DOI": "10.1038/nm0296-148", "volume": "2", "author": "TM Ellis", "year": "1996", "unstructured": "Ellis TM, Atkinson MA. The clinical significance of an autoimmune response against glutamic acid decarboxylase. Nat Med. 1996;2:148\u201353.", "journal-title": "Nat Med"}, {"key": "19_CR21", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.1001/archneur.58.2.225", "volume": "58", "author": "J Honnorat", "year": "2001", "unstructured": "Honnorat J, Saiz A, Giometto B, et al. Cerebellar ataxia with antiglutamic acid decarboxylase antibodies. Arch Neurol. 2001;58:225\u201330.", "journal-title": "Arch Neurol"}, {"key": "19_CR22", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1155/2017/2913297", "volume": "2017", "author": "Hiroshi Mitoma", "year": "2017", "unstructured": "Mitoma H, Manto M, Hampe CS. Pathogenic roles of glutamic acid decarboxylase 65 autoantibodies in cerebellar ataxias. J Immunol Res. 2017; \n                    https://doi.org/10.1155/2017/2913297\n                    \n                  .", "journal-title": "Journal of Immunology Research"}, {"key": "19_CR23", "unstructured": "Manto M, Mitoma H, Hampe CS. Anti-gad antibodies and the cerebellum: where do we stand? Cerebellum. 2018; \n                    https://doi.org/10.1007/s12311-0180986\n                    \n                  .", "DOI": "10.1007/s12311-0180986", "doi-asserted-by": "publisher"}, {"issue": "8", "key": "19_CR24", "doi-asserted-by": "publisher", "first-page": "1009", "DOI": "10.1001/jamaneurol.2014.1011", "volume": "71", "author": "H Arino", "year": "2014", "unstructured": "Arino H, Gresa-Arribas N, Blanco Y, et al. Cerebellar ataxia and glutamic acid decarboxylase antibodies; immune profile and long-term effect of immunotherapy. JAMA Neurol. 2014;71(8):1009\u201316.", "journal-title": "JAMA Neurol"}, {"key": "19_CR25", "doi-asserted-by": "publisher", "first-page": "14", "DOI": "10.1186/s40673-015-0034-y", "volume": "2", "author": "H Mitoma", "year": "2015", "unstructured": "Mitoma H, Hadjivassiliou M, Honnorat J. Guidelines for treatment of immune-mediated ataxias. Cerebellum Ataxias. 2015;2:14.", "journal-title": "Cerebellum Ataxias"}, {"issue": "10", "key": "19_CR26", "doi-asserted-by": "publisher", "first-page": "1270", "DOI": "10.1002/mds.22129", "volume": "23", "author": "M Hadjivassiliou", "year": "2008", "unstructured": "Hadjivassiliou M, Boscolo S, Tongiorgi E, et al. Cerebellar ataxia as a possible organ specific autoimmune disease. Mov Disord. 2008;23(10):1270\u2013377.", "journal-title": "Mov Disord"}, {"key": "19_CR27", "doi-asserted-by": "publisher", "first-page": "213", "DOI": "10.1007/s12311-015-0664-x", "volume": "15", "author": "H Mitoma", "year": "2015", "unstructured": "Mitoma H, Adhikari K, Aeschlimann D, et al. Consensus paper: neuroimmune mechanisms of cerebellar ataxia. Cerebellum. 2015;15:213. \n                    https://doi.org/10.1007/s12311-015-0664-x\n                    \n                  .", "journal-title": "Cerebellum"}, {"key": "19_CR28", "first-page": "467", "volume": "46", "author": "M Takeguchi", "year": "2006", "unstructured": "Takeguchi M, Nanri K, Okita M, et al. Efficacy of intravenous immunoglobulin for slowly progressive cerebellar atrophy. Rinsho Shinkeigaku. 2006;46:467\u201374.", "journal-title": "Rinsho Shinkeigaku"}, {"key": "19_CR29", "doi-asserted-by": "publisher", "first-page": "1304", "DOI": "10.1001/jamaneurol.2015.2378", "volume": "72", "author": "AL Jones", "year": "2015", "unstructured": "Jones AL, Flanagan EP, Pittock SJ, et al. Responses to and outcomes of treatment of autoimmune cerebellar ataxia in adults. JAMA Neurol. 2015;72:1304\u201312.", "journal-title": "JAMA Neurol"}, {"key": "19_CR30", "doi-asserted-by": "publisher", "first-page": "327", "DOI": "10.1016/S1474-4422(08)70060-7", "volume": "7", "author": "J Dalmau", "year": "2008", "unstructured": "Dalmau J, Rosenfield MR. Lancet Neurol. 2008;7:327\u201340.", "journal-title": "Lancet Neurol"}, {"key": "19_CR31", "doi-asserted-by": "publisher", "first-page": "310", "DOI": "10.1016/j.neurorad.2012.08.003", "volume": "40", "author": "M Hadjivassiliou", "year": "2013", "unstructured": "Hadjivassiliou M, Currie S, Hoggard N. MR spectroscopy in paraneoplastic cerebellar degeneration. J Neuroradiol. 2013;40:310. \n                    https://doi.org/10.1016/j.neurorad.2012.08.003\n                    \n                  .", "journal-title": "J Neuroradiol"}, {"key": "19_CR32", "doi-asserted-by": "publisher", "first-page": "509", "DOI": "10.1007/s00415-009-5431-9", "volume": "257", "author": "F Graus", "year": "2010", "unstructured": "Graus F, Dalmau J. Autoantibodies and neuronal autoimmune disorders of the CNS. J Neurol Sci. 2010;257:509\u201317.", "journal-title": "J Neurol Sci"}, {"key": "19_CR33", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1002/1531-8249(200001)47:1<9::AID-ANA5>3.0.CO;2-I", "volume": "47", "author": "ML Albert", "year": "2010", "unstructured": "Albert ML, Austin LM, Darnell RB. Detection and treatment of activated T cells in cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol. 2010;47:9\u201317.", "journal-title": "Ann Neurol"}, {"key": "19_CR34", "doi-asserted-by": "publisher", "first-page": "186", "DOI": "10.1111/j.1600-0404.2008.01089.x", "volume": "119", "author": "M Hadjivassiliou", "year": "2009", "unstructured": "Hadjivassiliou M, Alder SJ, Van Beek EJR, et al. PET scan in clinically suspected paraneoplastic neurological syndromes: a six year prospective study in a regional neuroscience unit. Acta Neurol Scand. 2009;119:186\u201393.", "journal-title": "Acta Neurol Scand"}, {"key": "19_CR35", "doi-asserted-by": "publisher", "first-page": "156", "DOI": "10.1016/j.ejpn.2009.03.002", "volume": "14", "author": "KK Pang", "year": "2009", "unstructured": "Pang KK, De Sousa C, Lang B, et al. A prospective study of the presentation and management of dancing eye syndrome/opsoclonus myoclonus syndrome in the UK. Eur J Paediatr Neurol. 2009;14:156\u201361.", "journal-title": "Eur J Paediatr Neurol"}, {"key": "19_CR36", "doi-asserted-by": "publisher", "first-page": "1372", "DOI": "10.1016/j.clinph.2018.03.026", "volume": "129", "author": "DJ Blackburn", "year": "2018", "unstructured": "Blackburn DJ, Forbes M, Unwin Z, Hoggard N, Hadjivassiliou M, Sarrigiannis PG. Exaggerated startle in post-infectious opsoclonus myoclonus syndrome. Clin Neurophysiol. 2018;129:1372\u20133.", "journal-title": "Clin Neurophysiol"}, {"key": "19_CR37", "doi-asserted-by": "publisher", "first-page": "312", "DOI": "10.1016/j.pediatrneurol.2005.08.034", "volume": "34", "author": "N Deconinck", "year": "2006", "unstructured": "Deconinck N, Scaillon M, Segers V, et al. Opsoclonus-myoclonus associated with celiac disease. Pediatr Neurol. 2006;34:312\u20134.", "journal-title": "Pediatr Neurol"}, {"key": "19_CR38", "doi-asserted-by": "publisher", "first-page": "437", "DOI": "10.1093/brain/124.2.437", "volume": "124", "author": "L Bataller", "year": "2001", "unstructured": "Bataller L, Graus F, Saiz A, Vilchez JJ. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain. 2001;124:437\u201343.", "journal-title": "Brain"}, {"key": "19_CR39", "doi-asserted-by": "publisher", "first-page": "1526", "DOI": "10.1212/WNL.62.9.1526", "volume": "62", "author": "MR Pranzatelli", "year": "2004", "unstructured": "Pranzatelli MR, Travelstead BS, Tate ED, et al. B and T-cell markers in opsoclonus-myoclonus syndrome. Neurology. 2004;62:1526\u201332.", "journal-title": "Neurology"}, {"key": "19_CR40", "doi-asserted-by": "publisher", "first-page": "238", "DOI": "10.1002/mds.22941", "volume": "25", "author": "MR Pranzatelli", "year": "2010", "unstructured": "Pranzatelli MR, Tate ED, Swan JA, et al. B cell depletion therapy for new-onset opsoclonus myolconus. Mov Disord. 2010;25:238\u201342.", "journal-title": "Mov Disord"}, {"key": "19_CR41", "doi-asserted-by": "publisher", "first-page": "120", "DOI": "10.1002/ana.23756", "volume": "73", "author": "A Boronat", "year": "2013", "unstructured": "Boronat A, Gelfand JM, Gresha-Arribas N, et al. Encephalitis and antibodies to DPPX, a subunit of Kv4.2 potassium channels. Ann Neurol. 2013;73:120\u20138.", "journal-title": "Ann Neurol"}, {"key": "19_CR42", "doi-asserted-by": "publisher", "first-page": "1521", "DOI": "10.1212/WNL.0000000000000372", "volume": "82", "author": "B Balint", "year": "2014", "unstructured": "Balint B, Jarius S, Nagel S, et al. Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies. Neurology. 2014;82:1521\u2013152869.", "journal-title": "Neurology"}, {"key": "19_CR43", "doi-asserted-by": "publisher", "first-page": "1797", "DOI": "10.1212/WNL.0000000000000991", "volume": "83", "author": "WO Tobin", "year": "2014", "unstructured": "Tobin WO, Lennon VA, Komorowski L, et al. DPPX potassium channel antibody; frequency, clinical accompaniments and outcomes in 20 patients. Neurology. 2014;83:1797\u2013803.", "journal-title": "Neurology"}, {"key": "19_CR44", "doi-asserted-by": "publisher", "first-page": "115", "DOI": "10.1007/s00415-017-8675-9", "volume": "265", "author": "P Zis", "year": "2018", "unstructured": "Zis P, Rao DG, Hoggard N, et al. Anti-MAG associated cerbellar ataxia and response to rituximab. J Neurol. 2018;265:115\u20138.", "journal-title": "J Neurol"}, {"key": "19_CR45", "doi-asserted-by": "publisher", "first-page": "2626", "DOI": "10.1093/brain/awq164", "volume": "133", "author": "SJ Pittock", "year": "2010", "unstructured": "Pittock SJ, Debruyne J, Krecke KN, et al. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain. 2010;133:2626\u201334.", "journal-title": "Brain"}, {"key": "19_CR46", "doi-asserted-by": "publisher", "first-page": "385", "DOI": "10.1111/cei.12204", "volume": "175", "author": "A Dudesek", "year": "2014", "unstructured": "Dudesek A, Rimmele E, Tesar S, et al. CLIPPERS: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Review of an increasingly recognized entity within the spectrum of inflammatory central nervous system disorders. Clin Exp Immunol. 2014;175:385\u201396.", "journal-title": "Clin Exp Immunol"}, {"key": "19_CR47", "doi-asserted-by": "publisher", "first-page": "475", "DOI": "10.1002/acr.21591", "volume": "64", "author": "SC Shiboski", "year": "2012", "unstructured": "Shiboski SC, Shiboski CH, Criswell LA, et al. American College of Rheumatology Classification Criteria for Sjogren\u2019s syndrome: a data-driven, expert consensus approach in the Sjogren\u2019s International Collaborative Clinical Alliance Cohort. Arthritis Care Res. 2012;64:475\u201387.", "journal-title": "Arthritis Care Res"}, {"key": "19_CR48", "doi-asserted-by": "publisher", "first-page": "1391", "DOI": "10.1212/WNL.31.11.1391", "volume": "31", "author": "GE Alexander", "year": "1981", "unstructured": "Alexander GE, Stevens MB, Provost TT, et al. Sjogren\u2019s syndrome: central nervous system manifestations. Neurology. 1981;31:1391\u20136.", "journal-title": "Neurology"}, {"key": "19_CR49", "doi-asserted-by": "publisher", "first-page": "323", "DOI": "10.7326/0003-4819-104-3-323", "volume": "104", "author": "EL Alexander", "year": "1986", "unstructured": "Alexander EL, Malinow K, Lejewski JE, et al. Primary Sjogren\u2019s syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med. 1986;104:323\u201330.", "journal-title": "Ann Intern Med"}, {"key": "19_CR50", "doi-asserted-by": "publisher", "first-page": "2518", "DOI": "10.1093/brain/awh605", "volume": "128", "author": "K Mori", "year": "2005", "unstructured": "Mori K, Lijima M, Koike H, et al. The wide spectrum of clinical manifestations in Sjogren\u2019s syndrome-associated neuropathy. Brain. 2005;128:2518\u201334.", "journal-title": "Brain"}, {"key": "19_CR51", "doi-asserted-by": "publisher", "first-page": "1034", "DOI": "10.1212/WNL.11.12.1034", "volume": "11", "author": "W Attwood", "year": "1961", "unstructured": "Attwood W, Poser CM. Neurologic complications of Sjogren\u2019s syndrome. Neurology. 1961;11:1034\u201341.", "journal-title": "Neurology"}, {"key": "19_CR52", "doi-asserted-by": "publisher", "first-page": "1207", "DOI": "10.1007/s10067-018-4000-y", "volume": "37", "author": "H Yang", "year": "2018", "unstructured": "Yang H, Sun Y, Zhao L, Zhang X, Zhang F. Cerebellar involvement in patients with primary Sjogren\u2019s syndrome: diagnosis and treatment. Clin Rheumatol. 2018;37:1207\u201313.", "journal-title": "Clin Rheumatol"}, {"key": "19_CR53", "doi-asserted-by": "publisher", "first-page": "899", "DOI": "10.1212/WNL.44.5.899", "volume": "44", "author": "EL Alexander", "year": "1994", "unstructured": "Alexander EL, Ranzenbach MR, Kumar AJ, et al. Anti-Ro autoantibodies in central nervous system disease associated with Sjogren\u2019s syndrome: clinical, neuroimaging and angiographic correlates. Neurology. 1994;44:899\u2013908.", "journal-title": "Neurology"}, {"issue": "21", "key": "19_CR54", "first-page": "7401", "volume": "22", "author": "S Casciato", "year": "2018", "unstructured": "Casciato S, Mascia A, Quarato PP, D\u2019Aniello A, Scoppetta C, Di Gennaro G. Subacute cerebellar ataxia as presenting symptom of systemic lupus erythematosus. Eur Rev Med Pharmacol Sci. 2018;22(21):7401\u20133.", "journal-title": "Eur Rev Med Pharmacol Sci"}, {"issue": "2", "key": "19_CR55", "doi-asserted-by": "publisher", "first-page": "157", "DOI": "10.1016/0303-8467(96)00013-3", "volume": "98", "author": "MU Manto", "year": "1996", "unstructured": "Manto MU, Rondeaux P, Jacquy J, Hildebrand JG. Subacute pancerebellar syndrome associated with systemic lupus erythematosus. Clin Neurol Neurosurg. 1996;98(2):157\u201360.", "journal-title": "Clin Neurol Neurosurg"}, {"issue": "12", "key": "19_CR56", "doi-asserted-by": "publisher", "first-page": "1312", "DOI": "10.1177/0961203311403346", "volume": "20", "author": "P Chattopadhyay", "year": "2011", "unstructured": "Chattopadhyay P, Dhua D, Philips CA, Saha S. Acute cerebellar ataxia in lupus. Lupus. 2011;20(12):1312\u20135.", "journal-title": "Lupus"}, {"key": "19_CR57", "doi-asserted-by": "publisher", "first-page": "387", "DOI": "10.1007/s12311-018-0925-6", "volume": "17", "author": "H Mitoma", "year": "2018", "unstructured": "Mitoma H, Manto M, Hampe CS. Time is cerebellum. Cerebellum. 2018;17:387\u201391.", "journal-title": "Cerebellum"}], "container-title": ["Neuroimmune Diseases"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-030-19515-1_19", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 13]], "date-time": "2019-08-13T09:27:15Z", "timestamp": 1565688435000}, "score": 33.558876, "issued": {"date-parts": [[2019]]}, "ISBN": ["9783030195144", "9783030195151"], "references-count": 57, "URL": "http://dx.doi.org/10.1007/978-3-030-19515-1_19", "relation": {"cites": []}, "assertion": [{"value": "14 August 2019", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ChapterHistory", "label": "Chapter History"}}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T13:28:46Z", "timestamp": 1574515726252}, "reference-count": 18, "publisher": "Societas Neurologica Japonica", "issue": "7", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Rinsho Shinkeigaku"], "published-print": {"date-parts": [[2009]]}, "DOI": "10.5692/clinicalneurol.49.401", "type": "journal-article", "created": {"date-parts": [[2011, 6, 3]], "date-time": "2011-06-03T14:51:22Z", "timestamp": 1307112682000}, "page": "401-406", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Elemental deficits underlying cerebellar ataxia"], "prefix": "10.5692", "volume": "49", "author": [{"given": "Hiroshi", "family": "Mitoma", "sequence": "first", "affiliation": []}], "member": "3663", "container-title": ["Rinsho Shinkeigaku"], "original-title": ["\u5c0f\u8133\u75c7\u5019\u306e\u75c5\u614b\u751f\u7406"], "deposited": {"date-parts": [[2019, 6, 11]], "date-time": "2019-06-11T11:28:03Z", "timestamp": 1560252483000}, "score": 31.411543, "issued": {"date-parts": [[2009]]}, "references-count": 18, "journal-issue": {"published-print": {"date-parts": [[2009]]}, "issue": "7"}, "URL": "http://dx.doi.org/10.5692/clinicalneurol.49.401", "ISSN": ["0009-918X", "1882-0654"], "issn-type": [{"value": "0009-918X", "type": "print"}, {"value": "1882-0654", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T09:57:17Z", "timestamp": 1575367037750}, "reference-count": 26, "publisher": "Bentham Science Publishers Ltd.", "issue": "1", "license": [{"URL": "https://creativecommons.org/licenses/by/4.0/legalcode", "start": {"date-parts": [[2018, 12, 5]], "date-time": "2018-12-05T00:00:00Z", "timestamp": 1543968000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": ["eurekaselect.com"], "crossmark-restriction": true}, "short-container-title": ["CN"], "published-print": {"date-parts": [[2018, 12, 5]]}, "abstract": "<jats:sec>\n<jats:title />\n<jats:p> Major advances in our understanding of the neurology/pathology, anatomy/physiology, and molecular biology\nof the cerebellum have opened a new door for cerebellar ataxias (CAs). We have now entered in the \u2018era of therapies\u2019.\nCures are knocking at the door. We discuss the hot topics in the therapeutic protocols available for CAs, including aminopyridines,\nnoninvasive cerebellar stimulation, anti-oxidant drugs and therapies for immune-mediated cerbellar ataxias\n(IMCAs), topics emphasized in this issue. The history of the cerebellum is a typical example of the importance of apparently\ndivergent and multi-disciplinary approaches.</jats:p>\n</jats:sec>", "DOI": "10.2174/1570159x1701181129111212", "type": "journal-article", "created": {"date-parts": [[2018, 12, 13]], "date-time": "2018-12-13T10:34:42Z", "timestamp": 1544697282000}, "page": "3-6", "update-policy": "http://dx.doi.org/10.2174/bsp_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The Era of Cerebellar Therapy"], "prefix": "10.2174", "volume": "17", "author": [{"given": "Hiroshi", "family": "Mitoma", "sequence": "first", "affiliation": [{"name": "Medical Education Promotion Center, Tokyo Medical University, Tokyo, Japan"}]}, {"given": "Mario", "family": "Manto", "sequence": "additional", "affiliation": [{"name": "Service de Neurologie, CHUCharleroi, Charleroi, Belgium"}]}], "member": "965", "reference": [{"key": "ref=1", "doi-asserted-by": "crossref", "first-page": "505", "DOI": "10.1007/s12311-008-0063-7", "volume": "7", "author": "Manto M.", "year": "2008", "unstructured": "Manto M. Cerebellum, The cerebellum, cerebellar disorders, and cerebellar research-two centuries of discoveries.,, 2008, 7,, 505-516,[http://dx.doi.org/10.1007/s12311-008-0063-]. [PMID: 188550].", "journal-title": "Cerebellum"}, {"key": "ref=2", "doi-asserted-by": "crossref", "first-page": "369", "DOI": "10.1007/s12311-015-0687-3", "volume": "15", "author": "Bodranghien F.", "year": "2016", "unstructured": "Bodranghien F, Bastian A, Casali C, Hallett M, Louis ED, Manto M, Mari\u00ebn P, Nowak DA, Schmahmann JD, Serrao M, Steiner KM, Strupp M, Tilikete C, Timmann D, van Dun K. Cerebellum, Consensus paper: Revisiting the symptoms and signs of cerebellar syndrome.,, 2016, 15,, 369-391,[http://dx.doi.org/ 10.1007/s12311-015-0687-]. [PMID: 261050].", "journal-title": "Cerebellum"}, {"key": "ref=3", "first-page": "1013", "volume": "10", "author": "Babinski J.", "year": "1902", "unstructured": "Babinski J. Rev Neurol (Paris), Sur le r\u00f4le du cervelet dans les actes volitionnels n\u00e9cessitant une succession rapide de mouvements (diadococin\u00e9sie).,, 1902, 10,, 1013-1015,", "journal-title": "Rev Neurol (Paris)"}, {"key": "ref=4", "doi-asserted-by": "crossref", "first-page": "461", "DOI": "10.1093/brain/40.4.461", "volume": "40", "author": "Holmes G.", "year": "1917", "unstructured": "Holmes G. Brain, The symptoms of acute cerebellar injuries due to gunshot injuries.,, 1917, 40,, 461-535,[http://dx.doi.org/10.1093/ brain/40.4.].", "journal-title": "Brain"}, {"key": "ref=5", "author": "Eccles J.C.", "unstructured": "Eccles JC, Ito M, Szent\u00e1gothai J, , Springer-Verlag,, New York, [http://dx.doi.org/10. 1007/978-3-662-13147-], The cerebellum as a neuronal machine., 1967,-", "journal-title": "The cerebellum as a neuronal machine"}, {"key": "ref=6", "doi-asserted-by": "crossref", "first-page": "797", "DOI": "10.1016/j.neuroscience.2009.04.045", "volume": "162", "author": "Llin\u00e1s R.R.", "year": "2009", "unstructured": "Llin\u00e1s RR. Neuroscience, Inferior olive oscillation as the temporal basis for motricity and oscillatory reset as the basis for motor error correction.,, 2009, 162,, 797-804,[http://dx.doi.org/10. 1016/j.neuroscience.2009.04.0]. [PMID: 19393].", "journal-title": "Neuroscience"}, {"key": "ref=7", "doi-asserted-by": "crossref", "first-page": "272", "DOI": "10.1016/j.pneurobio.2006.02.006", "volume": "78", "author": "Ito M.", "year": "2006", "unstructured": "Ito M. Prog Neurobiol, Cerebellar circuitry as a neuronal machine.,, 2006, 78,, 272-303,[http://dx.doi.org/10.1016/j.pneurobio. 2006.02.00]. [PMID: 167597].", "journal-title": "Prog Neurobiol"}, {"key": "ref=8", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1080/14734220701496448", "volume": "6", "author": "Timmann D.", "year": "2007", "unstructured": "Timmann D, Daum I. Cerebellum, Cerebellar contributions to cognitive functions: a progress report after two decades of research.,, 2007, 6,, 159-162,[http://dx.doi.org/10.1080/14734220701496]. [PMID: 177868].", "journal-title": "Cerebellum"}, {"key": "ref=9", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1007/s12311-013-0511-x", "volume": "13", "author": "Koziol L.F.", "year": "2014", "unstructured": "Koziol LF, Budding D, Andreasen N, D\u2019Arrigo S, Bulgheroni S, Imamizu H, Ito M, Manto M, Marvel C, Parker K, Pezzulo G, Ramnani N, Riva D, Schmahmann J, Vandervert L, Yamazaki T. Cerebellum, Consensus paper: the cerebellum\u2019s role in movement and cognition.,, 2014, 13,, 151-177,[http://dx.doi.org/10.1007/s12311-013-0511-x]. [PMID: 239966].", "journal-title": "Cerebellum"}, {"key": "ref=10", "first-page": "386", "volume": "13", "author": "Mari\u00ebn P.", "year": "2014", "unstructured": "Mari\u00ebn P, Ackermann H, Adamaszek M, Barwood CH, Beaton A, Desmond J, De Witte E, Fawcett AJ, Hertrich I, K\u00fcper M, Leggio M, Marvel C, Molinari M, Murdoch BE, Nicolson RI, Schmahmann JD, Stoodley CJ, Th\u00fcrling M, Timmann D, Wouters E, Ziegler W. Cerebellum, Consensus paper: Language and the cerebellum: an ongoing enigma.,, 2014, 13,, 386-410,[PMID: 24318].", "journal-title": "Cerebellum"}, {"key": "ref=11", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1186/s40673-015-0023-1", "volume": "2", "author": "Manto M.", "year": "2015", "unstructured": "Manto M, Mari\u00ebn P. Cerebellum Ataxias, Schmahmann\u2019s syndrome - identification of the third cornerstone of clinical ataxiology.,, 2015, 2,, 2-,[http://dx.doi.org/10.1186/s40673-015-0023-]. [PMID: 263310].", "journal-title": "Cerebellum Ataxias"}, {"key": "ref=12", "doi-asserted-by": "crossref", "first-page": "248", "DOI": "10.1093/brain/awx317", "volume": "141", "author": "Hoche F.", "year": "2018", "unstructured": "Hoche F, Guell X, Vangel MG, Sherman JC, Schmahmann JD. Brain, The cerebellar cognitive affective/Schmahmann syndrome scale.,, 2018, 141,, 248-270,[http://dx.doi.org/10.1093/ brain/awx]. [PMID: 292068].", "journal-title": "Brain"}, {"key": "ref=13", "doi-asserted-by": "crossref", "first-page": "338", "DOI": "10.1038/s41583-018-0002-7", "volume": "19", "author": "Bostan A.C.", "year": "2018", "unstructured": "Bostan AC, Strick PL. Nat Rev Neurosci, The basal ganglia and the cerebellum: nodes in an integrated network.,, 2018, 19,, 338-350,[http://dx.doi.org/10.1038/s41583-018-0002-]. [PMID: 29643].", "journal-title": "Nat Rev Neurosci"}, {"key": "ref=14", "doi-asserted-by": "crossref", "first-page": "248", "DOI": "10.1007/s12311-013-0531-6", "volume": "13", "author": "Ilg W.", "year": "2014", "unstructured": "Ilg W, Bastian AJ, Boesch S, Burciu RG, Celnik P, Claa\u00dfen J, Feil K, Kalla R, Miyai I, Nachbauer W, Sch\u00f6ls L, Strupp M, Synofzik M, Teufel J, Timmann D. Cerebellum, Consensus paper: management of degenerative cerebellar disorders.,, 2014, 13,, 248-268,[http://dx.doi.org/10.1007/s12311-013-0531-]. [PMID: 242226].", "journal-title": "Cerebellum"}, {"key": "ref=15", "doi-asserted-by": "crossref", "first-page": "48", "DOI": "10.1007/s12311-015-0697-1", "volume": "15", "author": "Cendelin J.", "year": "2016", "unstructured": "Cendelin J. Cerebellum, Transplantation and stem cell therapy for cerebellar degenerations.,, 2016, 15,, 48-50,[http://dx.doi.org/ 10.1007/s12311-015-0697-]. [PMID: 261557].", "journal-title": "Cerebellum"}, {"key": "ref=16", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1212/WNL.0b013e318225ab07", "volume": "77", "author": "Strupp M.", "year": "2011", "unstructured": "Strupp M, Kalla R, Claassen J, Adrion C, Mansmann U, Klopstock T, Freilinger T, Neugebauer H, Spiegel R, Dichgans M, Lehmann-Horn F, Jurkat-Rott K, Brandt T, Jen JC, Jahn K. Neurology, A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.,, 2011, 77,, 269-275,[http://dx.doi.org/10.1212/WNL.0b013e318225ab0]. [PMID: 21734].", "journal-title": "Neurology"}, {"key": "ref=17", "doi-asserted-by": "crossref", "first-page": "2441", "DOI": "10.1093/brain/awm172", "volume": "130", "author": "Kalla R.", "year": "2007", "unstructured": "Kalla R, Glasauer S, B\u00fcttner U, Brandt T, Strupp M. Brain, 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.,, 2007, 130,, 2441-2451,[http://dx.doi.org/10.1093/brain/awm]. [PMID: 17664].", "journal-title": "Brain"}, {"key": "ref=18", "doi-asserted-by": "crossref", "first-page": "7258", "DOI": "10.1523/JNEUROSCI.3582-09.2010", "volume": "30", "author": "Alvi\u00f1a K.", "year": "2010", "unstructured": "Alvi\u00f1a K, Khodakhah K. J Neurosci, The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia.,, 2010, 30,, 7258-7268,[http://dx.doi.org/10.1523/JNEUROSCI.3582-09.20]. [PMID: 205050].", "journal-title": "J Neurosci"}, {"key": "ref=19", "doi-asserted-by": "crossref", "first-page": "1701", "DOI": "10.1002/mds.26356", "volume": "30", "author": "Benussi A.", "year": "2015", "unstructured": "Benussi A, Koch G, Cotelli M, Padovani A, Borroni B. Mov Disord, Cerebellar transcranial direct current stimulation in patients with ataxia: A double-blind, randomized, sham-controlled study.,, 2015, 30,, 1701-1705,[http://dx.doi.org/10.1002/mds.26]. [PMID: 262748].", "journal-title": "Mov Disord"}, {"key": "ref=20", "doi-asserted-by": "crossref", "first-page": "396", "DOI": "10.1177/1756285616648940", "volume": "9", "author": "Mitoma H.", "year": "2016", "unstructured": "Mitoma H, Manto M. Ther Adv Neurol Disorder, The physiological basis of therapies for cerebellar ataxias.,, 2016, 9,, 396-413,[http://dx.doi.org/10.1177/17562856166489]. [PMID: 275828].", "journal-title": "Ther Adv Neurol Disorder"}, {"key": "ref=21", "doi-asserted-by": "crossref", "first-page": "1075", "DOI": "10.1111/ejn.13211", "volume": "43", "author": "Panyakaew P.", "year": "2016", "unstructured": "Panyakaew P, Cho HJ, Srivanitchapoom P, Popa T, Wu T, Hallett M. Eur J Neurosci, Cerebellar brain inhibition in the target and surround muscles during voluntary tonic activation.,, 2016, 43,, 1075-1081,[http://dx.doi.org/10.1111/ejn.13]. [PMID: 269008].", "journal-title": "Eur J Neurosci"}, {"key": "ref=22", "doi-asserted-by": "crossref", "first-page": "425", "DOI": "10.1093/hmg/8.3.425", "volume": "8", "author": "Wong A.", "year": "1999", "unstructured": "Wong A, Yang J, Cavadini P, Gellera C, Lonnerdal B, Taroni F, Cortopassi G. Hum Mol Genet, The Friedreich\u2019s ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis.,, 1999, 8,, 425-430,[http://dx.doi.org/10.1093/hmg/8.3.]. [PMID: 9949].", "journal-title": "Hum Mol Genet"}, {"key": "ref=23", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1007/s12311-015-0664-x", "volume": "15", "author": "Mitoma H.", "year": "2016", "unstructured": "Mitoma H, Adhikari K, Aeschlimann D, Chattopadhyay P, Hadjivassiliou M, Hampe CS, Honnorat J, Joubert B, Kakei S, Lee J, Manto M, Matsunaga A, Mizusawa H, Nanri K, Shanmugarajah P, Yoneda M, Yuki N. Cerebellum, Consensus paper: neuroimmune mechanisms of cerebellar ataxias.,, 2016, 15,, 213-232,[http://dx.doi.org/10.1007/s12311-015-0664-x]. [PMID: 258238].", "journal-title": "Cerebellum"}, {"key": "ref=24", "doi-asserted-by": "crossref", "first-page": "929", "DOI": "10.1007/s12311-017-0867-4", "volume": "16", "author": "Neureither F.", "year": "2017", "unstructured": "Neureither F, Ziegler K, Pitzer C, Frings S, M\u00f6hrlen F. Cerebellum, Impaired motor coordination and learning in mice lacking anoctamin 2 calcium-gated chloride channels.,, 2017, 16,, 929-937,[http://dx.doi.org/10.1007/s12311-017-0867-]. [PMID: 285368].", "journal-title": "Cerebellum"}, {"key": "ref=25", "doi-asserted-by": "crossref", "first-page": "945", "DOI": "10.1007/s12311-017-0871-8", "volume": "16", "author": "Grothe M.", "year": "2017", "unstructured": "Grothe M, Lotze M, Langner S, Dressel A. Cerebellum, Impairments in walking ability, dexterity, and cognitive function in multiple sclerosis are associated with different regional cerebellar gray matter loss.,, 2017, 16,, 945-950,[http://dx.doi.org/10. 1007/s12311-017-0871-]. [PMID: 28612].", "journal-title": "Cerebellum"}, {"key": "ref=26", "doi-asserted-by": "crossref", "first-page": "951", "DOI": "10.1007/s12311-017-0872-7", "volume": "16", "author": "He N.", "year": "2017", "unstructured": "He N, Langley J, Huddleston DE, Ling H, Xu H, Liu C, Yan F, Hu XP. Cerebellum, Improved neuroimaging atlas of the dentate nucleus.,, 2017, 16,, 951-956,[http://dx.doi.org/10. 1007/s12311-017-0872-]. [PMID: 286690].", "journal-title": "Cerebellum"}], "container-title": ["Current Neuropharmacology"], "language": "en", "link": [{"URL": "http://eurekaselect.com/article/download/167853", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 7, 17]], "date-time": "2019-07-17T18:22:58Z", "timestamp": 1563387778000}, "score": 31.38538, "issued": {"date-parts": [[2018, 12, 5]]}, "references-count": 26, "journal-issue": {"published-print": {"date-parts": [[2018, 12, 5]]}, "issue": "1"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/1570159x1701181129111212", "relation": {"cites": []}, "ISSN": ["1570-159X"], "issn-type": [{"value": "1570-159X", "type": "print"}], "subject": ["Pharmacology (medical)", "Pharmacology", "Neurology", "Psychiatry and Mental health", "Clinical Neurology", "General Medicine"], "assertion": [{"value": "Peer Reviewed", "order": 0, "name": "review_status", "label": "Review Status", "group": {"name": "peer_review_details", "label": "Peer Review Details"}}, {"value": "Single blind", "order": 1, "name": "review_process", "label": "Review Process", "group": {"name": "peer_review_details", "label": "Peer Review Details"}}, {"value": "Checked with iThenticate", "order": 0, "name": "screening_status", "label": "Screening Status", "group": {"name": "plagiarism_screening", "label": "Plagiarism Screening"}}, {"order": 0, "name": "received", "label": "Received", "group": {"name": "publication_history", "label": "Publication History"}}, {"order": 1, "name": "revised", "label": "Revised", "group": {"name": "publication_history", "label": "Publication History"}}, {"order": 2, "name": "accepted", "label": "Accepted", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2018-12-05", "order": 3, "name": "published", "label": "Published", "group": {"name": "publication_history", "label": "Publication History"}}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T14:19:21Z", "timestamp": 1574173161136}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1994, 1, 1]], "date-time": "1994-01-01T00:00:00Z", "timestamp": 757382400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuroscience Research Supplements"], "published-print": {"date-parts": [[1994, 1]]}, "DOI": "10.1016/0921-8696(94)92444-9", "type": "journal-article", "created": {"date-parts": [[2003, 9, 17]], "date-time": "2003-09-17T01:25:44Z", "timestamp": 1063761944000}, "page": "S65", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Long-lasting enhancement by serotonin and noradrenaline of GABA-mediated inhibitory transmission in rat cerebellar purkinje cells"], "prefix": "10.1016", "volume": "19", "author": [{"given": "Hiroshi", "family": "Mitoma", "sequence": "first", "affiliation": []}, {"given": "Takayoshi", "family": "Kobayashi", "sequence": "additional", "affiliation": []}, {"given": "Shiro", "family": "Konishi", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuroscience Research Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0921869694924449?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0921869694924449?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 24]], "date-time": "2019-02-24T06:52:10Z", "timestamp": 1550991130000}, "score": 30.827662, "issued": {"date-parts": [[1994, 1]]}, "references-count": 0, "alternative-id": ["0921869694924449"], "URL": "http://dx.doi.org/10.1016/0921-8696(94)92444-9", "ISSN": ["0921-8696"], "issn-type": [{"value": "0921-8696", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T21:40:50Z", "timestamp": 1575322850737}, "reference-count": 0, "publisher": "Bentham Science Publishers Ltd.", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CNSNDDT"], "published-print": {"date-parts": [[2018, 6, 19]]}, "DOI": "10.2174/187152731703180619151532", "type": "journal-article", "created": {"date-parts": [[2018, 6, 20]], "date-time": "2018-06-20T06:30:08Z", "timestamp": 1529476208000}, "page": "157-160", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Editorial: Advances in Therapies of Cerebellar Disorders"], "prefix": "10.2174", "volume": "17", "author": [{"given": "Hiroshi", "family": "Mitoma", "sequence": "first", "affiliation": [{"name": "Medical Education Promotion Center, Tokyo Medical University, Tokyo, Japan"}]}, {"given": "Mario", "family": "Manto", "sequence": "additional", "affiliation": [{"name": "Service de Neurologie, CHU-Charleroi, 6000 Charleroi, Belgium, and Service des Neurosciences, University of Mons, 7000 Mons, Belgium"}]}], "member": "965", "container-title": ["CNS & Neurological Disorders - Drug Targets"], "language": "en", "link": [{"URL": "http://eurekaselect.com/article/download/163110", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 6, 20]], "date-time": "2018-06-20T06:30:15Z", "timestamp": 1529476215000}, "score": 30.411442, "issued": {"date-parts": [[2018, 6, 19]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2018, 6, 19]]}, "issue": "3"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/187152731703180619151532", "ISSN": ["1871-5273"], "issn-type": [{"value": "1871-5273", "type": "print"}], "subject": ["General Neuroscience", "Pharmacology"]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T19:15:44Z", "timestamp": 1575314144819}, "reference-count": 59, "publisher": "Elsevier", "isbn-type": [{"value": "9780444641892", "type": "print"}], "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2018, 1, 1]], "date-time": "2018-01-01T00:00:00Z", "timestamp": 1514764800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018]]}, "DOI": "10.1016/b978-0-444-64189-2.00008-1", "type": "book-chapter", "created": {"date-parts": [[2018, 6, 12]], "date-time": "2018-06-12T16:40:17Z", "timestamp": 1528821617000}, "page": "117-127", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Metabolic ataxias"], "prefix": "10.1016", "author": [{"given": "Fatima Y.", "family": "Ismail", "sequence": "first", "affiliation": []}, {"given": "Hiroshi", "family": "Mitoma", "sequence": "additional", "affiliation": []}, {"given": "Ali", "family": "Fatemi", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["The Cerebellum: Disorders and Treatment", "Handbook of Clinical Neurology"], "link": [{"URL": "https://api.elsevier.com/content/article/PII:B9780444641892000081?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:B9780444641892000081?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 8, 21]], "date-time": "2018-08-21T07:02:14Z", "timestamp": 1534834934000}, "score": 30.284565, "issued": {"date-parts": [[2018]]}, "ISBN": ["9780444641892"], "references-count": 59, "URL": "http://dx.doi.org/10.1016/b978-0-444-64189-2.00008-1", "ISSN": ["0072-9752"], "issn-type": [{"value": "0072-9752", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T16:54:59Z", "timestamp": 1574528099435}, "reference-count": 0, "publisher": "Japan Society for Clinical Immunology", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Jpn.J.clin.Immun"], "published-print": {"date-parts": [[2003]]}, "DOI": "10.2177/jsci.26.198", "type": "journal-article", "created": {"date-parts": [[2011, 7, 20]], "date-time": "2011-07-20T08:17:53Z", "timestamp": 1311149873000}, "page": "198-198", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Introduction to Mucosally-Induced Tolerance: from Bench to Bedside"], "prefix": "10.2177", "volume": "26", "author": [{"given": "Hiroshi", "family": "KIYONO", "sequence": "first", "affiliation": []}], "member": "972", "container-title": ["Japanese Journal of Clinical Immunology"], "deposited": {"date-parts": [[2011, 7, 20]], "date-time": "2011-07-20T08:18:11Z", "timestamp": 1311149891000}, "score": 29.776293, "issued": {"date-parts": [[2003]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2003]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.2177/jsci.26.198", "ISSN": ["0911-4300", "1349-7413"], "issn-type": [{"value": "0911-4300", "type": "print"}, {"value": "1349-7413", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T17:27:24Z", "timestamp": 1574098044662}, "reference-count": 46, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1999, 2, 1]], "date-time": "1999-02-01T00:00:00Z", "timestamp": 917827200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuroscience"], "published-print": {"date-parts": [[1999, 2]]}, "DOI": "10.1016/s0306-4522(98)00260-7", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T15:25:37Z", "timestamp": 1027610737000}, "page": "871-883", "source": "Crossref", "is-referenced-by-count": 51, "title": ["Monoaminergic long-term facilitation of GABA-mediated inhibitory transmission at cerebellar synapses"], "prefix": "10.1016", "volume": "88", "author": [{"given": "H", "family": "Mitoma", "sequence": "first", "affiliation": []}, {"given": "S", "family": "Konishi", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuroscience"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0306452298002607?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0306452298002607?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 27]], "date-time": "2019-04-27T06:23:08Z", "timestamp": 1556346188000}, "score": 29.551598, "issued": {"date-parts": [[1999, 2]]}, "references-count": 46, "journal-issue": {"published-print": {"date-parts": [[1999, 2]]}, "issue": "3"}, "alternative-id": ["S0306452298002607"], "URL": "http://dx.doi.org/10.1016/s0306-4522(98)00260-7", "ISSN": ["0306-4522"], "issn-type": [{"value": "0306-4522", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:04:17Z", "timestamp": 1574111057387}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1997, 1, 1]], "date-time": "1997-01-01T00:00:00Z", "timestamp": 852076800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuroscience Research"], "published-print": {"date-parts": [[1997, 1]]}, "DOI": "10.1016/s0168-0102(97)90135-8", "type": "journal-article", "created": {"date-parts": [[2004, 1, 28]], "date-time": "2004-01-28T17:47:27Z", "timestamp": 1075312047000}, "page": "S54", "source": "Crossref", "is-referenced-by-count": 0, "title": ["304 Climbing fiber-stimulation induced inhibition of GABA-operated transmission in the rat cerebellar cortex"], "prefix": "10.1016", "volume": "28", "author": [{"given": "Shiro", "family": "Konishi", "sequence": "first", "affiliation": []}, {"given": "Hiroshi", "family": "Mitoma", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuroscience Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0168010297901358?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0168010297901358?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 15]], "date-time": "2019-02-15T10:24:50Z", "timestamp": 1550226290000}, "score": 29.167826, "issued": {"date-parts": [[1997, 1]]}, "references-count": 0, "alternative-id": ["S0168010297901358"], "URL": "http://dx.doi.org/10.1016/s0168-0102(97)90135-8", "ISSN": ["0168-0102"], "issn-type": [{"value": "0168-0102", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T02:51:36Z", "timestamp": 1574131896844}, "reference-count": 19, "publisher": "Elsevier BV", "issue": "2-3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1996, 10, 1]], "date-time": "1996-10-01T00:00:00Z", "timestamp": 844128000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuroscience Letters"], "published-print": {"date-parts": [[1996, 10]]}, "DOI": "10.1016/0304-3940(96)13090-1", "type": "journal-article", "created": {"date-parts": [[2004, 7, 8]], "date-time": "2004-07-08T15:14:16Z", "timestamp": 1089299656000}, "page": "141-144", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Long-lasting facilitation of inhibitory transmission by monoaminergic and cAMP-dependent mechanism in rat cerebellar GABAergic synapses"], "prefix": "10.1016", "volume": "217", "author": [{"given": "Hiroshi", "family": "Mitoma", "sequence": "first", "affiliation": []}, {"given": "Shiro", "family": "Konishi", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuroscience Letters"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0304394096130901?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0304394096130901?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 6]], "date-time": "2019-02-06T01:54:03Z", "timestamp": 1549418043000}, "score": 29.167826, "issued": {"date-parts": [[1996, 10]]}, "references-count": 19, "journal-issue": {"published-print": {"date-parts": [[1996, 10]]}, "issue": "2-3"}, "alternative-id": ["0304394096130901"], "URL": "http://dx.doi.org/10.1016/0304-3940(96)13090-1", "ISSN": ["0304-3940"], "issn-type": [{"value": "0304-3940", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T11:57:28Z", "timestamp": 1575287848559}, "reference-count": 0, "publisher": "OMICS Publishing Group", "issue": "02", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Brain Disord Ther"], "DOI": "10.4172/2168-975x.1000105", "type": "journal-article", "created": {"date-parts": [[2013, 10, 10]], "date-time": "2013-10-10T16:28:57Z", "timestamp": 1381422537000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Is Anti-Gliadin Antibody Pathogenic in Gluten Ataxia? Analysis using Rat Cerebellar Slices and Patch-Clamp Recording"], "prefix": "10.4172", "volume": "02", "author": [{"given": "Hiroshi Mitoma", "family": "Kazunori Nanri", "sequence": "first", "affiliation": []}], "member": "2674", "published-online": {"date-parts": [[2013]]}, "container-title": ["Brain Disorders & Therapy"], "deposited": {"date-parts": [[2017, 4, 26]], "date-time": "2017-04-26T14:43:10Z", "timestamp": 1493217790000}, "score": 29.167826, "issued": {"date-parts": [[2013]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2013]]}, "issue": "02"}, "URL": "http://dx.doi.org/10.4172/2168-975x.1000105", "ISSN": ["2168-975X"], "issn-type": [{"value": "2168-975X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T11:17:44Z", "timestamp": 1574162264746}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1989, 1, 1]], "date-time": "1989-01-01T00:00:00Z", "timestamp": 599616000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuroscience Research Supplements"], "published-print": {"date-parts": [[1989, 1]]}, "DOI": "10.1016/0921-8696(89)90739-1", "type": "journal-article", "created": {"date-parts": [[2003, 4, 25]], "date-time": "2003-04-25T07:41:48Z", "timestamp": 1051256508000}, "page": "99", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Distribution patterns of axon terminals from the cerebellar nuclei in the cat red nucleus"], "prefix": "10.1016", "volume": "9", "author": [{"given": "Hiroshi", "family": "Mitoma", "sequence": "first", "affiliation": []}, {"given": "Takahiro", "family": "Futami", "sequence": "additional", "affiliation": []}, {"given": "Yoshikazu", "family": "Shinoda", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuroscience Research Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0921869689907391?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0921869689907391?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 22]], "date-time": "2019-03-22T02:55:46Z", "timestamp": 1553223346000}, "score": 28.316647, "issued": {"date-parts": [[1989, 1]]}, "references-count": 0, "alternative-id": ["0921869689907391"], "URL": "http://dx.doi.org/10.1016/0921-8696(89)90739-1", "ISSN": ["0921-8696"], "issn-type": [{"value": "0921-8696", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}